cohortGo,feature,e_nr,ne_nr,e_r,ne_r,events,no_events,responders,non_responders,total_patients,direction,fisher_pval,or,ci_low,ci_high,group,ct,no_dcb,dcb,type,p_bh,p_by,mechanism
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,94,97,14,104,108,201,118,191,309,Non-Response,5.197294556021e-12,0.139778803835776,0.0688431642535295,0.26658978517029,mechanism,309,191,118,combination,4.34985421963806e-08,5.47048755130156e-07,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_purity_tmbPerMb_lt75,179,68,63,99,242,167,162,247,409,Non-Response,1.57125564653818e-11,0.242673672171906,0.155104325120691,0.376568394505647,mechanism,409,247,162,combination,6.55084681066192e-08,8.238511940566e-07,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_and_rna_geneset_vhio_tcell_lt75,98,93,18,100,116,193,118,191,309,Non-Response,7.57879459683524e-11,0.171796064169733,0.0905418867700695,0.312220896034511,mechanism,309,191,118,combination,1.81601734909989e-07,2.2838697113912e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,94,97,17,101,111,198,118,191,309,Non-Response,2.44604269439144e-10,0.174665909726111,0.0907747518713781,0.320713102091078,mechanism,309,191,118,combination,3.5510861609166e-07,4.46593647878846e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_vhio_tcell_lt75,80,111,11,107,91,218,118,191,309,Non-Response,2.76812989262618e-10,0.143464302450849,0.0652029415741119,0.289622453782003,mechanism,309,191,118,combination,3.84694345539514e-07,4.83801415419646e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,148,43,49,69,197,112,118,191,309,Non-Response,2.75482578260868e-10,0.207526538802588,0.12139629675385,0.350272309595331,mechanism,309,191,118,combination,3.84694345539514e-07,4.83801415419646e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,145,46,47,71,192,117,118,191,309,Non-Response,3.95998607715007e-10,0.21120717790254,0.124044912875111,0.355119292860084,mechanism,309,191,118,combination,4.59918440123177e-07,5.78405154349567e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_gene_set_t_cell_gep_10_lt75,78,113,11,107,89,220,118,191,309,Non-Response,5.87778075419204e-10,0.149771496147444,0.0680432784028036,0.302543455337838,mechanism,309,191,118,combination,5.97322121918823e-07,7.51207527213601e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,148,43,50,68,198,111,118,191,309,Non-Response,6.16291952045353e-10,0.214843446416107,0.125792221196652,0.362381156510261,mechanism,309,191,118,combination,6.07320235264669e-07,7.63781409425106e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,61,130,5,113,66,243,118,191,309,Non-Response,6.15813473863478e-10,0.0948666597014471,0.0287321612853469,0.245338799283105,mechanism,309,191,118,combination,6.07320235264669e-07,7.63781409425106e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,147,44,49,69,196,113,118,191,309,Non-Response,6.47934796374072e-10,0.213768642745054,0.125319390480934,0.360146830598557,mechanism,309,191,118,combination,6.16098842227084e-07,7.74821609321658e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_gene_set_t_cell_effector_lt75,75,116,10,108,85,224,118,191,309,Non-Response,7.48681970524488e-10,0.144017304866568,0.0630712536314004,0.298234894055167,mechanism,309,191,118,combination,6.76301061351893e-07,8.50533454743088e-06,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,141,47,46,70,187,117,116,188,304,Non-Response,9.45791882229551e-10,0.22027974533217,0.129180204013014,0.371057276270295,mechanism,304,188,116,combination,8.05957949217022e-07,1.01359326208204e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,136,55,42,76,178,131,118,191,309,Non-Response,9.7395041476351e-10,0.224695922388894,0.13282060494624,0.375373956070942,mechanism,309,191,118,combination,8.07888761396374e-07,1.01602150069825e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,171,20,70,48,241,68,118,191,309,Non-Response,9.63309349517028e-10,0.1716791613131,0.0895797210419909,0.319085842289053,mechanism,309,191,118,combination,8.07888761396374e-07,1.01602150069825e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_vhio_tcell_lt75,77,111,11,105,88,216,116,188,304,Non-Response,1.00091165834403e-09,0.151879705382664,0.0689074492450461,0.307344567638208,mechanism,304,188,116,combination,8.1782027046946e-07,1.02851161967849e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75,123,124,33,129,156,253,162,247,409,Non-Response,1.20627855887872e-09,0.258766526252483,0.158199073280747,0.415462032334596,mechanism,409,247,162,univariate,8.9517131417349e-07,1.12579026404149e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_gene_set_t_cell_effector_lt75,74,114,10,106,84,220,116,188,304,Non-Response,1.28428730451074e-09,0.146162565309562,0.0639183055966995,0.303205807074806,mechanism,304,188,116,combination,9.19923115149063e-07,1.15691875991105e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,159,29,60,56,219,85,116,188,304,Non-Response,1.35849868316397e-09,0.196621439656691,0.109832104163942,0.345844545417149,mechanism,304,188,116,combination,9.60387690804762e-07,1.20780804176188e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_vhio_tcell_lt75,74,117,10,108,84,225,118,191,309,Non-Response,1.41613638087774e-09,0.147211011130834,0.0644468321439945,0.304964816477666,mechanism,309,191,118,combination,9.88244391665059e-07,1.24284133887529e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,121,70,33,85,154,155,118,191,309,Non-Response,1.54978430926529e-09,0.225782604241104,0.131916917486756,0.379924202983766,mechanism,309,191,118,combination,1.04996595465799e-06,1.32046394987575e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,95,96,19,99,114,195,118,191,309,Non-Response,1.57149168517397e-09,0.19496519657423,0.104059115989059,0.35108606864632,mechanism,309,191,118,combination,1.05587357448726e-06,1.32789352316765e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_gene_set_t_cell_effector_lt75,71,120,9,109,80,229,118,191,309,Non-Response,1.72763159508874e-09,0.140314477504454,0.0588029243829859,0.299305285913139,mechanism,309,191,118,combination,1.10088814851563e-06,1.38450499895863e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,159,32,60,58,219,90,118,191,309,Non-Response,1.83265937847681e-09,0.2094029146487,0.118970569660515,0.362959916532809,mechanism,309,191,118,combination,1.15052799081688e-06,1.44693333003501e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,144,47,48,70,192,117,118,191,309,Non-Response,1.94250204101554e-09,0.225028484939523,0.13259068315637,0.377413771949643,mechanism,309,191,118,combination,1.2101415588699e-06,1.52190487286291e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_APM_lt75,163,25,64,52,227,77,116,188,304,Non-Response,2.03328690114373e-09,0.189953478036403,0.103514294023156,0.341185686281257,mechanism,304,188,116,combination,1.25230448315215e-06,1.5749300412401e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50_and_rna_geneset_vhio_tcell_lt75,62,129,6,112,68,241,118,191,309,Non-Response,2.31735604598724e-09,0.112113097973752,0.0381449056434162,0.271746746011331,mechanism,309,191,118,combination,1.38528477340233e-06,1.74216944413728e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,143,48,48,70,191,118,118,191,309,Non-Response,2.46590748630158e-09,0.231394838219857,0.136592648131439,0.387509504202471,mechanism,309,191,118,combination,1.40793196218874e-06,1.77065112606783e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,143,48,48,70,191,118,118,191,309,Non-Response,2.46590748630158e-09,0.231394838219857,0.136592648131439,0.387509504202471,mechanism,309,191,118,combination,1.40793196218874e-06,1.77065112606783e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75_or_rna_geneset_vhio_tcell_lt75,143,48,48,70,191,118,118,191,309,Non-Response,2.46590748630158e-09,0.231394838219857,0.136592648131439,0.387509504202471,mechanism,309,191,118,combination,1.40793196218874e-06,1.77065112606783e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75_or_rna_geneset_vhio_tcell_lt75,143,48,48,70,191,118,118,191,309,Non-Response,2.46590748630158e-09,0.231394838219857,0.136592648131439,0.387509504202471,mechanism,309,191,118,combination,1.40793196218874e-06,1.77065112606783e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_gene_set_t_cell_gep_10_lt75,78,110,12,104,90,214,116,188,304,Non-Response,2.83982314407848e-09,0.163622384780268,0.0765203497463197,0.324308345402322,mechanism,304,188,116,combination,1.50898550189828e-06,1.89773863362159e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_purity_tml_lt75,177,70,68,94,245,164,162,247,409,Non-Response,3.00258578258818e-09,0.287017157612373,0.184459674813625,0.443499969910776,mechanism,409,247,162,combination,1.5799820164313e-06,1.98702566011211e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,70,118,9,107,79,225,116,188,304,Non-Response,3.03367945057522e-09,0.142574245720779,0.0596656008001141,0.304644692123939,mechanism,304,188,116,combination,1.58607784985411e-06,1.99469193561711e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_vhio_tcell_lt75,152,39,55,63,207,102,118,191,309,Non-Response,3.20469733847427e-09,0.225223570522482,0.130987337309704,0.38249943186077,mechanism,309,191,118,combination,1.66478395476434e-06,2.09367473949568e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,145,46,50,68,195,114,118,191,309,Non-Response,4.0177419343451e-09,0.234496623555615,0.138216967165174,0.393391460749721,mechanism,309,191,118,combination,1.98564377823904e-06,2.49719623272338e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_or_rna_geneset_vhio_tcell_lt75,145,46,50,68,195,114,118,191,309,Non-Response,4.0177419343451e-09,0.234496623555615,0.138216967165174,0.393391460749721,mechanism,309,191,118,combination,1.98564377823904e-06,2.49719623272338e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,74,117,11,107,85,224,118,191,309,Non-Response,4.59173566766212e-09,0.163407206600705,0.0741497255410975,0.330632647982095,mechanism,309,191,118,combination,2.20889655648084e-06,2.77796461770776e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_gene_set_t_cell_gep_10_lt75,74,117,11,107,85,224,118,191,309,Non-Response,4.59173566766212e-09,0.163407206600705,0.0741497255410975,0.330632647982095,mechanism,309,191,118,combination,2.20889655648084e-06,2.77796461770776e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,142,49,48,70,190,119,118,191,309,Non-Response,5.10748296792422e-09,0.237850322636286,0.140649947225852,0.397725765009642,mechanism,309,191,118,combination,2.40714932063346e-06,3.02729234768356e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,141,50,47,71,188,121,118,191,309,Non-Response,5.37982762448297e-09,0.235968964978752,0.139588941551137,0.394366226525714,mechanism,309,191,118,combination,2.51364716116575e-06,3.16122674673588e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,138,53,46,72,184,125,118,191,309,Non-Response,8.37002671640958e-09,0.246603575839834,0.146352884683334,0.410884199612481,mechanism,309,191,118,combination,3.66832777367861e-06,4.61338251967266e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,144,47,50,68,194,115,118,191,309,Non-Response,8.34388537988376e-09,0.241228439257596,0.142441105725043,0.404046022603894,mechanism,309,191,118,combination,3.66832777367861e-06,4.61338251967266e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_APM_lt75,159,32,62,56,221,88,118,191,309,Non-Response,1.30883047892943e-08,0.224042199054891,0.12729373285044,0.3886209112401,mechanism,309,191,118,combination,5.45674918494788e-06,6.86254687618385e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,122,69,36,82,158,151,118,191,309,Non-Response,1.37442660910402e-08,0.249512152149158,0.147198690271995,0.41677255117461,mechanism,309,191,118,combination,5.70099535171162e-06,7.16971708172819e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,150,41,55,63,205,104,118,191,309,Non-Response,1.52647144250862e-08,0.239864971577993,0.1402512492926,0.405531681436918,mechanism,309,191,118,combination,6.15883879923118e-06,7.7455126724846e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,143,48,50,68,193,116,118,191,309,Non-Response,1.77112947766224e-08,0.248053816806285,0.146732833402343,0.41482366021378,mechanism,309,191,118,combination,6.95608963306582e-06,8.74815564430357e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_purity_tmbPerMb_lt75,134,86,40,93,174,179,133,220,353,Non-Response,1.79471307597157e-08,0.277101488107516,0.169512437041481,0.447303367082493,mechanism,353,220,133,combination,6.98126212265132e-06,8.77981320889299e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,157,34,61,57,218,91,118,191,309,Non-Response,1.99718049545093e-08,0.232987287777197,0.133448165840465,0.401348290560591,mechanism,309,191,118,combination,7.60509494612015e-06,9.56436127017571e-05,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,122,66,37,79,159,145,116,188,304,Non-Response,2.25270903866187e-08,0.25461530559167,0.150018509180994,0.426107959812222,mechanism,304,188,116,combination,8.30580463193521e-06,0.000104455916332582,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_APM_lt75,166,25,69,49,235,74,118,191,309,Non-Response,2.2675715291656e-08,0.213300258898379,0.116278159577153,0.383246451244361,mechanism,309,191,118,combination,8.34168768097892e-06,0.000104907190704515,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,156,35,60,58,216,93,118,191,309,Non-Response,2.33213040296423e-08,0.233330716180473,0.134136582569399,0.400590542013001,mechanism,309,191,118,combination,8.52134245530737e-06,0.000107166574943321,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75,130,61,42,76,172,137,118,191,309,Non-Response,2.58184724586791e-08,0.260567210842249,0.155069207725323,0.432685167348266,mechanism,409,247,162,univariate,9.30827491094524e-06,0.00011706323810699,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_vhio_tcell_lt75,138,53,47,71,185,124,118,191,309,Non-Response,2.72927547138782e-08,0.255476725822062,0.151839869148267,0.425254332051247,mechanism,309,191,118,combination,9.68940465276674e-06,0.000121856422896155,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,60,131,7,111,67,242,118,191,309,Non-Response,3.02285061204438e-08,0.13843854464421,0.0512801831421213,0.319718239432776,mechanism,309,191,118,combination,1.04778042465256e-05,0.00013177153716283,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt75,150,41,56,62,206,103,118,191,309,Non-Response,3.08046573003096e-08,0.248129923816598,0.14515484206933,0.41945776781029,mechanism,309,191,118,combination,1.05893777330142e-05,0.000133174713770763,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,158,33,62,56,220,89,118,191,309,Non-Response,3.19985215464652e-08,0.232461034023645,0.132618803178973,0.401886295796671,mechanism,309,191,118,combination,1.09304529546474e-05,0.000137464162703506,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,137,54,47,71,184,125,118,191,309,Non-Response,3.43031204354906e-08,0.262168156662524,0.156044835950478,0.43586955593411,mechanism,309,191,118,combination,1.15478649618424e-05,0.000145228893494106,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,125,63,39,77,164,140,116,188,304,Non-Response,3.68564748265079e-08,0.256531017902386,0.15159262648391,0.428478809644651,mechanism,304,188,116,combination,1.23562661728671e-05,0.000155395553198245,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,73,115,12,104,85,219,116,188,304,Non-Response,3.86071151543411e-08,0.182706422794516,0.0853020755803203,0.362863086954396,mechanism,304,188,116,combination,1.2837300020175e-05,0.000161445157485148,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_purity_tml_lt75,110,137,30,132,140,269,162,247,409,Non-Response,4.22672441523552e-08,0.283920613550599,0.170886160697027,0.461816590768356,mechanism,409,247,162,combination,1.3828107373611e-05,0.000173905803334472,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_or_rna_geneset_gene_set_t_cell_effector_lt75,147,44,54,64,201,108,118,191,309,Non-Response,4.38430255206852e-08,0.253801892194998,0.14943387166804,0.426601595770943,mechanism,309,191,118,combination,1.42007734334908e-05,0.000178592546702011,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_APM_lt75,72,119,12,106,84,225,118,191,309,Non-Response,4.47250598849456e-08,0.188034241767195,0.0878829517619078,0.373096252276912,mechanism,309,191,118,combination,1.43719472078506e-05,0.000180745271723271,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,107,84,29,89,136,173,118,191,309,Non-Response,4.92642461131814e-08,0.256971394879105,0.148374429874476,0.43623824336447,mechanism,309,191,118,combination,1.57064076264923e-05,0.00019752778612324,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_APM_lt75,70,118,11,105,81,223,116,188,304,Non-Response,5.03587774792723e-08,0.177509494053533,0.0803328904592023,0.360308803738898,mechanism,304,188,116,combination,1.5992649415185e-05,0.000201127635825412,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,138,53,48,70,186,123,118,191,309,Non-Response,5.42183215743303e-08,0.264602376390917,0.157469936915975,0.440071521104789,mechanism,309,191,118,combination,1.69861091548034e-05,0.000213621638759501,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_vhio_tcell_lt75,138,53,48,70,186,123,118,191,309,Non-Response,5.42183215743303e-08,0.264602376390917,0.157469936915975,0.440071521104789,mechanism,309,191,118,combination,1.69861091548034e-05,0.000213621638759501,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,70,121,11,107,81,228,118,191,309,Non-Response,5.51740393195696e-08,0.178598995908756,0.0809163366847257,0.362046739988841,mechanism,309,191,118,combination,1.7087977991016e-05,0.000214902767211693,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,121,70,37,81,158,151,118,191,309,Non-Response,5.4782248773555e-08,0.265478758038285,0.157210810562906,0.442187814771483,mechanism,309,191,118,combination,1.7087977991016e-05,0.000214902767211693,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,70,121,11,107,81,228,118,191,309,Non-Response,5.51740393195696e-08,0.178598995908756,0.0809163366847257,0.362046739988841,mechanism,309,191,118,combination,1.7087977991016e-05,0.000214902767211693,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,59,132,7,111,66,243,118,191,309,Non-Response,5.684710056927e-08,0.141849703741887,0.0525166606557459,0.327829754784974,mechanism,309,191,118,combination,1.74072031230926e-05,0.000218917423848239,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,122,69,38,80,160,149,118,191,309,Non-Response,6.16645810142807e-08,0.269873747728071,0.16015578909604,0.448798950825141,mechanism,309,191,118,combination,1.87062267607463e-05,0.000235254276257105,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,155,36,61,57,216,93,118,191,309,Non-Response,6.25244178278018e-08,0.24978557067854,0.144115591628562,0.427833881087674,mechanism,309,191,118,combination,1.88965525835779e-05,0.000237647862322107,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_gene_set_t_cell_effector_lt75,167,24,71,47,238,71,118,191,309,Non-Response,6.37136401410256e-08,0.218321085720371,0.117987924496147,0.395397213445485,mechanism,309,191,118,combination,1.92202420401679e-05,0.00024171866344176,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_gene_set_t_cell_effector_lt75,158,30,64,52,222,82,116,188,304,Non-Response,6.42716010473168e-08,0.234915822756718,0.131790565297405,0.412480082662011,mechanism,304,188,116,combination,1.93168831554374e-05,0.000242934046742743,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_vhio_tcell_lt75,136,55,47,71,183,126,118,191,309,Non-Response,6.52982673441682e-08,0.268942980906894,0.160297565540663,0.446646009883736,mechanism,309,191,118,combination,1.94457283399763e-05,0.000244554436628186,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_purity_tml_lt75,129,118,41,121,170,239,162,247,409,Non-Response,7.69422809019431e-08,0.310872359691704,0.195592799803182,0.487747282925226,mechanism,409,247,162,combination,2.21427628143259e-05,0.00027847302969448,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_neo_ct_lt75,172,48,67,66,239,114,133,220,353,Non-Response,9.60621350786302e-08,0.284434104530664,0.172890985829558,0.464093717110437,mechanism,353,220,133,combination,2.68376478342184e-05,0.00033751710050532,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,125,66,40,78,165,144,118,191,309,Non-Response,9.7538453247335e-08,0.272006752972653,0.16191441426485,0.451474507635451,mechanism,309,191,118,combination,2.71567764060106e-05,0.000341530542775114,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt75,156,32,63,53,219,85,116,188,304,Non-Response,1.01256085516378e-07,0.245127064579648,0.1387984077886,0.426882378429847,mechanism,304,188,116,combination,2.7952524605759e-05,0.00035153807498399,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,111,80,32,86,143,166,118,191,309,Non-Response,1.03898641917493e-07,0.269368782445102,0.157511806615367,0.452874671400514,mechanism,309,191,118,combination,2.85849600313038e-05,0.000359491744113464,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75,123,97,36,97,159,194,133,220,353,Non-Response,1.0722477425613e-07,0.293741124318852,0.178064802852519,0.477418285073426,mechanism,409,247,162,univariate,2.92525735645943e-05,0.000367887822093407,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt75,137,54,48,70,185,124,118,191,309,Non-Response,1.08964367548836e-07,0.271522021001182,0.161853089756223,0.451063017178097,mechanism,309,191,118,combination,2.95782775203767e-05,0.000371983958068431,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_vhio_tcell_lt75,124,67,40,78,164,145,118,191,309,Non-Response,1.1502140485884e-07,0.278325793612344,0.16578102393502,0.461668649710536,mechanism,309,191,118,combination,3.09639907073471e-05,0.000389411040348046,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,164,24,70,46,234,70,116,188,304,Non-Response,1.19881321081502e-07,0.223942920303055,0.120665289606934,0.406843872496859,mechanism,304,188,116,combination,3.1954857451164e-05,0.00040187243310594,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_and_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,61,6,17,23,78,29,40,67,107,Non-Response,1.41886658530714e-07,0.0750493622035345,0.0213820563299852,0.226754611223222,mechanism,107,67,40,combination,3.65617859013899e-05,0.000459810339675128,Taxane
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75,132,59,45,73,177,132,118,191,309,Non-Response,1.45374282122775e-07,0.276797084932367,0.165271905808764,0.458686077381587,mechanism,409,247,162,univariate,3.70700786789441e-05,0.000466202759217542,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_vhio_tcell_lt75,132,59,45,73,177,132,118,191,309,Non-Response,1.45374282122775e-07,0.276797084932367,0.165271905808764,0.458686077381587,mechanism,409,247,162,univariate,3.70700786789441e-05,0.000466202759217542,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_vhio_tcell_lt75,157,31,64,52,221,83,116,188,304,Non-Response,1.45889156818666e-07,0.244308851144554,0.137673922211257,0.427293863860465,mechanism,304,188,116,combination,3.70700786789441e-05,0.000466202759217542,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,160,31,66,52,226,83,118,191,309,Non-Response,1.61359491257361e-07,0.247180990622972,0.139658014355859,0.43132281699093,mechanism,309,191,118,combination,4.04263953150453e-05,0.000508412652811506,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75,130,61,44,74,174,135,118,191,309,Non-Response,1.62020152409717e-07,0.28026123023829,0.167432834531068,0.464161056262395,mechanism,409,247,162,univariate,4.04672085123121e-05,0.000508925929984265,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75_and_rna_geneset_KEGG_STEROID_BIOSYNTHESIS_gt25,64,3,21,19,85,22,40,67,107,Non-Response,1.70459444429219e-07,0.0535683064915817,0.00922483359802122,0.207166910268814,mechanism,107,67,40,combination,4.22156580646196e-05,0.000530914877261613,Taxane
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75,131,60,45,73,176,133,118,191,309,Non-Response,1.7339045667475e-07,0.283601833095052,0.169521752980975,0.469554201331271,mechanism,409,247,162,univariate,4.27165779915167e-05,0.000537214573954706,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50_or_rna_geneset_vhio_tcell_lt75,156,35,63,55,219,90,118,191,309,Non-Response,1.78322647109234e-07,0.258274537835826,0.148453175930728,0.443892798193074,mechanism,309,191,118,combination,4.37482174612103e-05,0.000550188734906839,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_vhio_tcell_lt75,128,63,43,75,171,138,118,191,309,Non-Response,1.82577492750835e-07,0.28343986623339,0.169336068723194,0.469287653259612,mechanism,309,191,118,combination,4.46417070169929e-05,0.000561425487325024,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,106,85,30,88,136,173,118,191,309,Non-Response,1.88716434595611e-07,0.274529334909297,0.159323441896454,0.464252698969141,mechanism,309,191,118,combination,4.57301264267916e-05,0.000575113727278027,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_gene_set_t_cell_gep_10_lt75,125,66,41,77,166,143,118,191,309,Non-Response,1.90317076430249e-07,0.282385092763344,0.168425301894415,0.467921861896381,mechanism,309,191,118,combination,4.59809450124898e-05,0.000578268085749404,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_gene_set_t_cell_gep_10_lt75,113,78,34,84,147,162,118,191,309,Non-Response,2.10319625266632e-07,0.28060137967595,0.165208795549869,0.469264615650432,mechanism,309,191,118,combination,4.97780937832661e-05,0.000626021996644148,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_vhio_tcell_lt75,165,26,71,47,236,73,118,191,309,Non-Response,2.28423637499322e-07,0.239285076086715,0.131138250502654,0.428741793176812,mechanism,309,191,118,combination,5.38278646523402e-05,0.000676952947444464,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,35,156,1,117,36,273,118,191,309,Non-Response,2.51450134493715e-07,0.0383188411037146,0.000934824092303003,0.235034316283594,mechanism,309,191,118,combination,5.74231586634959e-05,0.000722168281426237,Anti-PD-1
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_and_rna_geneset_KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM_gt50,26,6,1,16,27,22,17,32,49,Non-Response,3.14017555044041e-07,0.0163287635702596,0.000338801857453216,0.13914620041783,mechanism,49,32,17,combination,6.99322161703848e-05,0.000879485377390077,Anti-EGFR
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_gene_set_t_cell_gep_10_lt75,166,25,72,46,238,71,118,191,309,Non-Response,3.13716523183395e-07,0.236965261899787,0.128865092689898,0.427339807590831,mechanism,309,191,118,combination,6.99322161703848e-05,0.000879485377390077,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_APM_lt75,160,31,67,51,227,82,118,191,309,Non-Response,3.17086452656612e-07,0.255802602250638,0.144416233622698,0.446752860464001,mechanism,309,191,118,combination,7.00511182460052e-05,0.000880980720203104,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_purity_tml_lt75,128,92,40,93,168,185,133,220,353,Non-Response,3.50412793561075e-07,0.310213815680468,0.190145629981889,0.499931070578834,mechanism,353,220,133,combination,7.64784153120049e-05,0.000961812046525102,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_vhio_tcell_lt75,124,67,41,77,165,144,118,191,309,Non-Response,3.58291620739571e-07,0.288946284876929,0.172499965491145,0.478495482135065,mechanism,309,191,118,combination,7.7676667932017e-05,0.000976881576927977,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,65,126,11,107,76,233,118,191,309,Non-Response,3.69559590300328e-07,0.200214080940706,0.0905136095908851,0.407076835644673,mechanism,309,191,118,combination,7.99064498186871e-05,0.00100492388234152,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_gene_set_t_cell_effector_lt75,155,36,63,55,218,91,118,191,309,Non-Response,3.78266795622032e-07,0.267323620271183,0.154198291318651,0.458174402417469,mechanism,309,191,118,combination,8.08218455118938e-05,0.00101643613192817,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_gene_set_t_cell_effector_lt75,114,77,35,83,149,160,118,191,309,Non-Response,3.76548534483123e-07,0.286038085185057,0.168932540998201,0.477251792249076,mechanism,309,191,118,combination,8.08218455118938e-05,0.00101643613192817,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_CD_8_T_effector_lt50,81,110,18,100,99,210,118,191,309,Non-Response,4.11281809494404e-07,0.245523622320984,0.129219808987704,0.447414508520244,mechanism,409,247,162,univariate,8.6177319149705e-05,0.00108378793359247,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_cd8_t_effector_lt50,81,110,18,100,99,210,118,191,309,Non-Response,4.11281809494404e-07,0.245523622320984,0.129219808987704,0.447414508520244,mechanism,409,247,162,univariate,8.6177319149705e-05,0.00108378793359247,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt50,81,110,18,100,99,210,118,191,309,Non-Response,4.11281809494404e-07,0.245523622320984,0.129219808987704,0.447414508520244,mechanism,409,247,162,univariate,8.6177319149705e-05,0.00108378793359247,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,38,153,2,116,40,269,118,191,309,Non-Response,4.43625360877314e-07,0.0697931670911557,0.0079863812796351,0.279714774090507,mechanism,309,191,118,combination,9.20058627907264e-05,0.0011570891842102,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,38,153,2,116,40,269,118,191,309,Non-Response,4.43625360877314e-07,0.0697931670911557,0.0079863812796351,0.279714774090507,mechanism,309,191,118,combination,9.20058627907264e-05,0.0011570891842102,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_purity_tmbPerMb_lt75,103,117,27,106,130,223,133,220,353,Non-Response,4.47063363434593e-07,0.290345734572821,0.168909244871105,0.487590601045623,mechanism,353,220,133,combination,9.24829628088269e-05,0.00116308931565819,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_APM_lt75,67,124,12,106,79,230,118,191,309,Non-Response,4.92750437902921e-07,0.210481499657152,0.0981648742170233,0.418787689009107,mechanism,309,191,118,combination,9.95282431082474e-05,0.00125169255665742,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_gene_set_t_cell_gep_6_lt75,164,27,71,47,235,74,118,191,309,Non-Response,5.07437229305478e-07,0.249956544203919,0.137840481527804,0.445713778907248,mechanism,309,191,118,combination,0.000102114206201253,0.00128421428771807,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_or_cn_simple_chr22_q_gt25,71,2,24,16,95,18,40,73,113,Non-Response,5.09144400807673e-07,0.0436503672450147,0.00456296878908445,0.205972639792129,mechanism,113,73,40,combination,0.000102204767015464,0.00128535320360298,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_CD_8_T_effector_lt75,131,60,46,72,177,132,118,191,309,Non-Response,5.30866730164634e-07,0.293885350829968,0.175933538812048,0.486075187160102,mechanism,409,247,162,univariate,0.000105891583856247,0.00133171955202076,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_cd8_t_effector_lt75,131,60,46,72,177,132,118,191,309,Non-Response,5.30866730164634e-07,0.293885350829968,0.175933538812048,0.486075187160102,mechanism,409,247,162,univariate,0.000105891583856247,0.00133171955202076,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt50,85,106,20,98,105,204,118,191,309,Non-Response,5.73892493576273e-07,0.255603845577738,0.13793578658159,0.457111344869356,mechanism,409,247,162,univariate,0.000113658674385524,0.00142940046247154,Anti-PD-1
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_rna_geneset_gene_set_t_cell_gep_6_lt50,29,22,5,44,34,66,49,51,100,Non-Response,6.79753060369558e-07,0.0885709111522798,0.0234557517381359,0.273447628170233,mechanism,100,51,49,combination,0.000132367051628706,0.00166468178374396,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50,80,111,18,100,98,211,118,191,309,Non-Response,7.10900481579318e-07,0.250833416593161,0.131997088545711,0.457238124403936,mechanism,409,247,162,univariate,0.000135204880038743,0.00170037103723607,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,156,35,65,53,221,88,118,191,309,Non-Response,7.01320120139597e-07,0.276436878093374,0.158820160270299,0.475752651584824,mechanism,309,191,118,combination,0.000135204880038743,0.00170037103723607,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt75,154,37,63,55,217,92,118,191,309,Non-Response,8.15084096398265e-07,0.276489990461247,0.159994186471894,0.472604572043203,mechanism,309,191,118,combination,0.000151637350007054,0.00190702996845482,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_vhio_tcell_lt50,82,109,19,99,101,208,118,191,309,Non-Response,8.52259116116272e-07,0.256205535064004,0.136606683105667,0.462425272051119,mechanism,409,247,162,univariate,0.000157472304275311,0.00198041184075483,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,133,58,48,70,181,128,118,191,309,Non-Response,8.85282503631406e-07,0.300304666716958,0.179865833536911,0.496714473261201,mechanism,309,191,118,combination,0.000162100410501643,0.00203861608443489,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,90,101,23,95,113,196,118,191,309,Non-Response,9.12651608633285e-07,0.2728485922732,0.151606951266435,0.477157622835455,mechanism,309,191,118,combination,0.000166549187722284,0.00209456504082555,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,58,133,9,109,67,242,118,191,309,Non-Response,9.52276638178487e-07,0.190202031516483,0.0791992938972717,0.409208934326509,mechanism,309,191,118,combination,0.000173391127451899,0.00218061101898417,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_cn_simple_chr22_q_gt25,67,6,20,20,87,26,40,73,113,Non-Response,9.74040030396931e-07,0.0919948811542631,0.026436359765222,0.277023318888745,mechanism,113,73,40,combination,0.000177155437206354,0.00222795193803847,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION_lt75,132,59,48,70,180,129,118,191,309,Non-Response,1.02554666539687e-06,0.307761580103827,0.18454490880457,0.508550381840656,mechanism,409,247,162,univariate,0.000185692468485746,0.00233531581963282,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,121,67,41,75,162,142,116,188,304,Non-Response,1.04868601811931e-06,0.303965135572287,0.181046774422891,0.504687471548263,mechanism,304,188,116,combination,0.000189176085916996,0.00237912668047756,Anti-PD-1
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_or_signature_log_SBS1_lt25,33,25,0,21,33,46,21,58,79,Non-Response,1.04943990391721e-06,0,0,0.167738915629617,mechanism,79,58,21,combination,0.000189176085916996,0.00237912668047756,Anti-AR
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,108,83,33,85,141,168,118,191,309,Non-Response,1.19512632036817e-06,0.299582579048129,0.176046944779932,0.501769311991997,mechanism,309,191,118,combination,0.000212377212501884,0.00267090996274434,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,146,45,58,60,204,105,118,191,309,Non-Response,1.22040884550796e-06,0.299233652397062,0.176819910750035,0.501938956792088,mechanism,309,191,118,combination,0.0002166332286702,0.00272443470700313,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_vhio_tcell_lt75,111,80,35,83,146,163,118,191,309,Non-Response,1.29964633680317e-06,0.30515120813754,0.180446957080501,0.50861585435934,mechanism,309,191,118,combination,0.000227961051857089,0.00286689629904328,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,36,152,2,114,38,266,116,188,304,Non-Response,1.40488192884415e-06,0.0744713588613198,0.00850722584845643,0.299695087866132,mechanism,304,188,116,combination,0.00024223859158664,0.00304645427825348,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,168,23,76,42,244,65,118,191,309,Non-Response,1.4178046343118e-06,0.248973320762231,0.132823874948315,0.45703761821029,mechanism,309,191,118,combination,0.000243949415798762,0.00306797003966137,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75,116,131,38,124,154,255,162,247,409,Non-Response,1.43121544554434e-06,0.34697770434001,0.216268859162401,0.548797924392835,mechanism,409,247,162,univariate,0.000244446185939725,0.00307421754758871,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,165,26,73,45,238,71,118,191,309,Non-Response,1.4266403883513e-06,0.256877427614796,0.140543417853091,0.461500998553223,mechanism,309,191,118,combination,0.000244446185939725,0.00307421754758871,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,117,74,39,79,156,153,118,191,309,Non-Response,1.4907640442423e-06,0.313451925924769,0.187080698974518,0.519018510782596,mechanism,309,191,118,combination,0.000251970116492422,0.00316884041618868,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,40,24,4,29,44,53,33,64,97,Non-Response,1.50639107932619e-06,0.0850381833704283,0.0193322883759846,0.28326863631263,mechanism,97,64,33,combination,0.000254347016320125,0.00319873291433135,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,driver_B2M_or_rna_geneset_gene_set_t_cell_gep_6_lt50,28,23,5,44,33,67,49,51,100,Non-Response,1.72972793042585e-06,0.0958208071056004,0.0254010576491968,0.295448855751374,mechanism,100,51,49,combination,0.000288166293064941,0.00362405275974431,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,76,115,17,101,93,216,118,191,309,Non-Response,1.77168643844156e-06,0.255774738814022,0.132566143613958,0.471698793034172,mechanism,309,191,118,combination,0.000292714748465513,0.00368125529433535,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,131,60,48,70,179,130,118,191,309,Non-Response,1.82510417449367e-06,0.315333211731696,0.189294935658667,0.520613546930764,mechanism,309,191,118,combination,0.000298470420294211,0.00375364009046511,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_drivers_total_gt50,57,53,10,54,67,107,64,110,174,Non-Response,1.94337546795353e-06,0.173931635257625,0.0714542887033702,0.389201091088757,mechanism,174,110,64,combination,0.000314416879938615,0.00395418683195868,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_vhio_tcell_lt75,152,39,63,55,215,94,118,191,309,Non-Response,1.95169991398059e-06,0.295183888529455,0.171872235951293,0.502106477624258,mechanism,309,191,118,combination,0.000314823911322833,0.00395930576240536,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_or_cn_simple_chr3_q_gt25,24,0,15,20,39,20,35,24,59,Non-Response,2.0020220400297e-06,0,0,0.156778733929157,mechanism,59,24,35,combination,0.000319768938766944,0.00402149568810844,Aromatase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt75,129,62,47,71,176,133,118,191,309,Non-Response,2.08153524669088e-06,0.319418369547843,0.19188819800354,0.526916890288914,mechanism,409,247,162,univariate,0.000331167776948575,0.00416485038282532,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_gene_set_t_cell_gep_6_lt75,78,113,18,100,96,213,118,191,309,Non-Response,2.18396389128724e-06,0.261860786128455,0.137726846345892,0.477656698705666,mechanism,309,191,118,combination,0.0003451002534456,0.0043400687588612,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,clin_hasRadiotherapyPreTreatment_or_purity_tmbPerMb_lt75,32,5,5,17,37,22,22,37,59,Non-Response,2.38034946268004e-06,0.0496878919834054,0.00921006259357639,0.2125375854375,mechanism,59,37,22,combination,0.000372512090406977,0.00468480700819958,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25,32,2,6,13,38,15,19,34,53,Non-Response,2.49910574938823e-06,0.031986133781461,0.00283737233668841,0.189791337741546,mechanism,53,34,19,combination,0.000387738164731896,0.00487629400027766,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,119,72,41,77,160,149,118,191,309,Non-Response,2.64069386275086e-06,0.323378801692931,0.19372163756573,0.534081346847058,mechanism,309,191,118,combination,0.000405326245765998,0.00509748619084339,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr15_q_gt50_or_cn_simple_chr3_q_gt25,23,1,13,22,36,23,35,24,59,Non-Response,2.67408292953339e-06,0.027357911502439,0.000603145820360282,0.206806479496291,mechanism,59,24,35,combination,0.000409031548613613,0.00514408502399547,Aromatase inhibitor
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,61,20,16,33,77,53,49,81,130,Non-Response,2.72363676359296e-06,0.161612811794529,0.0673522182468663,0.371593345866091,mechanism,130,81,49,combination,0.00041582900515182,0.00522957157019947,Multikinase inhibitor
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt50_or_rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50,38,13,13,36,51,49,49,51,100,Non-Response,2.78795689624546e-06,0.126662643824775,0.0457201618170252,0.32808539590213,mechanism,100,51,49,combination,0.000424851185956625,0.00534303681589773,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_cn_simple_chr13_q_gt25,69,4,23,17,92,21,40,73,113,Non-Response,2.96173805747105e-06,0.0805685779363658,0.0178746415516662,0.27993914560281,mechanism,113,73,40,combination,0.000447312445874767,0.00562551534635976,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,132,59,49,69,181,128,118,191,309,Non-Response,2.98764371821938e-06,0.318681209105817,0.191325899559707,0.526228067955368,mechanism,309,191,118,combination,0.000450217695361478,0.00566205250449882,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,161,30,71,47,232,77,118,191,309,Non-Response,3.18462577910991e-06,0.282758762497646,0.158493285556269,0.497814867555721,mechanism,309,191,118,combination,0.000466462574510519,0.00586635224575456,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_drivers_total_gt50,30,80,1,63,31,143,64,110,174,Non-Response,3.18726651703377e-06,0.0428000064631256,0.00102630263489922,0.272329659305808,mechanism,174,110,64,combination,0.000466462574510519,0.00586635224575456,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_cn_simple_chr11_p_gt25,68,5,22,18,90,23,40,73,113,Non-Response,3.1929842029435e-06,0.0922310969502106,0.0238869998407956,0.29546658704349,mechanism,113,73,40,combination,0.000466462574510519,0.00586635224575456,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-EGFR,cn_simple_chr1_p_lt75_and_rna_geneset_HALLMARK_APICAL_SURFACE_lt50,26,6,2,15,28,21,17,32,49,Non-Response,3.24460250276298e-06,0.0341116218932408,0.00303502148595883,0.200931075922691,mechanism,49,32,17,combination,0.000471883611578046,0.00593452858982413,Anti-EGFR
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_rna_geneset_gene_set_t_cell_gep_18_lt25,22,29,2,47,24,76,49,51,100,Non-Response,3.25693379066389e-06,0.0576070419069627,0.00613427742027623,0.262197534005252,mechanism,100,51,49,combination,0.00047240938491915,0.00594114084938982,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,130,61,48,70,178,131,118,191,309,Non-Response,3.27442380847956e-06,0.323021870233054,0.194119481266162,0.532848281368784,mechanism,409,247,162,univariate,0.000473257566587697,0.00595180779826844,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_rna_geneset_gene_set_t_cell_gep_6_lt75,130,61,48,70,178,131,118,191,309,Non-Response,3.27442380847956e-06,0.323021870233054,0.194119481266162,0.532848281368784,mechanism,309,191,118,combination,0.000473257566587697,0.00595180779826844,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_rna_geneset_gene_set_t_cell_gep_6_lt75,130,61,48,70,178,131,118,191,309,Non-Response,3.27442380847956e-06,0.323021870233054,0.194119481266162,0.532848281368784,mechanism,309,191,118,combination,0.000473257566587697,0.00595180779826844,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,140,51,55,63,195,114,118,191,309,Non-Response,3.42130386938521e-06,0.319310315353716,0.190584379627354,0.530699832047047,mechanism,309,191,118,combination,0.000490335025501261,0.00616657827488062,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_cn_simple_chr22_q_gt50,55,18,12,28,67,46,40,73,113,Non-Response,3.51922288178786e-06,0.143185296615776,0.0539315471820396,0.358553960301058,mechanism,113,73,40,combination,0.000503270538375499,0.00632925858225447,Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,59,8,18,22,77,30,40,67,107,Non-Response,3.60701584117566e-06,0.113801466708737,0.0369259296468431,0.318739689009862,mechanism,107,67,40,combination,0.0005135670418069,0.00645875003414984,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_and_signature_log_DBS_denovo_5_eq0,54,44,13,53,67,97,66,98,164,Non-Response,5.23463362261744e-06,0.201908631186633,0.0890531490270379,0.433210974608463,mechanism,164,98,66,combination,0.000706341043792822,0.00888312502427609,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_or_signature_log_DBS_denovo_5_eq0,94,4,46,20,140,24,66,98,164,Non-Response,5.26623012984446e-06,0.0993231147822142,0.0233178939133856,0.319742172668789,mechanism,164,98,66,combination,0.000709427080905095,0.00892193581367986,Platinum/Pyrimidine (ant)agonist
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_HALLMARK_ANGIOGENESIS_gt75,29,5,4,15,33,20,19,34,53,Non-Response,5.55702853955035e-06,0.0501459393149812,0.0082305677792401,0.234136960274077,mechanism,53,34,19,combination,0.000737601409366374,0.00927626335049218,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,29,5,4,15,33,20,19,34,53,Non-Response,5.55702853955035e-06,0.0501459393149812,0.0082305677792401,0.234136960274077,mechanism,53,34,19,combination,0.000737601409366374,0.00927626335049218,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50_or_rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75,22,3,5,18,27,21,23,25,48,Non-Response,5.65265373797464e-06,0.0419015502630073,0.00560535682453215,0.214932304123299,mechanism,48,25,23,combination,0.000749071061521761,0.00942050861979462,Multikinase inhibitor
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25_and_cn_simple_chr3_p_gt25,17,4,4,23,21,27,27,21,48,Non-Response,5.7338238813242e-06,0.0452102206414348,0.00672454393679377,0.224483601906621,mechanism,48,21,27,combination,0.000758590964569204,0.00954023334729359,Alkaloid/Platinum
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_cyt_lt75,130,61,49,69,179,130,118,191,309,Non-Response,5.88438276831425e-06,0.334485511064691,0.201248963415766,0.551344311905565,mechanism,409,247,162,univariate,0.000771930343411945,0.00970799277603918,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,29,162,1,117,30,279,118,191,309,Non-Response,5.88627531853135e-06,0.048010529676059,0.00116379818403485,0.298238896773022,mechanism,309,191,118,combination,0.000771930343411945,0.00970799277603918,Anti-PD-1
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr16_q_gt50_or_cn_simple_chr22_q_gt25,23,2,7,18,30,20,25,25,50,Non-Response,6.30991365738587e-06,0.0370965969699426,0.00339690344478482,0.20972600417587,mechanism,50,25,25,combination,0.000811692516506035,0.0102080520008792,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr21_p_gt75_or_cn_simple_chr22_q_gt25,23,2,7,18,30,20,25,25,50,Non-Response,6.30991365738587e-06,0.0370965969699426,0.00339690344478482,0.20972600417587,mechanism,50,25,25,combination,0.000811692516506035,0.0102080520008792,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,37,154,3,115,40,269,118,191,309,Non-Response,6.30309754572517e-06,0.109136961383773,0.0210391478163151,0.357994011491176,mechanism,309,191,118,combination,0.000811692516506035,0.0102080520008792,Anti-PD-1
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_and_rna_geneset_KEGG_JAK_STAT_SIGNALING_PATHWAY_lt75,40,1,8,10,48,11,18,41,59,Non-Response,6.52406638424694e-06,0.022030842952035,0.000456843776665321,0.188720357483746,mechanism,59,41,18,combination,0.000833962378888195,0.0104881234671384,Taxane
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_cn_simple_chr18_p_gt25,63,10,18,22,81,32,40,73,113,Non-Response,6.56046888250213e-06,0.132792137072863,0.0466898634070621,0.35282530802576,mechanism,113,73,40,combination,0.000837956888732978,0.0105383594412103,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,49,142,7,111,56,253,118,191,309,Non-Response,6.62742218121586e-06,0.183609159533047,0.0674872166541091,0.428564051341436,mechanism,409,247,162,univariate,0.000840846456020737,0.0105746993760177,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,166,25,76,42,242,67,118,191,309,Non-Response,7.38031410222937e-06,0.273780252780564,0.148247481344463,0.496859634160255,mechanism,309,191,118,combination,0.00091744978011796,0.011538082307267,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,58,9,18,22,76,31,40,67,107,Non-Response,7.45429572039788e-06,0.129989338305235,0.0440101692224047,0.354548736824869,mechanism,107,67,40,combination,0.000922415202089235,0.0116005287197426,Taxane
Skin Melanoma ## Anti-PD-1,rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,37,14,13,36,50,50,49,51,100,Non-Response,7.7002941110781e-06,0.139848997906511,0.0512197004329772,0.358680559356155,mechanism,100,51,49,combination,0.000948524562025058,0.0119288866859855,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt50,77,114,19,99,96,213,118,191,309,Non-Response,7.71604158109786e-06,0.285253110329273,0.151882099645837,0.515796109202141,mechanism,409,247,162,univariate,0.00094897800163381,0.0119345892580941,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,47,20,10,30,57,50,40,67,107,Non-Response,7.72732059535274e-06,0.144857353982146,0.0524218919243863,0.371964548142448,mechanism,107,67,40,combination,0.00094897800163381,0.0119345892580941,Taxane
Skin Melanoma ## Anti-PD-1,driver_B2M_or_rna_geneset_gene_set_t_cell_gep_18_lt25,21,30,2,47,23,77,49,51,100,Non-Response,7.83531773783416e-06,0.0623656231819472,0.00663028586071543,0.284718741741461,mechanism,100,51,49,combination,0.000958334616810138,0.0120522604357013,Anti-PD-1
Skin Melanoma ## Anti-PD-1,driver_B2M_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,21,30,2,47,23,77,49,51,100,Non-Response,7.83531773783416e-06,0.0623656231819472,0.00663028586071543,0.284718741741461,mechanism,100,51,49,combination,0.000958334616810138,0.0120522604357013,Anti-PD-1
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,21,30,2,47,23,77,49,51,100,Non-Response,7.83531773783416e-06,0.0623656231819472,0.00663028586071543,0.284718741741461,mechanism,100,51,49,combination,0.000958334616810138,0.0120522604357013,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_purity_polyclonalProportion_gt25,54,56,10,54,64,110,64,110,174,Non-Response,8.40047705671461e-06,0.193838255756574,0.079636835506095,0.433913996125996,mechanism,174,110,64,combination,0.00101553960480869,0.01277168494723,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_infiltrate_lt75,132,59,51,67,183,126,118,191,309,Non-Response,9.34096124427132e-06,0.341497262593967,0.205426198344504,0.563214917286787,mechanism,409,247,162,univariate,0.00110379477935758,0.0138816045200009,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_rna_geneset_gene_set_t_cell_gep_10_lt75,132,59,51,67,183,126,118,191,309,Non-Response,9.34096124427132e-06,0.341497262593967,0.205426198344504,0.563214917286787,mechanism,309,191,118,combination,0.00110379477935758,0.0138816045200009,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_rna_geneset_vhio_tcell_lt75,132,59,51,67,183,126,118,191,309,Non-Response,9.34096124427132e-06,0.341497262593967,0.205426198344504,0.563214917286787,mechanism,309,191,118,combination,0.00110379477935758,0.0138816045200009,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_rna_geneset_gene_set_t_cell_gep_10_lt75,132,59,51,67,183,126,118,191,309,Non-Response,9.34096124427132e-06,0.341497262593967,0.205426198344504,0.563214917286787,mechanism,309,191,118,combination,0.00110379477935758,0.0138816045200009,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_rna_geneset_vhio_tcell_lt75,132,59,51,67,183,126,118,191,309,Non-Response,9.34096124427132e-06,0.341497262593967,0.205426198344504,0.563214917286787,mechanism,309,191,118,combination,0.00110379477935758,0.0138816045200009,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_gene_set_t_cell_gep_10_lt75,78,113,20,98,98,211,118,191,309,Non-Response,9.35638314892489e-06,0.296783707236312,0.15994201167074,0.531920441546293,mechanism,309,191,118,combination,0.00110430747336876,0.0138880522905794,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,32,159,2,116,34,275,118,191,309,Non-Response,9.38960432688193e-06,0.086096702205451,0.00980290147136773,0.349153331197055,mechanism,309,191,118,combination,0.00110712899517212,0.0139235364680291,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt50_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,29,22,7,42,36,64,49,51,100,Non-Response,9.51267179878697e-06,0.129373408877112,0.0409463677490002,0.362081315485284,mechanism,100,51,49,combination,0.00112001550263517,0.0140856004708596,Anti-PD-1
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_and_cn_simple_chr20_q_gt25,19,6,3,22,22,28,25,25,50,Non-Response,9.54565479910262e-06,0.0470508615140251,0.00660026011356541,0.230456018318317,mechanism,50,25,25,combination,0.00112065298124512,0.0140936175643617,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,86,105,24,94,110,199,118,191,309,Non-Response,9.56239202089946e-06,0.312887621333995,0.175188526093914,0.544364537492225,mechanism,409,247,162,univariate,0.00112099914766706,0.0140979710415274,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_or_rna_geneset_KEGG_RIBOSOME_gt50,61,3,19,14,80,17,33,64,97,Non-Response,9.60153174684682e-06,0.0690987945443069,0.0115223440027062,0.282769096239907,mechanism,97,64,33,combination,0.00112279600528289,0.0141205687809516,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_rna_geneset_HALLMARK_ADIPOGENESIS_lt25,92,6,44,22,136,28,66,98,164,Non-Response,9.76132246260358e-06,0.132202675128972,0.0408495726598652,0.366476630884571,mechanism,164,98,66,combination,0.00113288473217303,0.0142474471820985,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_signature_log_DBS_denovo_5_eq0,92,6,44,22,136,28,66,98,164,Non-Response,9.76132246260358e-06,0.132202675128972,0.0408495726598652,0.366476630884571,mechanism,164,98,66,combination,0.00113288473217303,0.0142474471820985,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,41,40,6,43,47,83,49,81,130,Non-Response,9.8887186560606e-06,0.13819108500826,0.0432185594552484,0.374627653018148,mechanism,130,81,49,combination,0.00114603412404714,0.014412817286296,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_or_cn_simple_chr22_q_gt25,68,5,23,17,91,22,40,73,113,Non-Response,9.97620447013529e-06,0.101961714855571,0.0263584641092894,0.328245103883785,mechanism,113,73,40,combination,0.00115206739661581,0.0144886932600964,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_or_cn_simple_chr22_q_gt25,68,5,23,17,91,22,40,73,113,Non-Response,9.97620447013529e-06,0.101961714855571,0.0263584641092894,0.328245103883785,mechanism,113,73,40,combination,0.00115206739661581,0.0144886932600964,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_and_cn_simple_chr18_p_gt25,52,21,11,29,63,50,40,73,113,Non-Response,1.0102320423944e-05,0.156140018073965,0.0586838443285022,0.389987828998246,mechanism,113,73,40,combination,0.00116415102501236,0.01464066005112,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_or_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,60,4,18,15,78,19,33,64,97,Non-Response,1.01679322661072e-05,0.082647038025095,0.0176937563071585,0.301011907688463,mechanism,97,64,33,combination,0.00117005339745541,0.0147148897915722,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_rna_geneset_gene_set_t_cell_gep_10_lt50,26,25,5,44,31,69,49,51,100,Non-Response,1.01864379656943e-05,0.111884396779364,0.0297238011335356,0.345079475947353,mechanism,100,51,49,combination,0.00117052610625156,0.0147208346978935,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr3_q_gt25,22,2,12,23,34,25,35,24,59,Non-Response,1.03372662377109e-05,0.0502834970031931,0.00494183296138701,0.258341374327595,mechanism,59,24,35,univariate,0.00118284223484822,0.0148757254707016,Aromatase inhibitor
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,35,16,12,37,47,53,49,51,100,Non-Response,1.05138174881663e-05,0.151563541391999,0.0557423226240089,0.387301071972053,mechanism,100,51,49,combination,0.00119798577150726,0.0150661744480535,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_rna_geneset_gene_set_t_cell_effector_lt75,130,61,50,68,180,129,118,191,309,Non-Response,1.05578508064249e-05,0.346285592023506,0.208568772413052,0.570435490773119,mechanism,309,191,118,combination,0.00120047931847768,0.0150975339303981,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_rna_geneset_gene_set_t_cell_effector_lt75,130,61,50,68,180,129,118,191,309,Non-Response,1.05578508064249e-05,0.346285592023506,0.208568772413052,0.570435490773119,mechanism,309,191,118,combination,0.00120047931847768,0.0150975339303981,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_cyt_lt50,80,111,21,97,101,208,118,191,309,Non-Response,1.06438720482283e-05,0.301523127277937,0.164257818709591,0.53588242366217,mechanism,409,247,162,univariate,0.00120484092887235,0.0151523866545652,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_or_rna_geneset_vhio_tcell_lt75,164,27,75,43,239,70,118,191,309,Non-Response,1.0670309213989e-05,0.288424133765421,0.158418312884401,0.5173591405947,mechanism,309,191,118,combination,0.00120484092887235,0.0151523866545652,Anti-PD-1
Prostate ## Anti-AR,chord_BRCA1_gt0_or_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,29,29,0,21,29,50,21,58,79,Non-Response,1.07367110251842e-05,0,0,0.220215717975934,mechanism,79,58,21,combination,0.00120898042885935,0.0152044460616259,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_ASTHMA_gt50_or_signature_log_SBS1_lt25,29,29,0,21,29,50,21,58,79,Non-Response,1.07367110251842e-05,0,0,0.220215717975934,mechanism,79,58,21,combination,0.00120898042885935,0.0152044460616259,Anti-AR
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_rna_geneset_KEGG_RIBOSOME_gt50,46,18,8,25,54,43,33,64,97,Non-Response,1.07779214697667e-05,0.12840047322135,0.0417094414060664,0.358549609429563,mechanism,97,64,33,combination,0.0012125280525532,0.0152490618815454,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_and_fusion_total_gt50,44,29,7,33,51,62,40,73,113,Non-Response,1.12010447001267e-05,0.142396974953089,0.0466863946660593,0.383098671263511,mechanism,113,73,40,combination,0.00125259110464319,0.0157529050373367,Pyrimidine (ant)agonist
Lung NSCLC ## Anti-PD-1,clin_hasSystemicPreTreatment_and_cn_simple_chr3_p_lt75,39,6,7,15,46,21,22,45,67,Non-Response,1.14414274112699e-05,0.0758354829147003,0.0171000267435925,0.287532150667179,mechanism,67,45,22,combination,0.00127160165018296,0.0159919865041344,Anti-PD-1
Lung NSCLC ## Anti-PD-1,clin_pretreatment_contains_Platinum_and_cn_simple_chr3_p_lt75,39,6,7,15,46,21,22,45,67,Non-Response,1.14414274112699e-05,0.0758354829147003,0.0171000267435925,0.287532150667179,mechanism,67,45,22,combination,0.00127160165018296,0.0159919865041344,Anti-PD-1
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr16_q_gt50_or_cn_simple_chr21_p_gt75,20,5,4,21,24,26,25,25,50,Non-Response,1.15490705498585e-05,0.0519731463402565,0.00851297482991509,0.240417184896875,mechanism,50,25,25,combination,0.00127919330603944,0.016087461103419,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,36,155,3,115,39,270,118,191,309,Non-Response,1.16887427824101e-05,0.112889716858603,0.0217229408208472,0.371042788446947,mechanism,309,191,118,combination,0.00129202324876568,0.0162488137337002,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,57,24,15,34,72,58,49,81,130,Non-Response,1.16859885373954e-05,0.188483486966319,0.0794106944128667,0.42886042513957,mechanism,130,81,49,combination,0.00129202324876568,0.0162488137337002,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,40,41,6,43,46,84,49,81,130,Non-Response,1.17374960319231e-05,0.145116741799951,0.045387480559526,0.393537560110222,mechanism,130,81,49,combination,0.00129389381681263,0.0162723384742961,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,40,41,6,43,46,84,49,81,130,Non-Response,1.17374960319231e-05,0.145116741799951,0.045387480559526,0.393537560110222,mechanism,130,81,49,combination,0.00129389381681263,0.0162723384742961,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,160,31,72,46,232,77,118,191,309,Non-Response,1.18190092832829e-05,0.304541133768478,0.171339025107572,0.534881008982504,mechanism,309,191,118,combination,0.00130085831797336,0.0163599258162553,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,35,46,4,45,39,91,49,81,130,Non-Response,1.20449004460427e-05,0.118564477269178,0.0282781300060594,0.370686430662078,mechanism,130,81,49,combination,0.001313532342539,0.0165193175800027,Multikinase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_and_rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75,16,9,1,22,17,31,23,25,48,Non-Response,1.27932327640272e-05,0.0278691014932845,0.000590302291956185,0.227033054667577,mechanism,48,25,23,combination,0.00138492281022989,0.0174171423002461,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,50,31,11,38,61,69,49,81,130,Non-Response,1.3062024589033e-05,0.182037507317513,0.0726199043479502,0.427504649461997,mechanism,130,81,49,combination,0.00140652918816397,0.0176888696169535,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,38,153,4,114,42,267,118,191,309,Non-Response,1.34841556836028e-05,0.141956680238135,0.0357884006998789,0.410749420217201,mechanism,309,191,118,combination,0.00144433250714259,0.0181642937930944,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75_and_rna_geneset_vhio_tcell_lt75,38,153,4,114,42,267,118,191,309,Non-Response,1.34841556836028e-05,0.141956680238135,0.0357884006998789,0.410749420217201,mechanism,309,191,118,combination,0.00144433250714259,0.0181642937930944,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,42,39,7,42,49,81,49,81,130,Non-Response,1.44562838871947e-05,0.156995267082514,0.0531066409139134,0.407071058902329,mechanism,130,81,49,combination,0.00153803569452937,0.0193427289640996,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,29,52,2,47,31,99,49,81,130,Non-Response,1.47046711206462e-05,0.0774859398772077,0.00849939562214823,0.334406794948584,mechanism,130,81,49,combination,0.00156067239874336,0.0196274139267497,Multikinase inhibitor
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_p_gt50_or_cn_simple_chr3_q_gt25,31,4,13,22,44,26,35,35,70,Non-Response,1.48597612470753e-05,0.0796407104605602,0.0165902825149151,0.295615064402435,mechanism,70,35,35,combination,0.00157507657056842,0.0198085644634735,Aromatase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_tim3_lt75,135,56,54,64,189,120,118,191,309,Non-Response,1.50471643159463e-05,0.351269722859654,0.211060384715017,0.580445264305562,mechanism,409,247,162,univariate,0.00159182747133652,0.0200192280616036,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_or_cn_simple_chr22_q_gt50,67,6,22,18,89,24,40,73,113,Non-Response,1.52751621003723e-05,0.112084696484159,0.0321701300195614,0.339757879587997,mechanism,113,73,40,combination,0.00161173561548001,0.0202695979572538,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_rna_geneset_APM_lt50,27,24,6,43,33,67,49,51,100,Non-Response,1.56616752575778e-05,0.126864547541929,0.0373801548025714,0.36999324527287,mechanism,100,51,49,combination,0.00164612609795193,0.0207021014315002,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_signature_log_DBS_denovo_5_eq0,92,28,35,41,127,69,76,120,196,Non-Response,1.61644742653667e-05,0.261784026590879,0.133531001448764,0.504513563703872,mechanism,196,120,76,combination,0.0016891460068124,0.0212431307717868,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,31,157,2,114,33,271,116,188,304,Non-Response,1.62934793294178e-05,0.0892977569198885,0.0101521893997201,0.363223142577573,mechanism,304,188,116,combination,0.00170044104749979,0.0213851800827564,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,31,160,2,116,33,276,118,191,309,Non-Response,1.6453972161553e-05,0.0894268807119267,0.0101704017423438,0.36352732500306,mechanism,309,191,118,combination,0.00171389043275093,0.0215543229801364,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,60,21,17,32,77,53,49,81,130,Non-Response,1.68678132058496e-05,0.188704611973406,0.0799419209465909,0.428983215538644,mechanism,130,81,49,combination,0.0017418669723107,0.0219061630733038,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,57,134,11,107,68,241,118,191,309,Non-Response,1.69803658497333e-05,0.242672826109304,0.109189306968827,0.496591624977071,mechanism,309,191,118,combination,0.00174745159900945,0.0219763967622773,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,19,15,0,19,19,34,19,34,53,Non-Response,1.71517728956884e-05,0,0,0.212828113216599,mechanism,53,34,19,combination,0.0017606338189982,0.0221421797212127,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_vhio_tcell_lt75,79,112,21,97,100,209,118,191,309,Non-Response,1.77508343957546e-05,0.308068384109159,0.167805743736655,0.54770138849793,mechanism,309,191,118,combination,0.00181639406613021,0.0228434348033165,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_purity_tml_lt75,105,115,33,100,138,215,133,220,353,Non-Response,1.79577473559087e-05,0.362468805463631,0.217560332600768,0.594176606844437,mechanism,353,220,133,combination,0.00183214339483606,0.0230415023758751,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_KEGG_STEROID_BIOSYNTHESIS_gt25,49,18,12,28,61,46,40,67,107,Non-Response,1.79597690070835e-05,0.160614670832519,0.0601697594898487,0.404819740482429,mechanism,107,67,40,combination,0.00183214339483606,0.0230415023758751,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt50,37,4,6,12,43,16,18,41,59,Non-Response,1.79910986484715e-05,0.0582327697429842,0.00997190804825611,0.266690688330873,mechanism,59,41,18,combination,0.00183214339483606,0.0230415023758751,Taxane
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment,133,114,52,110,185,224,162,247,409,Non-Response,1.85508746959448e-05,0.406106612543131,0.261698581874269,0.625169369725434,mechanism,409,247,162,univariate,0.00187583030087763,0.0235909200427393,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50_or_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,49,15,10,23,59,38,33,64,97,Non-Response,1.88549583264232e-05,0.136475574352782,0.0463436510215028,0.373838541697286,mechanism,97,64,33,combination,0.0019030282519924,0.0239329684091478,Pyrimidine (ant)agonist
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_or_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,33,25,1,20,34,45,21,58,79,Non-Response,1.94276233670076e-05,0.0391848591976479,0.000892901001369865,0.277398157307722,mechanism,79,58,21,combination,0.00195355145592375,0.0245683611009546,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50_or_signature_log_SBS1_lt25,33,25,1,20,34,45,21,58,79,Non-Response,1.94276233670076e-05,0.0391848591976479,0.000892901001369865,0.277398157307722,mechanism,79,58,21,combination,0.00195355145592375,0.0245683611009546,Anti-AR
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_neo_ct_lt75,81,139,21,112,102,251,133,220,353,Non-Response,1.96862487736947e-05,0.322742729407891,0.17802360176738,0.565774137565668,mechanism,353,220,133,combination,0.00197573462686794,0.024847342313591,Anti-PD-1
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,41,0,10,8,51,8,18,41,59,Non-Response,1.97332872116111e-05,0,0,0.179215504930808,mechanism,59,41,18,combination,0.00197573462686794,0.024847342313591,Taxane
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt25_or_rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50,32,19,10,39,42,58,49,51,100,Non-Response,1.97175898745609e-05,0.155541929400889,0.0556036098958283,0.404355576268694,mechanism,100,51,49,combination,0.00197573462686794,0.024847342313591,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_battle_tcell_term_diff_cd8_lt50,88,103,26,92,114,195,118,191,309,Non-Response,1.9867442971589e-05,0.331956378294218,0.18856720154866,0.571174679492,mechanism,409,247,162,univariate,0.00198549876600764,0.0249701386164458,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_or_rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50,37,14,14,35,51,49,49,51,100,Non-Response,2.00782303103317e-05,0.154689876050351,0.0574717211187137,0.392831886027515,mechanism,100,51,49,combination,0.00200287122208547,0.0251886190525952,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,28,6,4,15,32,21,19,34,53,Non-Response,2.01848426118454e-05,0.0616334914516373,0.0106677423466382,0.276470972193835,mechanism,53,34,19,combination,0.00200980712737345,0.0252758467655691,Anti-PD-1
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_and_rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75,29,3,5,12,34,15,17,32,49,Non-Response,2.02432385390931e-05,0.0475336887506259,0.00621721313217608,0.253092643832904,mechanism,49,32,17,combination,0.002011925488985,0.0253024878212,Anti-EGFR
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,46,145,7,111,53,256,118,191,309,Non-Response,2.03220183426574e-05,0.199672700508181,0.0732027733008883,0.467909728964039,mechanism,309,191,118,combination,0.00201482898687769,0.0253390029508461,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50_and_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,44,23,9,31,53,54,40,67,107,Non-Response,2.04331453838893e-05,0.154752959107384,0.054886386526357,0.401104911353552,mechanism,107,67,40,combination,0.00202337915537736,0.0254465320494716,Taxane
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_or_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,56,8,15,18,71,26,33,64,97,Non-Response,2.04906211487028e-05,0.122389878899221,0.0378458649181859,0.361936622022238,mechanism,97,64,33,combination,0.00202660220044816,0.0254870658858873,Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,58,23,16,33,74,56,49,81,130,Non-Response,2.08136883198122e-05,0.195035943299859,0.0827525803422425,0.442123071409636,mechanism,130,81,49,combination,0.00204117255333222,0.0256703063579713,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,66,1,28,12,94,13,40,67,107,Non-Response,2.13287322877468e-05,0.0364293722257681,0.000820473822447087,0.267267401239438,mechanism,120,77,43,univariate,0.0020778964724524,0.0261321557263363,Taxane
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_or_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,66,1,28,12,94,13,40,67,107,Non-Response,2.13287322877468e-05,0.0364293722257681,0.000820473822447087,0.267267401239438,mechanism,107,67,40,combination,0.0020778964724524,0.0261321557263363,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_and_signature_log_SBS20_eq0,54,44,14,52,68,96,66,98,164,Non-Response,2.13913441762847e-05,0.221491104713068,0.0996289718766178,0.468968646983916,mechanism,164,98,66,combination,0.00207901361648269,0.0261462052144389,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_and_signature_log_DBS_denovo_5_eq0,54,44,14,52,68,96,66,98,164,Non-Response,2.13913441762847e-05,0.221491104713068,0.0996289718766178,0.468968646983916,mechanism,164,98,66,combination,0.00207901361648269,0.0261462052144389,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,purity_msIndelsPerMb_lt75,200,47,100,62,300,109,162,247,409,Non-Response,2.18034445855056e-05,0.379988998663927,0.23587506242621,0.608548151649311,mechanism,409,247,162,univariate,0.00211149284259323,0.0265546722414751,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_and_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,63,4,24,16,87,20,40,67,107,Non-Response,2.20272011911192e-05,0.0977088980812541,0.0215613873824886,0.342519211296286,mechanism,107,67,40,combination,0.0021299582642251,0.0267868980910464,Taxane
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_or_cn_simple_chr22_q_gt25,23,2,8,17,31,19,25,25,50,Non-Response,2.21448218696622e-05,0.0444103558276728,0.00411973351012902,0.247490601132362,mechanism,50,25,25,combination,0.00213438277792729,0.0268425419032438,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_and_rna_geneset_vhio_tcell_lt75,37,154,4,114,41,268,118,191,309,Non-Response,2.29712363981832e-05,0.146736239164217,0.0369505255199352,0.425398007310968,mechanism,309,191,118,combination,0.00220618847954624,0.0277455887112163,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_gene_set_t_cell_effector_lt75,155,36,69,49,224,85,118,191,309,Non-Response,2.30567249024627e-05,0.328335162894117,0.188904414581754,0.565562623005756,mechanism,309,191,118,combination,0.00221178605055494,0.0278159851911314,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,82,109,23,95,105,204,118,191,309,Non-Response,2.32752058168885e-05,0.322979400261394,0.179266946844938,0.565928459097697,mechanism,309,191,118,combination,0.00223142801616417,0.0280630075576817,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,40,151,5,113,45,264,118,191,309,Non-Response,2.33614660027333e-05,0.167807612462144,0.0500865635809016,0.444217884446816,mechanism,309,191,118,combination,0.00223837810790361,0.0281504136830855,Anti-PD-1
Skin Melanoma ## Anti-PD-1,driver_B2M_or_rna_geneset_gene_set_t_cell_gep_10_lt50,25,26,5,44,30,70,49,51,100,Non-Response,2.36268093178338e-05,0.12087480646923,0.0321314392079188,0.37318564639935,mechanism,100,51,49,combination,0.00226053073554292,0.0284290107753337,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,117,74,43,75,160,149,118,191,309,Non-Response,2.4253129977809e-05,0.363861621510875,0.219112977857646,0.598541937793267,mechanism,309,191,118,combination,0.00231019943065717,0.0290536569464288,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_or_cn_simple_chr13_q_gt25,70,3,26,14,96,17,40,73,113,Non-Response,2.45633766096822e-05,0.0816698546495032,0.0139282667377661,0.324836687861277,mechanism,113,73,40,combination,0.00233155628136667,0.0293222461451515,Pyrimidine (ant)agonist
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr3_q_gt25_or_rna_geneset_battle_tcell_term_diff_cd8_lt25,19,1,10,18,29,19,28,20,48,Non-Response,2.47514594337294e-05,0.0316172829128716,0.000673763232471631,0.254420043531213,mechanism,48,20,28,combination,0.0023317136738155,0.0293242255527098,Aromatase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_and_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,53,11,13,20,66,31,33,64,97,Non-Response,2.51721000476772e-05,0.138414341796116,0.04648787653839,0.386021317915753,mechanism,97,64,33,combination,0.00236585729685099,0.0297536244597554,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_and_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,53,11,13,20,66,31,33,64,97,Non-Response,2.51721000476772e-05,0.138414341796116,0.04648787653839,0.386021317915753,mechanism,97,64,33,combination,0.00236585729685099,0.0297536244597554,Pyrimidine (ant)agonist
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr3_p_gt25,17,4,5,22,22,26,27,21,48,Non-Response,2.55577374244378e-05,0.0582204477509463,0.00947348839949522,0.273472074194003,mechanism,48,21,27,univariate,0.00239242198603266,0.0300877087626648,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_or_cn_simple_chr3_p_gt25,17,4,5,22,22,26,27,21,48,Non-Response,2.55577374244378e-05,0.0582204477509463,0.00947348839949522,0.273472074194003,mechanism,48,21,27,combination,0.00239242198603266,0.0300877087626648,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr3_p_gt25_or_cn_simple_chr3_p_gt50,17,4,5,22,22,26,27,21,48,Non-Response,2.55577374244378e-05,0.0582204477509463,0.00947348839949522,0.273472074194003,mechanism,48,21,27,combination,0.00239242198603266,0.0300877087626648,Alkaloid/Platinum
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt75,154,37,68,50,222,87,118,191,309,Non-Response,2.563636916609e-05,0.328037625178543,0.189477598611256,0.562943467285538,mechanism,309,191,118,combination,0.0023970226300563,0.0301455676346831,Anti-PD-1
Skin Melanoma ## Anti-PD-1,driver_B2M_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,34,17,12,37,46,54,49,51,100,Non-Response,2.56822820076113e-05,0.165550114761551,0.0613917412074586,0.42055400539181,mechanism,100,51,49,combination,0.00239965836129862,0.0301787152626763,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,clin_hasRadiotherapyPreTreatment_or_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,22,12,1,18,23,30,19,34,53,Non-Response,2.5910930601737e-05,0.0323906031752564,0.00070244849295432,0.252342157216921,mechanism,53,34,19,combination,0.00241135488509517,0.0303258137275712,Anti-PD-1
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50_and_rna_geneset_KEGG_RIBOFLAVIN_METABOLISM_lt50,21,3,2,11,23,14,13,24,37,Non-Response,2.64420672717473e-05,0.0306673093091926,0.00224005971158463,0.22589121915287,mechanism,37,24,13,combination,0.00244329179476419,0.0307274604447937,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_gene_set_cd8_t_effector_lt50_and_rna_geneset_KEGG_RIBOFLAVIN_METABOLISM_lt50,21,3,2,11,23,14,13,24,37,Non-Response,2.64420672717473e-05,0.0306673093091926,0.00224005971158463,0.22589121915287,mechanism,37,24,13,combination,0.00244329179476419,0.0307274604447937,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_and_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,52,12,12,21,64,33,33,64,97,Non-Response,2.66297440820644e-05,0.135320484110718,0.045817776258008,0.374314295819755,mechanism,97,64,33,combination,0.00245461628585913,0.0308698801315961,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_and_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,52,12,12,21,64,33,33,64,97,Non-Response,2.66297440820644e-05,0.135320484110718,0.045817776258008,0.374314295819755,mechanism,97,64,33,combination,0.00245461628585913,0.0308698801315961,Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_KEGG_STEROID_BIOSYNTHESIS_gt25,61,6,22,18,83,24,40,67,107,Non-Response,2.72795801706854e-05,0.123066868707294,0.0352071311040367,0.374373461810673,mechanism,107,67,40,combination,0.00249752543727089,0.0314095165579738,Taxane
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_and_rna_geneset_KEGG_STEROID_BIOSYNTHESIS_gt25,61,6,22,18,83,24,40,67,107,Non-Response,2.72795801706854e-05,0.123066868707294,0.0352071311040367,0.374373461810673,mechanism,107,67,40,combination,0.00249752543727089,0.0314095165579738,Taxane
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,17,8,2,21,19,29,23,25,48,Non-Response,2.73791387509426e-05,0.0486019915801105,0.00448427114171262,0.273040236673286,mechanism,48,25,23,combination,0.00249920166147526,0.0314305971808641,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_gene_set_t_cell_effector_lt75,75,116,20,98,95,214,118,191,309,Non-Response,2.7525439517576e-05,0.316780949933391,0.170528561530412,0.568515394642767,mechanism,309,191,118,combination,0.00250464252244764,0.0314990228354145,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,31,50,3,46,34,96,49,81,130,Non-Response,2.7600966211415e-05,0.106749500801218,0.0195675849372008,0.377607875245803,mechanism,130,81,49,combination,0.00250858686643022,0.0315486279108153,Multikinase inhibitor
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50_or_rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50,35,16,13,36,48,52,49,51,100,Non-Response,2.77685031466806e-05,0.168498714774939,0.0630823427181151,0.425441933445799,mechanism,100,51,49,combination,0.00251958876933257,0.0316869906462749,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_rna_geneset_APM_lt75,131,60,52,66,183,126,118,191,309,Non-Response,2.79109097618124e-05,0.362148211594197,0.218308559016539,0.59641417729993,mechanism,309,191,118,combination,0.00252827749607308,0.0317962622886577,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_rna_geneset_APM_lt75,131,60,52,66,183,126,118,191,309,Non-Response,2.79109097618124e-05,0.362148211594197,0.218308559016539,0.59641417729993,mechanism,309,191,118,combination,0.00252827749607308,0.0317962622886577,Anti-PD-1
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_or_rna_geneset_KEGG_ASTHMA_gt50,32,26,1,20,33,46,21,58,79,Non-Response,2.80066870634808e-05,0.0419685175306367,0.000956333095143202,0.296961281065975,mechanism,79,58,21,combination,0.00252990627952658,0.0318167462845718,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_or_signature_log_SBS1_lt25,32,26,1,20,33,46,21,58,79,Non-Response,2.80066870634808e-05,0.0419685175306367,0.000956333095143202,0.296961281065975,mechanism,79,58,21,combination,0.00252990627952658,0.0318167462845718,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25_or_signature_log_SBS1_lt25,36,22,2,19,38,41,21,58,79,Non-Response,2.85770692233545e-05,0.0665593043655519,0.00687606438014377,0.317660363140033,mechanism,79,58,21,combination,0.00256420832808702,0.0322481375914042,Anti-AR
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,30,158,2,114,32,272,116,188,304,Non-Response,2.89057474147219e-05,0.0928554345693046,0.0105435125448496,0.378697523167928,mechanism,304,188,116,combination,0.00258669054382991,0.0325308796676603,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,41,40,7,42,48,82,49,81,130,Non-Response,2.90196680396887e-05,0.164867690941698,0.0557805216288416,0.427546734691269,mechanism,130,81,49,combination,0.0025914525479707,0.0325907678456452,Multikinase inhibitor
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,29,22,8,41,37,63,49,51,100,Non-Response,2.97702150883414e-05,0.151177210160672,0.050592682158078,0.409454086884593,mechanism,100,51,49,combination,0.00263791685718481,0.0331751148428114,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,48,143,8,110,56,253,118,191,309,Non-Response,3.0045639445641e-05,0.217610201983462,0.0853301824292694,0.488860505450118,mechanism,309,191,118,combination,0.00265653120314428,0.0334092136026898,Anti-PD-1
Prostate ## Anti-AR,rna_geneset_KEGG_ASTHMA_gt50_or_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,27,31,0,21,27,52,21,58,79,Non-Response,3.06423025778695e-05,0,0,0.252624623525716,mechanism,79,58,21,combination,0.00270000176169269,0.0339559104283296,Anti-AR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_rna_geneset_HALLMARK_ADIPOGENESIS_lt50,95,3,49,17,144,20,66,98,164,Non-Response,3.11832197925076e-05,0.0923572999588298,0.0165437072299531,0.341183846027782,mechanism,164,98,66,combination,0.00272808492642067,0.0343090914667928,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50,95,3,49,17,144,20,66,98,164,Non-Response,3.11832197925076e-05,0.0923572999588298,0.0165437072299531,0.341183846027782,mechanism,164,98,66,combination,0.00272808492642067,0.0343090914667928,Platinum/Pyrimidine (ant)agonist
Prostate ## Anti-AR,purity_svTMB_gt75_or_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,39,19,3,18,42,37,21,58,79,Non-Response,3.19927620998439e-05,0.0840374446649822,0.0141349581297663,0.337462497686714,mechanism,79,58,21,combination,0.00279374819114416,0.0351348894225633,Anti-AR
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt25_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,23,28,4,45,27,73,49,51,100,Non-Response,3.24455486712289e-05,0.110684192267961,0.0251679414594162,0.370468967603859,mechanism,100,51,49,combination,0.00282569969086474,0.0355367196279936,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_or_rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50,74,24,28,38,102,62,66,98,164,Non-Response,3.26912212828387e-05,0.241296083423264,0.115539437540331,0.492500901161894,mechanism,164,98,66,combination,0.00284100865748103,0.0357292490946584,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_and_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,26,38,1,32,27,70,33,64,97,Non-Response,3.35008195068768e-05,0.0467218256964446,0.00108588338771398,0.317101270676115,mechanism,97,64,33,combination,0.00290360674316586,0.036516498577476,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_and_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,26,38,1,32,27,70,33,64,97,Non-Response,3.35008195068768e-05,0.0467218256964446,0.00108588338771398,0.317101270676115,mechanism,97,64,33,combination,0.00290360674316586,0.036516498577476,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,41,10,19,30,60,40,49,51,100,Non-Response,3.37804191217674e-05,0.15779773039118,0.0563061321623007,0.411275381981272,mechanism,100,51,49,combination,0.00292316582669566,0.0367624785978673,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_rna_geneset_KEGG_RIBOSOME_lt25,49,49,12,54,61,103,66,98,164,Non-Response,3.39007606646205e-05,0.22428945881753,0.0968267927640256,0.488468105206898,mechanism,164,98,66,combination,0.00292927051658344,0.0368392527340784,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_or_cn_simple_chr22_q_gt50,61,12,18,22,79,34,40,73,113,Non-Response,3.39230272372761e-05,0.164098506156197,0.0606986622930846,0.421402419409274,mechanism,113,73,40,combination,0.00292927051658344,0.0368392527340784,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,45,146,7,111,52,257,118,191,309,Non-Response,3.43573019344434e-05,0.205502527832632,0.0752680240982347,0.482273378879122,mechanism,309,191,118,combination,0.00295578231742679,0.037172671899763,Anti-PD-1
Skin Melanoma ## Anti-PD-1,driver_B2M_or_purity_tmbPerMb_lt75,31,28,9,48,40,76,57,59,116,Non-Response,3.48073865940909e-05,0.172166765366361,0.0625191223760669,0.435708380231803,mechanism,116,59,57,combination,0.00298975776303539,0.0375999557646168,Anti-PD-1
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_purity_tmbPerMb_lt75,31,28,9,48,40,76,57,59,116,Non-Response,3.48073865940909e-05,0.172166765366361,0.0625191223760669,0.435708380231803,mechanism,116,59,57,combination,0.00298975776303539,0.0375999557646168,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_rna_geneset_KEGG_RIBOSOME_lt25,32,66,4,62,36,128,66,98,164,Non-Response,3.5634748526967e-05,0.134488820773777,0.032660650029805,0.410683404545771,mechanism,164,98,66,combination,0.00304794257811035,0.038331702831232,Platinum/Pyrimidine (ant)agonist
Lung NSCLC ## Anti-PD-1,cn_simple_chr3_p_lt75_and_neo_ct_lt75,22,22,0,21,22,43,21,44,65,Non-Response,3.56826654516781e-05,0,0,0.229357000224767,mechanism,65,44,21,combination,0.00304883344041616,0.0383429065426848,Anti-PD-1
Skin Melanoma ## Anti-PD-1,driver_B2M_or_rna_geneset_APM_lt50,26,25,6,43,32,68,49,51,100,Non-Response,3.585549567895e-05,0.137077735735409,0.0404239288523692,0.39991776856487,mechanism,100,51,49,combination,0.0030619915369779,0.0385083861192527,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_gt50_or_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,44,20,8,25,52,45,33,64,97,Non-Response,3.81099777579246e-05,0.148755790243628,0.0488609498057029,0.41159839500605,mechanism,97,64,33,combination,0.00321901618882235,0.0404831681689234,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75_and_signature_log_DBS_denovo_5_eq0,85,13,38,28,123,41,66,98,164,Non-Response,3.82855224791683e-05,0.209800256070969,0.0891642854346597,0.471401850320697,mechanism,164,98,66,combination,0.00323048748524536,0.0406274341169546,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,36,155,4,114,40,269,118,191,309,Non-Response,3.95514391629723e-05,0.151781042142309,0.0381652782577305,0.44093308214318,mechanism,309,191,118,combination,0.00330580366352736,0.0415746295743177,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,36,155,4,114,40,269,118,191,309,Non-Response,3.95514391629723e-05,0.151781042142309,0.0381652782577305,0.44093308214318,mechanism,309,191,118,combination,0.00330580366352736,0.0415746295743177,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_and_rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75,15,10,1,22,16,32,23,25,48,Non-Response,3.97931149430648e-05,0.032755427465446,0.000695568222812231,0.265617678537732,mechanism,48,25,23,combination,0.00332149943712138,0.0417720236241378,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75_or_rna_geneset_KEGG_RIBOSOME_lt25,72,26,27,39,99,65,66,98,164,Non-Response,4.1309672828362e-05,0.252332914414701,0.121766577304487,0.511599327695984,mechanism,164,98,66,combination,0.00343047506769459,0.0431425289338435,Platinum/Pyrimidine (ant)agonist
Bladder Urothelial ## Anti-PD-1,clin_hasRadiotherapyPreTreatment_or_rna_geneset_HALLMARK_ANGIOGENESIS_gt75,21,13,1,18,22,31,19,34,53,Non-Response,4.22284101023431e-05,0.0365752125272126,0.000794663610946843,0.283852279142485,mechanism,53,34,19,combination,0.00349962029858348,0.0440121169837184,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,clin_hasRadiotherapyPreTreatment_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,21,13,1,18,22,31,19,34,53,Non-Response,4.22284101023431e-05,0.0365752125272126,0.000794663610946843,0.283852279142485,mechanism,53,34,19,combination,0.00349962029858348,0.0440121169837184,Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_or_cn_simple_chr3_p_gt50,12,9,1,26,13,35,27,21,48,Non-Response,4.21897779599494e-05,0.031399575461164,0.000656968591492052,0.262863862434326,mechanism,48,21,27,combination,0.00349962029858348,0.0440121169837184,Alkaloid/Platinum
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75,50,141,9,109,59,250,118,191,309,Non-Response,4.33032332120018e-05,0.233777718869513,0.0967521613434925,0.507219185758871,mechanism,409,247,162,univariate,0.00357898193247569,0.0450101891220864,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_or_rna_geneset_vhio_tcell_lt75,154,37,69,49,223,86,118,191,309,Non-Response,4.33401113485076e-05,0.339627384680771,0.196040231914542,0.583404261930086,mechanism,309,191,118,combination,0.00357898193247569,0.0450101891220864,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_and_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,48,19,12,28,60,47,40,67,107,Non-Response,4.34919700214578e-05,0.172882074320465,0.0652232217682442,0.433314154703868,mechanism,107,67,40,combination,0.00358787790032927,0.0451220670815364,Taxane
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_or_cn_simple_chr16_q_gt50,21,4,6,19,27,23,25,25,50,Non-Response,4.38040641370287e-05,0.0648811565976518,0.0112837259229885,0.289281832688724,mechanism,50,25,25,combination,0.00359175654087376,0.0451708458537508,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr20_q_gt25_and_cn_simple_chr22_q_gt25,21,4,6,19,27,23,25,25,50,Non-Response,4.38040641370287e-05,0.0648811565976518,0.0112837259229885,0.289281832688724,mechanism,50,25,25,combination,0.00359175654087376,0.0451708458537508,Pyrimidine (ant)agonist
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,18,7,3,20,21,27,23,25,48,Non-Response,4.3804064137029e-05,0.0629865995713412,0.00904559770146725,0.304050950533491,mechanism,48,25,23,combination,0.00359175654087376,0.0451708458537508,Multikinase inhibitor
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr2_q_gt50_or_cn_simple_chr3_p_gt25,18,3,7,20,25,23,27,21,48,Non-Response,4.38040641370291e-05,0.0629865995713412,0.00904559770146727,0.304050950533491,mechanism,48,21,27,combination,0.00359175654087376,0.0451708458537508,Alkaloid/Platinum
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,33,48,4,45,37,93,49,81,130,Non-Response,4.48135368558705e-05,0.131102902205815,0.03128587863774,0.410972051473891,mechanism,130,81,49,combination,0.00364876888617468,0.0458878476416065,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_neo_ct_lt75,124,96,45,88,169,184,133,220,353,Non-Response,4.54355747499671e-05,0.396958760891788,0.246446797845815,0.633557702063012,mechanism,353,220,133,combination,0.00369202078120697,0.0464317944991268,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_neo_ct_lt75,124,96,45,88,169,184,133,220,353,Non-Response,4.54355747499671e-05,0.396958760891788,0.246446797845815,0.633557702063012,mechanism,353,220,133,combination,0.00369202078120697,0.0464317944991268,Anti-PD-1
Prostate ## Anti-AR,purity_svTMB_gt75_or_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,44,14,5,16,49,30,21,58,79,Non-Response,4.60959088681281e-05,0.103077371749316,0.0247938460302418,0.35958488618431,mechanism,79,58,21,combination,0.00373448061292471,0.0469657801664938,Anti-AR
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,32,35,4,36,36,71,40,67,107,Non-Response,4.67648681269096e-05,0.123798784616618,0.0288050373088163,0.401145037968082,mechanism,107,67,40,combination,0.0037699007135739,0.0474112323814036,Taxane
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_and_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,32,35,4,36,36,71,40,67,107,Non-Response,4.67648681269096e-05,0.123798784616618,0.0288050373088163,0.401145037968082,mechanism,107,67,40,combination,0.0037699007135739,0.0474112323814036,Taxane
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,64,127,15,103,79,230,118,191,309,Non-Response,4.68283355514839e-05,0.290068480481351,0.144708098241241,0.551632277295112,mechanism,309,191,118,combination,0.00377126978900455,0.0474284502230184,Anti-PD-1
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_or_cn_simple_chr21_p_gt75,20,5,5,20,25,25,25,25,50,Non-Response,4.72776788310318e-05,0.0673429274856372,0.0123273306937826,0.294235746960016,mechanism,50,25,25,combination,0.00378641064494511,0.0476188654869713,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_and_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,54,44,15,51,69,95,66,98,164,Non-Response,4.73938536213973e-05,0.241825933844851,0.110670987421188,0.506152865751588,mechanism,164,98,66,combination,0.00378641064494511,0.0476188654869713,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_and_signature_log_SBS_denovo_26_eq0,54,44,15,51,69,95,66,98,164,Non-Response,4.73938536213973e-05,0.241825933844851,0.110670987421188,0.506152865751588,mechanism,164,98,66,combination,0.00378641064494511,0.0476188654869713,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_and_signature_log_SBS_denovo_26_eq0,54,44,15,51,69,95,66,98,164,Non-Response,4.73938536213973e-05,0.241825933844851,0.110670987421188,0.506152865751588,mechanism,164,98,66,combination,0.00378641064494511,0.0476188654869713,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_and_signature_log_SBS20_eq0,54,44,15,51,69,95,66,98,164,Non-Response,4.73938536213973e-05,0.241825933844851,0.110670987421188,0.506152865751588,mechanism,164,98,66,combination,0.00378641064494511,0.0476188654869713,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,65,16,22,27,87,43,49,81,130,Non-Response,4.81265875060326e-05,0.203430402933879,0.0847352042586062,0.47136545039144,mechanism,130,81,49,combination,0.00382094085708295,0.0480531262371157,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_and_rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50,43,24,9,31,52,55,40,67,107,Non-Response,4.86604438119123e-05,0.165083530632773,0.058743088545674,0.426728927840553,mechanism,107,67,40,combination,0.00385579475776283,0.048491457776878,Taxane
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_IL6_JAK_STAT3_SIGNALING_gt50_or_rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75,15,0,18,24,33,24,42,15,57,Non-Response,5.00130655145618e-05,0,0,0.251924157908804,mechanism,57,15,42,combination,0.00389111989039763,0.04893571564983,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_gene_set_impres_lt75,12,2,2,15,14,17,17,14,31,Non-Response,5.01352794645877e-05,0.0275288464950799,0.00167604220639693,0.234510076981764,mechanism,31,14,17,combination,0.00389111989039763,0.04893571564983,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_HALLMARK_COMPLEMENT_lt50,12,2,2,15,14,17,17,14,31,Non-Response,5.01352794645877e-05,0.0275288464950799,0.00167604220639693,0.234510076981764,mechanism,31,14,17,combination,0.00389111989039763,0.04893571564983,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75_and_rna_geneset_gene_set_t_cell_gep_10_lt75,12,2,2,15,14,17,17,14,31,Non-Response,5.01352794645877e-05,0.0275288464950799,0.00167604220639693,0.234510076981764,mechanism,31,14,17,combination,0.00389111989039763,0.04893571564983,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,12,2,2,15,14,17,17,14,31,Non-Response,5.01352794645877e-05,0.0275288464950799,0.00167604220639693,0.234510076981764,mechanism,31,14,17,combination,0.00389111989039763,0.04893571564983,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75_and_rna_geneset_HALLMARK_COMPLEMENT_lt50,12,2,2,15,14,17,17,14,31,Non-Response,5.01352794645877e-05,0.0275288464950799,0.00167604220639693,0.234510076981764,mechanism,31,14,17,combination,0.00389111989039763,0.04893571564983,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_HALLMARK_COMPLEMENT_lt50,12,2,2,15,14,17,17,14,31,Non-Response,5.01352794645877e-05,0.0275288464950799,0.00167604220639693,0.234510076981764,mechanism,31,14,17,combination,0.00389111989039763,0.04893571564983,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_HALLMARK_COMPLEMENT_lt50,12,2,2,15,14,17,17,14,31,Non-Response,5.01352794645877e-05,0.0275288464950799,0.00167604220639693,0.234510076981764,mechanism,31,14,17,combination,0.00389111989039763,0.04893571564983,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,27,24,7,42,34,66,49,51,100,Non-Response,5.04996387155794e-05,0.151235794852179,0.0480230112178226,0.422850416800575,mechanism,100,51,49,combination,0.00391566058935421,0.0492443457357214,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_12_chemokine_lt75,128,63,51,67,179,130,118,191,309,Non-Response,5.14590512580869e-05,0.375908715531501,0.227057769358385,0.617857627261131,mechanism,409,247,162,univariate,0.0039748877987945,0.0499892022195977,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_purity_tmbPerMb_lt75,77,170,22,140,99,310,162,247,409,Non-Response,5.17728557695782e-05,0.347786780497574,0.195613004238047,0.598796389582304,mechanism,409,247,162,combination,0.00399343586452651,0.0502224674224397,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_or_fusion_total_gt50,62,11,19,21,81,32,40,73,113,Non-Response,5.33743130986961e-05,0.163662456394904,0.0593435079633499,0.426929415120561,mechanism,113,73,40,combination,0.00410916503845729,0.0516779070149956,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_Immune_Checkpoint_lt75,129,62,52,66,181,128,118,191,309,Non-Response,5.3727165965437e-05,0.379931836892542,0.229495817300219,0.624674824578622,mechanism,409,247,162,univariate,0.00412461271560346,0.0518721809406438,Anti-PD-1
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_COLORECTAL_CANCER_lt50_or_rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,32,0,9,8,41,8,17,32,49,Non-Response,5.39050606509986e-05,0,0,0.212327637638868,mechanism,49,32,17,combination,0.00413046892164518,0.0519458300806643,Anti-EGFR
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_drivers_pathway_perplexity_total_gt75,43,67,7,57,50,124,64,110,174,Non-Response,5.42009870909825e-05,0.193016388482178,0.0678846932553912,0.47718798154653,mechanism,174,110,64,combination,0.00414923356827663,0.0521818190601076,Multikinase inhibitor
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_or_rna_geneset_gene_set_t_cell_gep_10_lt75,18,1,7,15,25,16,22,19,41,Non-Response,5.90551880603158e-05,0.0288266334170056,0.000591048611124194,0.248946742975493,mechanism,41,19,22,combination,0.0044148301003362,0.0555220287520581,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_or_rna_geneset_gene_set_t_cell_gep_6_lt75,18,1,7,15,25,16,22,19,41,Non-Response,5.90551880603158e-05,0.0288266334170056,0.000591048611124194,0.248946742975493,mechanism,41,19,22,combination,0.0044148301003362,0.0555220287520581,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_or_rna_geneset_gene_set_tim3_lt75,18,1,7,15,25,16,22,19,41,Non-Response,5.90551880603158e-05,0.0288266334170056,0.000591048611124194,0.248946742975493,mechanism,41,19,22,combination,0.0044148301003362,0.0555220287520581,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_gene_set_tim3_lt75,18,1,7,15,25,16,22,19,41,Non-Response,5.90551880603158e-05,0.0288266334170056,0.000591048611124194,0.248946742975493,mechanism,41,19,22,combination,0.0044148301003362,0.0555220287520581,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_gene_set_tim3_lt75,18,1,7,15,25,16,22,19,41,Non-Response,5.90551880603158e-05,0.0288266334170056,0.000591048611124194,0.248946742975493,mechanism,41,19,22,combination,0.0044148301003362,0.0555220287520581,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,53,28,14,35,67,63,49,81,130,Non-Response,5.93679228703318e-05,0.214115184315915,0.0902034768935823,0.485932719240286,mechanism,130,81,49,combination,0.00442458503056359,0.0556447092412843,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50,42,25,9,31,51,56,40,67,107,Non-Response,6.03619898258863e-05,0.175901522013068,0.0627706551979838,0.453643806590056,mechanism,107,67,40,combination,0.0044877635215864,0.0564392580495868,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75_or_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,42,25,9,31,51,56,40,67,107,Non-Response,6.03619898258863e-05,0.175901522013068,0.0627706551979838,0.453643806590056,mechanism,107,67,40,combination,0.0044877635215864,0.0564392580495868,Taxane
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,56,25,16,33,72,58,49,81,130,Non-Response,6.06943688365762e-05,0.219282599824676,0.0938678418814168,0.493490108854149,mechanism,130,81,49,combination,0.00450423687087614,0.0566464310895726,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_or_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,56,25,16,33,72,58,49,81,130,Non-Response,6.06943688365762e-05,0.219282599824676,0.0938678418814168,0.493490108854149,mechanism,130,81,49,combination,0.00450423687087614,0.0566464310895726,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,32,159,3,115,35,274,118,191,309,Non-Response,6.37702300844167e-05,0.130243925721189,0.0249192975621588,0.431954433017304,mechanism,309,191,118,combination,0.00467700129511321,0.0588191605291705,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,51,30,13,36,64,66,49,81,130,Non-Response,6.42941020642336e-05,0.215168466033285,0.0895572548728239,0.491781756166586,mechanism,130,81,49,combination,0.0047090506339821,0.0592222211846705,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75_or_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,66,1,29,11,95,12,40,67,107,Non-Response,6.47404867320332e-05,0.0411058698914081,0.000919968448934901,0.306006770434423,mechanism,107,67,40,combination,0.00471836560361055,0.0593393686172515,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50_or_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,66,1,29,11,95,12,40,67,107,Non-Response,6.47404867320332e-05,0.0411058698914081,0.000919968448934901,0.306006770434423,mechanism,107,67,40,combination,0.00471836560361055,0.0593393686172515,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75_or_rna_geneset_KEGG_STEROID_BIOSYNTHESIS_lt25,66,1,29,11,95,12,40,67,107,Non-Response,6.47404867320332e-05,0.0411058698914081,0.000919968448934901,0.306006770434423,mechanism,107,67,40,combination,0.00471836560361055,0.0593393686172515,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75_or_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,66,1,29,11,95,12,40,67,107,Non-Response,6.47404867320332e-05,0.0411058698914081,0.000919968448934901,0.306006770434423,mechanism,107,67,40,combination,0.00471836560361055,0.0593393686172515,Taxane
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,41,150,6,112,47,262,118,191,309,Non-Response,6.48316790334547e-05,0.196851451627412,0.0659660881297497,0.488385650041942,mechanism,309,191,118,combination,0.00472077982421929,0.0593697304710501,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_PRIMARY_IMMUNODEFICIENCY_lt75,136,55,57,61,193,116,118,191,309,Non-Response,6.51708748288892e-05,0.379161120584443,0.227840808306974,0.627033822318685,mechanism,409,247,162,univariate,0.00473276190505928,0.0595204201741164,Anti-PD-1
Pan-Cancer ## Anti-EGFR,cn_simple_chr1_p_lt75_and_rna_geneset_KEGG_COLORECTAL_CANCER_lt50,25,7,3,14,28,21,17,32,49,Non-Response,6.51603923295699e-05,0.0647290372120754,0.00922982853266888,0.316742621242501,mechanism,49,32,17,combination,0.00473276190505928,0.0595204201741164,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_COLORECTAL_CANCER_lt50_and_rna_geneset_KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM_gt50,25,7,3,14,28,21,17,32,49,Non-Response,6.51603923295699e-05,0.0647290372120754,0.00922982853266888,0.316742621242501,mechanism,49,32,17,combination,0.00473276190505928,0.0595204201741164,Anti-EGFR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,79,19,33,33,112,52,66,98,164,Non-Response,6.6114135855265e-05,0.242805008357015,0.11274022233895,0.509314407182204,mechanism,164,98,66,combination,0.00478843040614449,0.060220521434548,Platinum/Pyrimidine (ant)agonist
Prostate ## Anti-AR,purity_svTMB_gt75_or_rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,41,17,4,17,45,34,21,58,79,Non-Response,6.6101839363293e-05,0.100886176208512,0.0214823157873491,0.368516990137142,mechanism,79,58,21,combination,0.00478843040614449,0.060220521434548,Anti-AR
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,35,46,5,44,40,90,49,81,130,Non-Response,6.62341562834522e-05,0.151381854288524,0.0424067743026561,0.436822846464506,mechanism,130,81,49,combination,0.00479285329033234,0.0602761447535577,Multikinase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr3_q_gt25_or_rna_geneset_HALLMARK_ALLOGRAFT_REJECTION_lt25,19,1,11,17,30,18,28,20,48,Non-Response,6.77527192364481e-05,0.0365694779025525,0.000781169401795967,0.292964076832278,mechanism,48,20,28,combination,0.00486445553576075,0.0611766328446137,Aromatase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_or_signature_log_DBS_denovo_5_eq0,95,3,50,16,145,19,66,98,164,Non-Response,6.8312277687799e-05,0.100079940314101,0.0178486698848474,0.37302365932151,mechanism,164,98,66,combination,0.0048931452543968,0.0615374420596451,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,67,124,17,101,84,225,118,191,309,Non-Response,6.84695294400691e-05,0.312622305607122,0.161428567298749,0.579437599046553,mechanism,309,191,118,combination,0.00490224947067211,0.0616519390043325,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,38,153,5,113,43,266,118,191,309,Non-Response,6.87177976280619e-05,0.17895368792123,0.0532842889702264,0.475511272855971,mechanism,309,191,118,combination,0.00490427570033725,0.0616774213851194,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,35,156,4,114,39,270,118,191,309,Non-Response,6.88296113615764e-05,0.157113801653504,0.0394535510299592,0.457400057815895,mechanism,309,191,118,combination,0.00490427570033725,0.0616774213851194,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75_or_signature_log_DBS_denovo_5_eq0,94,4,49,17,143,21,66,98,164,Non-Response,6.88149474505186e-05,0.124276498748081,0.0288348184620004,0.408821062817581,mechanism,164,98,66,combination,0.00490427570033725,0.0616774213851194,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_or_signature_log_SBS20_eq0,94,4,49,17,143,21,66,98,164,Non-Response,6.88149474505186e-05,0.124276498748081,0.0288348184620004,0.408821062817581,mechanism,164,98,66,combination,0.00490427570033725,0.0616774213851194,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_and_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,47,17,10,23,57,40,33,64,97,Non-Response,6.86412634173257e-05,0.160786635094896,0.0556160011520585,0.434095492616303,mechanism,97,64,33,combination,0.00490427570033725,0.0616774213851194,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_and_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,47,17,10,23,57,40,33,64,97,Non-Response,6.86412634173257e-05,0.160786635094896,0.0556160011520585,0.434095492616303,mechanism,97,64,33,combination,0.00490427570033725,0.0616774213851194,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-EGFR,cn_simple_chr1_p_lt75_and_rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75,28,4,5,12,33,16,17,32,49,Non-Response,7.00893935924001e-05,0.0646764449273838,0.0103171383810442,0.314106846537247,mechanism,49,32,17,combination,0.00496358676800395,0.062423332491428,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_and_rna_geneset_KEGG_COLORECTAL_CANCER_lt50,28,4,5,12,33,16,17,32,49,Non-Response,7.00893935924001e-05,0.0646764449273838,0.0103171383810442,0.314106846537247,mechanism,49,32,17,combination,0.00496358676800395,0.062423332491428,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_and_rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75,28,4,5,12,33,16,17,32,49,Non-Response,7.00893935924001e-05,0.0646764449273838,0.0103171383810442,0.314106846537247,mechanism,49,32,17,combination,0.00496358676800395,0.062423332491428,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_and_rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,28,4,5,12,33,16,17,32,49,Non-Response,7.00893935924001e-05,0.0646764449273838,0.0103171383810442,0.314106846537247,mechanism,49,32,17,combination,0.00496358676800395,0.062423332491428,Anti-EGFR
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_drivers_total_gt50,100,10,42,22,142,32,64,110,174,Non-Response,7.06026771715326e-05,0.1929696401475,0.0746555044419802,0.467599401907783,mechanism,174,110,64,combination,0.00499341196291294,0.0627984217455188,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_and_fusion_total_gt50,43,30,8,32,51,62,40,73,113,Non-Response,7.1100721929912e-05,0.177255779974064,0.0616144536042105,0.460950649917758,mechanism,113,73,40,combination,0.00501554671772661,0.0630767940645556,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,neo_ct_lt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,49,139,9,107,58,246,116,188,304,Non-Response,7.16120973871728e-05,0.239565162104951,0.0989773525011998,0.52097755145479,mechanism,304,188,116,combination,0.00503850446168738,0.0633655165048993,Anti-PD-1
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_q_gt25,29,6,12,23,41,29,35,35,70,Non-Response,7.40762218599451e-05,0.112100044607571,0.0293413522198651,0.371105128324829,mechanism,70,35,35,univariate,0.00517159532931874,0.0650393011832049,Aromatase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_signature_log_SBS_denovo_26_eq0,94,26,38,38,132,64,76,120,196,Non-Response,7.7149477133397e-05,0.278613174578875,0.141009500388874,0.541339681932425,mechanism,196,120,76,combination,0.0053516854449386,0.0673041603850678,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,130,61,53,65,183,126,118,191,309,Non-Response,7.87340367302182e-05,0.383868343892083,0.231795210638846,0.631448991993112,mechanism,309,191,118,combination,0.00543147938237591,0.0683076692830198,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25,130,61,53,65,183,126,118,191,309,Non-Response,7.87340367302182e-05,0.383868343892083,0.231795210638846,0.631448991993112,mechanism,309,191,118,combination,0.00543147938237591,0.0683076692830198,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50,36,31,6,34,42,65,40,67,107,Non-Response,7.93359821285007e-05,0.154690581094398,0.0467543247873938,0.437993163442468,mechanism,107,67,40,combination,0.00546836457063585,0.0687715468131964,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75_and_signature_log_SBS20_eq0,85,13,39,27,124,40,66,98,164,Non-Response,7.95980304572954e-05,0.22317838235239,0.0947369357787201,0.502832954849001,mechanism,164,98,66,combination,0.00547713946521173,0.0688819021242426,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,53,138,11,107,64,245,118,191,309,Non-Response,7.97503186858936e-05,0.268700748796895,0.120542341558702,0.55214701670328,mechanism,409,247,162,univariate,0.00548297772418137,0.0689553255573095,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25,57,16,16,24,73,40,40,73,113,Non-Response,7.98792833411174e-05,0.190387977719237,0.0739885038876795,0.469922661991809,mechanism,113,73,40,univariate,0.0054872039343891,0.0690084754542101,Pyrimidine (ant)agonist
Lung NSCLC ## Anti-PD-1,neo_ct_lt75_or_purity_tmbPerMb_lt75,24,20,1,20,25,40,21,44,65,Non-Response,8.2754202423955e-05,0.0434243884898433,0.000971340213981794,0.318514787806353,mechanism,65,44,21,combination,0.00561882204869301,0.0706637384112414,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_or_fusion_total_gt50,69,4,26,14,95,18,40,73,113,Non-Response,8.27974367991516e-05,0.110117947128656,0.0241689196901599,0.391918586687655,mechanism,113,73,40,combination,0.00561882204869301,0.0706637384112414,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-EGFR,cn_simple_chr1_p_lt75_and_rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,27,5,4,13,31,18,17,32,49,Non-Response,8.44577179240746e-05,0.0619768177171295,0.0099508253444721,0.297501160596018,mechanism,49,32,17,combination,0.0056680423474913,0.0712827454359636,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM_gt50_and_rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75,27,5,4,13,31,18,17,32,49,Non-Response,8.44577179240746e-05,0.0619768177171295,0.0099508253444721,0.297501160596018,mechanism,49,32,17,combination,0.0056680423474913,0.0712827454359636,Anti-EGFR
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_cn_simple_chr17_p_lt75,95,15,38,26,133,41,64,110,174,Non-Response,8.39968416022558e-05,0.232996516150096,0.102395510845368,0.512998012334528,mechanism,174,110,64,combination,0.0056680423474913,0.0712827454359636,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50_or_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,58,9,20,20,78,29,40,67,107,Non-Response,8.41064963544023e-05,0.158415538307004,0.0538613007754921,0.432691511663502,mechanism,107,67,40,combination,0.0056680423474913,0.0712827454359636,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,91,2,51,14,142,16,65,93,158,Non-Response,8.54649197631502e-05,0.0812474307235164,0.00862626393589769,0.375245107650047,mechanism,158,93,65,combination,0.00573048454583451,0.0720680344398349,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50_and_rna_geneset_KEGG_STEROID_BIOSYNTHESIS_gt25,50,17,14,26,64,43,40,67,107,Non-Response,8.62864209863271e-05,0.186437335454238,0.0714364095196529,0.464349115067135,mechanism,107,67,40,combination,0.00578079912630194,0.072700803429778,Taxane
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,27,7,4,15,31,22,19,34,53,Non-Response,8.73099917370455e-05,0.0739165346434548,0.0132995420732357,0.321967235843857,mechanism,53,34,19,combination,0.00581106428017197,0.0730814257199153,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_or_rna_geneset_HALLMARK_ALLOGRAFT_REJECTION_lt25,17,3,7,21,24,24,28,20,48,Non-Response,8.82777082593549e-05,0.0635061055492916,0.00911073037955655,0.307171374214875,mechanism,48,20,28,combination,0.00586826607013679,0.0738008100121566,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_p_gt50_or_cn_simple_chr3_q_gt25,22,2,14,21,36,23,35,24,59,Non-Response,8.90612280477331e-05,0.063711659288663,0.00630382729057803,0.324644203283016,mechanism,59,24,35,combination,0.00590586360444752,0.0742736461878562,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_q_gt50_or_cn_simple_chr3_q_gt25,22,2,14,21,36,23,35,24,59,Non-Response,8.90612280477331e-05,0.063711659288663,0.00630382729057803,0.324644203283016,mechanism,59,24,35,combination,0.00590586360444752,0.0742736461878562,Aromatase inhibitor
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_and_rna_geneset_gene_set_t_cell_gep_10_lt75,12,7,1,21,13,28,22,19,41,Non-Response,9.26833667819587e-05,0.0309144346858584,0.0006279018432691,0.270956039608746,mechanism,41,19,22,combination,0.00607666535161811,0.0764216925003487,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_and_rna_geneset_gene_set_t_cell_gep_6_lt75,12,7,1,21,13,28,22,19,41,Non-Response,9.26833667819587e-05,0.0309144346858584,0.0006279018432691,0.270956039608746,mechanism,41,19,22,combination,0.00607666535161811,0.0764216925003487,Anti-CTLA-4/Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_and_rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50,12,13,0,23,12,36,23,25,48,Non-Response,9.40507511753335e-05,0,0,0.254580900197091,mechanism,48,25,23,combination,0.0061394469253902,0.0772112495761255,Multikinase inhibitor
Prostate ## Taxane,cn_simple_chr18_q_lt25_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50,32,9,4,14,36,23,18,41,59,Non-Response,9.40057533840415e-05,0.084917039172788,0.0161178336402023,0.352984468397664,mechanism,59,41,18,combination,0.0061394469253902,0.0772112495761255,Taxane
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75,17,2,6,16,23,18,22,19,41,Non-Response,9.62984994022189e-05,0.0487568904472356,0.0042475142415953,0.295971981514748,mechanism,50,24,26,univariate,0.00618158049972443,0.0777411321474694,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75,17,2,6,16,23,18,22,19,41,Non-Response,9.62984994022189e-05,0.0487568904472356,0.0042475142415953,0.295971981514748,mechanism,50,24,26,univariate,0.00618158049972443,0.0777411321474694,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50,29,3,6,11,35,14,17,32,49,Non-Response,9.55663172863119e-05,0.0613465531589278,0.00835013350543154,0.319316907032392,mechanism,57,38,19,univariate,0.00618158049972443,0.0777411321474694,Anti-EGFR
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,17,2,6,16,23,18,22,19,41,Non-Response,9.62984994022189e-05,0.0487568904472356,0.0042475142415953,0.295971981514748,mechanism,41,19,22,combination,0.00618158049972443,0.0777411321474694,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_gene_set_t_cell_gep_18_lt50,17,2,6,16,23,18,22,19,41,Non-Response,9.62984994022189e-05,0.0487568904472356,0.0042475142415953,0.295971981514748,mechanism,41,19,22,combination,0.00618158049972443,0.0777411321474694,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,17,2,6,16,23,18,22,19,41,Non-Response,9.62984994022189e-05,0.0487568904472356,0.0042475142415953,0.295971981514748,mechanism,41,19,22,combination,0.00618158049972443,0.0777411321474694,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt50_or_rna_geneset_gene_set_t_cell_gep_6_lt75,17,2,6,16,23,18,22,19,41,Non-Response,9.62984994022189e-05,0.0487568904472356,0.0042475142415953,0.295971981514748,mechanism,41,19,22,combination,0.00618158049972443,0.0777411321474694,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,126,65,51,67,177,132,118,191,309,Non-Response,9.58484100752889e-05,0.39392491229178,0.238385057936347,0.646510530750907,mechanism,309,191,118,combination,0.00618158049972443,0.0777411321474694,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,28,163,2,116,30,279,118,191,309,Non-Response,9.61205178656745e-05,0.100842962372855,0.0114130514699455,0.413386997322042,mechanism,309,191,118,combination,0.00618158049972443,0.0777411321474694,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,28,163,2,116,30,279,118,191,309,Non-Response,9.61205178656745e-05,0.100842962372855,0.0114130514699455,0.413386997322042,mechanism,309,191,118,combination,0.00618158049972443,0.0777411321474694,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_signature_log_SBS20_eq0,92,28,37,39,129,67,76,120,196,Non-Response,9.58765499999418e-05,0.290760746237404,0.148564411258784,0.56035121653221,mechanism,196,120,76,combination,0.00618158049972443,0.0777411321474694,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_and_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,39,59,8,58,47,117,66,98,164,Non-Response,9.78400549965049e-05,0.2105646050468,0.0781166438070319,0.507284189931159,mechanism,164,98,66,combination,0.00624022047241855,0.0784786033923299,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_and_rna_geneset_KEGG_RIBOSOME_gt50,31,33,3,30,34,63,33,64,97,Non-Response,9.79411963591935e-05,0.108696774814807,0.019291812055171,0.403645972890534,mechanism,97,64,33,combination,0.00624022047241855,0.0784786033923299,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_and_rna_geneset_KEGG_RIBOSOME_gt50,31,33,3,30,34,63,33,64,97,Non-Response,9.79411963591935e-05,0.108696774814807,0.019291812055171,0.403645972890534,mechanism,97,64,33,combination,0.00624022047241855,0.0784786033923299,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,123,68,49,69,172,137,118,191,309,Non-Response,9.884450075875e-05,0.393841944100049,0.238405297642001,0.645889916609341,mechanism,309,191,118,combination,0.00628791789294649,0.0790784583117185,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_or_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,59,5,19,14,78,19,33,64,97,Non-Response,9.95720757678221e-05,0.118189948289973,0.0292880081883559,0.402807087485726,mechanism,97,64,33,combination,0.00631331081735247,0.0793978062021073,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_DBS_denovo_5_eq0,109,11,52,24,161,35,76,120,196,Non-Response,0.000101063261809527,0.220519187255825,0.0901758712378316,0.509110927717327,mechanism,196,120,76,univariate,0.00636678971085063,0.0800703703993585,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,purity_tml_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,27,164,2,116,29,280,118,191,309,Non-Response,0.000100935798360654,0.105272431395129,0.0118783903431454,0.432747133417222,mechanism,309,191,118,combination,0.00636678971085063,0.0800703703993585,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_DBS_denovo_5_eq0_and_signature_log_SBS_denovo_26_eq0,109,11,52,24,161,35,76,120,196,Non-Response,0.000101063261809527,0.220519187255825,0.0901758712378316,0.509110927717327,mechanism,196,120,76,combination,0.00636678971085063,0.0800703703993585,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_DBS_denovo_5_eq0_and_signature_log_SBS20_eq0,109,11,52,24,161,35,76,120,196,Non-Response,0.000101063261809527,0.220519187255825,0.0901758712378316,0.509110927717327,mechanism,196,120,76,combination,0.00636678971085063,0.0800703703993585,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_MTOR_SIGNALING_PATHWAY_gt50,12,3,9,33,21,36,42,15,57,Non-Response,0.000101147026884536,0.072491796566936,0.010793635093922,0.342778965768668,mechanism,57,15,42,combination,0.00636713289871149,0.0800746864173808,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr21_p_gt75,14,11,1,24,15,35,25,25,50,Non-Response,0.000101921319381886,0.0351532935203461,0.000750204531972951,0.282807666792397,mechanism,50,25,25,univariate,0.00637557507354815,0.0801808573601708,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr20_q_gt25_and_cn_simple_chr21_p_gt75,14,11,1,24,15,35,25,25,50,Non-Response,0.000101921319381886,0.0351532935203461,0.000750204531972951,0.282807666792397,mechanism,50,25,25,combination,0.00637557507354815,0.0801808573601708,Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_Colostage_one_gt25,45,36,10,39,55,75,49,81,130,Non-Response,0.000101755975831994,0.207719717407041,0.0809156070872677,0.494728463168794,mechanism,130,81,49,combination,0.00637557507354815,0.0801808573601708,Multikinase inhibitor
Bladder Urothelial ## Anti-PD-1,clin_hasRadiotherapyPreTreatment_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,20,14,1,18,21,32,19,34,53,Non-Response,0.000103356744558222,0.0411753873247592,0.000895690093414705,0.318770337713111,mechanism,53,34,19,combination,0.00642661566029743,0.0808227567901851,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_and_signature_log_DBS_denovo_5_eq0,56,42,17,49,73,91,66,98,164,Non-Response,0.000105450502699815,0.26244370723106,0.123278345739875,0.539575864141159,mechanism,164,98,66,combination,0.00652685224133404,0.0820833575851962,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,57,24,17,32,74,56,49,81,130,Non-Response,0.000105779826386229,0.226553413423817,0.0975516258423018,0.508428121230724,mechanism,130,81,49,combination,0.00653626417732146,0.0822017244914257,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,36,45,6,43,42,88,49,81,130,Non-Response,0.00010698480586315,0.176651551812221,0.0551935193023114,0.480362367297857,mechanism,130,81,49,combination,0.0065964407461455,0.082958520360919,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,63,4,25,15,88,19,40,67,107,Non-Response,0.000107061631318208,0.108404916672603,0.0238274286199511,0.383040687744463,mechanism,107,67,40,combination,0.0065964407461455,0.082958520360919,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_signature_log_SBS20_eq0,92,6,47,19,139,25,66,98,164,Non-Response,0.000111132533273228,0.163255631513514,0.0499005132402232,0.460901252182608,mechanism,164,98,66,combination,0.00679576067888692,0.085465218644888,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_GRAFT_VERSUS_HOST_DISEASE_lt25,40,151,6,112,46,263,118,191,309,Non-Response,0.000111831281747959,0.203102917756552,0.0679804125520477,0.504783096299402,mechanism,409,247,162,univariate,0.00681286727225726,0.0856803555238554,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,17,17,0,19,17,36,19,34,53,Non-Response,0.000113395461937644,0,0,0.268002924810519,mechanism,53,34,19,combination,0.00688237227328744,0.0865544681347383,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75_and_signature_log_SBS_denovo_26_eq0,86,12,40,26,126,38,66,98,164,Non-Response,0.000115298971706163,0.216904840230305,0.0898350340064498,0.497792260760931,mechanism,164,98,66,combination,0.00699268265627702,0.0879417596310819,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt25,39,152,6,112,45,264,118,191,309,Non-Response,0.000115441687675875,0.209674540517108,0.0700923645485491,0.522132786965452,mechanism,409,247,162,univariate,0.00699611909531194,0.0879849771643878,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50_or_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,54,27,15,34,69,61,49,81,130,Non-Response,0.000117019405983088,0.223376615738343,0.0951884604387681,0.503678602444576,mechanism,130,81,49,combination,0.00704821979105843,0.0886402087953896,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75_and_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,57,41,18,48,75,89,66,98,164,Non-Response,0.000116854388334238,0.27200224130218,0.129059200199713,0.555295886845551,mechanism,164,98,66,combination,0.00704821979105843,0.0886402087953896,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,18,63,0,49,18,112,49,81,130,Non-Response,0.00011778142956312,0,0,0.313969131621636,mechanism,130,81,49,combination,0.00707724496825728,0.0890052368228204,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50,69,24,28,37,97,61,65,93,158,Non-Response,0.000117697546428515,0.265646839883961,0.126551550365564,0.54554527204092,mechanism,158,93,65,combination,0.00707724496825728,0.0890052368228204,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_drivers_pathway_perplexity_total_gt75,96,14,39,25,135,39,64,110,174,Non-Response,0.000118250720307294,0.229711853134836,0.099054165228935,0.513614715508976,mechanism,174,110,64,combination,0.00710019594554113,0.0892938741637104,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt25,34,157,4,114,38,271,118,191,309,Non-Response,0.000120945932456715,0.162759899741703,0.0408135881161241,0.474970326470205,mechanism,409,247,162,univariate,0.00723264682809744,0.0909596102265697,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,34,157,4,114,38,271,118,191,309,Non-Response,0.000120945932456715,0.162759899741703,0.0408135881161241,0.474970326470205,mechanism,309,191,118,combination,0.00723264682809744,0.0909596102265697,Anti-PD-1
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_and_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,38,3,8,10,46,13,18,41,59,Non-Response,0.000121887763613221,0.067500870159897,0.00968606305689941,0.335212910128911,mechanism,59,41,18,combination,0.00728093555767175,0.0915669015992595,Taxane
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75_or_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,10,5,5,37,15,42,42,15,57,Non-Response,0.000122978382886895,0.0725284471700686,0.0127802474100168,0.338547179895853,mechanism,57,15,42,combination,0.00730784568672011,0.0919053302419904,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,33,158,4,114,37,272,118,191,309,Non-Response,0.000126826770489402,0.168747792138699,0.0422515537799428,0.493632347526985,mechanism,309,191,118,combination,0.00746008968680122,0.0938199895964213,Anti-PD-1
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75,11,4,7,35,18,39,42,15,57,Non-Response,0.00012665171873306,0.077583807131835,0.0136596768759197,0.351360034285381,mechanism,57,15,42,combination,0.00746008968680122,0.0938199895964213,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75_or_rna_geneset_KEGG_MTOR_SIGNALING_PATHWAY_gt50,11,4,7,35,18,39,42,15,57,Non-Response,0.00012665171873306,0.077583807131835,0.0136596768759197,0.351360034285381,mechanism,57,15,42,combination,0.00746008968680122,0.0938199895964213,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Prostate ## Anti-AR,chord_BRCA1_gt0_or_signature_log_SBS1_lt25,23,45,0,29,23,74,29,68,97,Non-Response,0.000128649277946767,0,0,0.301487430032756,mechanism,97,68,29,combination,0.00754894092226215,0.0949374053831674,Anti-AR
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_impres_lt75,129,62,53,65,182,127,118,191,309,Non-Response,0.000129954205405279,0.393139829692899,0.237655381144764,0.646153794311162,mechanism,409,247,162,univariate,0.00760356023407253,0.0956243117718238,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_KRAS_SIGNALING_DN_gt25_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,52,139,11,107,63,246,118,191,309,Non-Response,0.000130506597743483,0.275832366839774,0.123637459826363,0.567504408930966,mechanism,309,191,118,combination,0.00763313373377513,0.0959962356428379,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_purity_polyclonalProportion_gt25,76,34,25,39,101,73,64,110,174,Non-Response,0.000132197104536097,0.28901843626523,0.142908344259649,0.573597938840998,mechanism,174,110,64,combination,0.00770982238284085,0.0969606916426418,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_and_signature_log_DBS_denovo_5_eq0,35,78,6,69,41,147,75,113,188,Non-Response,0.000132528974284129,0.195291742899446,0.063262006755487,0.507207342293437,mechanism,188,113,75,combination,0.00772363661672072,0.0971344229693823,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75_and_rna_geneset_tcga_gt25,8,7,2,40,10,47,42,15,57,Non-Response,0.000133240982589659,0.047651261029154,0.0041283526195779,0.301737638500916,mechanism,57,15,42,combination,0.00774846827149978,0.0974467121898665,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_and_cn_simple_chr18_p_gt25,53,20,14,26,67,46,40,73,113,Non-Response,0.000135253037449562,0.206453613835911,0.0813714523521061,0.50185278928352,mechanism,113,73,40,combination,0.00776837618458344,0.0976970791796494,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_ACUTE_MYELOID_LEUKEMIA_gt75_and_rna_geneset_KEGG_MELANOMA_gt50,6,9,0,42,6,51,42,15,57,Non-Response,0.000137923424914488,0,0,0.229374670224477,mechanism,57,15,42,combination,0.0078221391852968,0.0983732163816625,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_APOPTOSIS_gt75_and_rna_geneset_KEGG_MELANOMA_gt50,6,9,0,42,6,51,42,15,57,Non-Response,0.000137923424914488,0,0,0.229374670224477,mechanism,57,15,42,combination,0.0078221391852968,0.0983732163816625,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_MELANOMA_gt50_and_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,6,9,0,42,6,51,42,15,57,Non-Response,0.000137923424914488,0,0,0.229374670224477,mechanism,57,15,42,combination,0.0078221391852968,0.0983732163816625,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_q_gt50_and_cn_simple_chr3_q_gt25,17,7,7,28,24,35,35,24,59,Non-Response,0.000138138579811882,0.108042867969665,0.0256854252586945,0.396153827650324,mechanism,59,24,35,combination,0.00782888002797225,0.0984579909374967,Aromatase inhibitor
Bladder Urothelial ## Anti-PD-1,clin_hasRadiotherapyPreTreatment_or_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25,26,8,4,15,30,23,19,34,53,Non-Response,0.0001387966652596,0.0871220567649598,0.0160999255662091,0.371010787307573,mechanism,53,34,19,combination,0.00786343560204893,0.0988925706458491,Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr3_p_gt50,11,10,1,26,12,36,27,21,48,Non-Response,0.000140913858386231,0.0377360810883569,0.000789368518198362,0.316703471222757,mechanism,48,21,27,univariate,0.00793527427009632,0.0997960320480291,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25_and_cn_simple_chr3_p_gt50,11,10,1,26,12,36,27,21,48,Non-Response,0.000140913858386231,0.0377360810883569,0.000789368518198362,0.316703471222757,mechanism,48,21,27,combination,0.00793527427009632,0.0997960320480291,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr3_p_gt25_and_cn_simple_chr3_p_gt50,11,10,1,26,12,36,27,21,48,Non-Response,0.000140913858386231,0.0377360810883569,0.000789368518198362,0.316703471222757,mechanism,48,21,27,combination,0.00793527427009632,0.0997960320480291,Alkaloid/Platinum
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_or_rna_geneset_gene_set_t_cell_gep_18_lt50,15,4,4,18,19,22,22,19,41,Non-Response,0.000141128023215697,0.065108228396234,0.00942106407722582,0.336923909137663,mechanism,41,19,22,combination,0.00793527427009632,0.0997960320480291,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_and_fusion_total_gt50,42,31,8,32,50,63,40,73,113,Non-Response,0.000143285837684214,0.187399032899948,0.0652030100813099,0.48688329443991,mechanism,113,73,40,combination,0.00798149730585057,0.10037734472866,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50_and_rna_geneset_KEGG_RIBOSOME_gt50,24,40,1,32,25,72,33,64,97,Non-Response,0.000143641208808687,0.0532097663548201,0.00123377416500823,0.36267481153457,mechanism,97,64,33,combination,0.00799581419714991,0.100557397603243,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr16_q_gt50,18,7,4,21,22,28,25,25,50,Non-Response,0.000146579292150807,0.0791737721559599,0.0142575004504552,0.343996578918602,mechanism,50,25,25,univariate,0.00805005070698593,0.101239489776688,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25,21,4,7,18,28,22,25,25,50,Non-Response,0.000146579292150807,0.07917377215596,0.0142575004504552,0.343996578918602,mechanism,50,25,25,univariate,0.00805005070698593,0.101239489776688,Pyrimidine (ant)agonist
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,40,1,10,8,50,9,18,41,59,Non-Response,0.000146645408886286,0.0337302600555044,0.000694177165946369,0.296231930352889,mechanism,67,46,21,univariate,0.00805005070698593,0.101239489776688,Taxane
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr15_q_gt50_or_cn_simple_chr21_p_gt50,20,4,11,24,31,28,35,24,59,Non-Response,0.000146253036489118,0.0961557943884856,0.0191631276453789,0.376995772573434,mechanism,59,24,35,combination,0.00805005070698593,0.101239489776688,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr15_q_gt50_or_cn_simple_chr21_q_gt50,20,4,11,24,31,28,35,24,59,Non-Response,0.000146253036489118,0.0961557943884856,0.0191631276453789,0.376995772573434,mechanism,59,24,35,combination,0.00805005070698593,0.101239489776688,Aromatase inhibitor
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr16_q_gt50_and_cn_simple_chr20_q_gt25,18,7,4,21,22,28,25,25,50,Non-Response,0.000146579292150807,0.0791737721559599,0.0142575004504552,0.343996578918602,mechanism,50,25,25,combination,0.00805005070698593,0.101239489776688,Pyrimidine (ant)agonist
Prostate ## Taxane,cn_simple_chr1_q_lt75_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt50,40,1,10,8,50,9,18,41,59,Non-Response,0.000146645408886286,0.0337302600555044,0.000694177165946369,0.296231930352889,mechanism,59,41,18,combination,0.00805005070698593,0.101239489776688,Taxane
Prostate ## Taxane,cn_simple_chr18_q_lt25_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,40,1,10,8,50,9,18,41,59,Non-Response,0.000146645408886286,0.0337302600555044,0.000694177165946369,0.296231930352889,mechanism,59,41,18,combination,0.00805005070698593,0.101239489776688,Taxane
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt50,40,1,10,8,50,9,18,41,59,Non-Response,0.000146645408886286,0.0337302600555044,0.000694177165946369,0.296231930352889,mechanism,59,41,18,combination,0.00805005070698593,0.101239489776688,Taxane
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_or_rna_geneset_KEGG_PENTOSE_PHOSPHATE_PATHWAY_gt50,40,1,10,8,50,9,18,41,59,Non-Response,0.000146645408886286,0.0337302600555044,0.000694177165946369,0.296231930352889,mechanism,59,41,18,combination,0.00805005070698593,0.101239489776688,Taxane
Skin Melanoma ## Anti-PD-1,rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,27,24,8,41,35,65,49,51,100,Non-Response,0.00014573385879042,0.176741904185019,0.0593552432840006,0.478183366117976,mechanism,100,51,49,combination,0.00805005070698593,0.101239489776688,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_or_rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75,23,2,9,14,32,16,23,25,48,Non-Response,0.000148517472711001,0.060057329766963,0.00556136701227094,0.337632474346123,mechanism,48,25,23,combination,0.0081281198343532,0.102221307023517,Multikinase inhibitor
Prostate ## Anti-AR,chord_BRCA1_gt0_or_rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,30,28,1,20,31,48,21,58,79,Non-Response,0.000149148110182156,0.0480911363124143,0.00109549570588151,0.340235292213897,mechanism,79,58,21,combination,0.00814891949576553,0.102482888867602,Anti-AR
Prostate ## Anti-AR,chord_BRCA1_gt0_or_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,30,28,1,20,31,48,21,58,79,Non-Response,0.000149148110182156,0.0480911363124143,0.00109549570588151,0.340235292213897,mechanism,79,58,21,combination,0.00814891949576553,0.102482888867602,Anti-AR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,95,3,51,15,146,18,66,98,164,Non-Response,0.000150376561741044,0.108829899111683,0.0193010503912293,0.409775041116936,mechanism,164,98,66,combination,0.00819126572394314,0.103015445827889,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_or_signature_log_SBS_denovo_26_eq0,95,3,51,15,146,18,66,98,164,Non-Response,0.000150376561741044,0.108829899111683,0.0193010503912293,0.409775041116936,mechanism,164,98,66,combination,0.00819126572394314,0.103015445827889,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,72,9,29,20,101,29,49,81,130,Non-Response,0.000151622307860876,0.183982226874149,0.0654478105634533,0.480856302887851,mechanism,130,81,49,combination,0.00823847640357683,0.103609179369714,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50,50,48,14,52,64,100,66,98,164,Non-Response,0.000153912046591077,0.2606568587912,0.117439839164896,0.551619141534719,mechanism,164,98,66,combination,0.00834471188783459,0.10494522390085,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt50,61,186,16,146,77,332,162,247,409,Non-Response,0.00015522785749098,0.334974936130317,0.172738764317724,0.618103490462498,mechanism,409,247,162,univariate,0.0083767761585569,0.105348472343145,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_APM_lt75,77,114,23,95,100,209,118,191,309,Non-Response,0.000158967670575625,0.359600235980181,0.199330004602397,0.631288505100249,mechanism,309,191,118,combination,0.00849457394341048,0.106829927313988,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION_gt25,136,55,58,60,194,115,118,191,309,Non-Response,0.000159715616153477,0.392202651252121,0.235757841255189,0.648624775626203,mechanism,409,247,162,univariate,0.00849969135363258,0.10689428516945,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,16,18,0,19,16,37,19,34,53,Non-Response,0.000159854710140398,0,0,0.301256491123109,mechanism,53,34,19,combination,0.00849969135363258,0.10689428516945,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,16,18,0,19,16,37,19,34,53,Non-Response,0.000159854710140398,0,0,0.301256491123109,mechanism,53,34,19,combination,0.00849969135363258,0.10689428516945,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,16,18,0,19,16,37,19,34,53,Non-Response,0.000159854710140398,0,0,0.301256491123109,mechanism,53,34,19,combination,0.00849969135363258,0.10689428516945,Anti-PD-1
Prostate ## Anti-AR,rna_geneset_KEGG_ASTHMA_gt50_or_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,29,29,1,20,30,49,21,58,79,Non-Response,0.000159974070932739,0.0514683462191285,0.00117204534036286,0.364242200097837,mechanism,79,58,21,combination,0.00850047842664101,0.106904183600241,Anti-AR
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,66,15,24,25,90,40,49,81,130,Non-Response,0.000162723679824522,0.221099471778511,0.091240206178837,0.51730882031655,mechanism,130,81,49,combination,0.00862122674881317,0.108422745280541,Multikinase inhibitor
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25,24,10,3,16,27,26,19,34,53,Non-Response,0.000164175957228662,0.0826821289515024,0.012631396694138,0.375788586291817,mechanism,53,34,19,combination,0.00868402156586402,0.109212468907168,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_or_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,24,10,3,16,27,26,19,34,53,Non-Response,0.000164175957228662,0.0826821289515024,0.012631396694138,0.375788586291817,mechanism,53,34,19,combination,0.00868402156586402,0.109212468907168,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_lilac_hla_cn_B44_gt0,32,81,5,70,37,151,75,113,188,Non-Response,0.000165058262233187,0.182195535447364,0.0525637976809122,0.506350027602257,mechanism,188,113,75,combination,0.00872501408406754,0.109728001265738,Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50,19,6,5,20,24,26,25,25,50,Non-Response,0.000166373039768276,0.0842943540608593,0.0164111020901756,0.353962024160308,mechanism,50,25,25,univariate,0.00876601539865267,0.110243644249847,Pyrimidine (ant)agonist
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50_and_rna_geneset_KEGG_JAK_STAT_SIGNALING_PATHWAY_lt75,29,12,3,15,32,27,18,41,59,Non-Response,0.000167888592864149,0.0868993348356237,0.0136327567056123,0.383280981827802,mechanism,59,41,18,combination,0.00883441728884301,0.111103883857607,Taxane
Pan-Cancer ## Anti-PD-1,neo_ct_lt50,66,154,17,116,83,270,133,220,353,Non-Response,0.00016840418246151,0.342919697139981,0.178669943379719,0.629223899755063,mechanism,409,247,162,univariate,0.0088500915513499,0.111301007378512,Anti-PD-1
Prostate ## Anti-AR,chord_BRCA1_gt0_or_rna_geneset_KEGG_ASTHMA_gt50,24,34,0,21,24,55,21,58,79,Non-Response,0.000171866665395001,0,0,0.312045398201056,mechanism,79,58,21,combination,0.00897404497748759,0.112859877263314,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_and_rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,24,34,0,21,24,55,21,58,79,Non-Response,0.000171866665395001,0,0,0.312045398201056,mechanism,79,58,21,combination,0.00897404497748759,0.112859877263314,Anti-AR
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75,9,12,0,27,9,39,27,21,48,Non-Response,0.00017526017307999,0,0,0.279960117089177,mechanism,48,21,27,univariate,0.00901647378126319,0.113393472715371,Alkaloid/Platinum
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25,64,9,22,18,86,27,40,73,113,Non-Response,0.000175101438928954,0.175058975843063,0.0597122934642199,0.479386914994917,mechanism,113,73,40,univariate,0.00901647378126319,0.113393472715371,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75,13,1,4,13,17,14,17,14,31,Non-Response,0.000175784584598853,0.0280280090174463,0.000526019800204402,0.279578532079964,mechanism,37,17,20,univariate,0.00901647378126319,0.113393472715371,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75,13,1,4,13,17,14,17,14,31,Non-Response,0.000175784584598853,0.0280280090174463,0.000526019800204402,0.279578532079964,mechanism,37,17,20,univariate,0.00901647378126319,0.113393472715371,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25_and_cn_simple_chr11_q_gt75,9,12,0,27,9,39,27,21,48,Non-Response,0.00017526017307999,0,0,0.279960117089177,mechanism,48,21,27,combination,0.00901647378126319,0.113393472715371,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_and_cn_simple_chr3_p_gt25,9,12,0,27,9,39,27,21,48,Non-Response,0.00017526017307999,0,0,0.279960117089177,mechanism,48,21,27,combination,0.00901647378126319,0.113393472715371,Alkaloid/Platinum
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_and_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,38,60,8,58,46,118,66,98,164,Non-Response,0.000174285299222924,0.219708687622617,0.0814461318594251,0.530040240744445,mechanism,164,98,66,combination,0.00901647378126319,0.113393472715371,Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt75,13,1,4,13,17,14,17,14,31,Non-Response,0.000175784584598853,0.0280280090174463,0.000526019800204402,0.279578532079964,mechanism,31,14,17,combination,0.00901647378126319,0.113393472715371,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,13,1,4,13,17,14,17,14,31,Non-Response,0.000175784584598853,0.0280280090174463,0.000526019800204402,0.279578532079964,mechanism,31,14,17,combination,0.00901647378126319,0.113393472715371,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,13,1,4,13,17,14,17,14,31,Non-Response,0.000175784584598853,0.0280280090174463,0.000526019800204402,0.279578532079964,mechanism,31,14,17,combination,0.00901647378126319,0.113393472715371,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,13,1,4,13,17,14,17,14,31,Non-Response,0.000175784584598853,0.0280280090174463,0.000526019800204402,0.279578532079964,mechanism,31,14,17,combination,0.00901647378126319,0.113393472715371,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt50,79,112,24,94,103,206,118,191,309,Non-Response,0.000177181313216882,0.363135286563528,0.203026074697941,0.633178283376783,mechanism,409,247,162,univariate,0.00905668882943684,0.113899227412657,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_Immune_Checkpoint_lt50,79,112,24,94,103,206,118,191,309,Non-Response,0.000177181313216882,0.363135286563528,0.203026074697941,0.633178283376783,mechanism,409,247,162,univariate,0.00905668882943684,0.113899227412657,Anti-PD-1
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_p_gt50_or_rna_geneset_HALLMARK_XENOBIOTIC_METABOLISM_lt50,28,3,12,16,40,19,28,31,59,Non-Response,0.000181280727225825,0.084405497103985,0.0132942773400285,0.369692080534519,mechanism,59,31,28,combination,0.00920258622711979,0.115734070277479,Aromatase inhibitor
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_q_gt25_or_rna_geneset_HALLMARK_ANDROGEN_RESPONSE_lt50,28,3,12,16,40,19,28,31,59,Non-Response,0.000181280727225825,0.084405497103985,0.0132942773400285,0.369692080534519,mechanism,59,31,28,combination,0.00920258622711979,0.115734070277479,Aromatase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25_and_rna_geneset_KEGG_RIBOSOME_gt50,35,29,5,28,40,57,33,64,97,Non-Response,0.000181947893963462,0.15089311179637,0.0402858563693918,0.463658533519278,mechanism,97,64,33,combination,0.00921631266749875,0.115906697490772,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25_and_rna_geneset_KEGG_RIBOSOME_gt50,35,29,5,28,40,57,33,64,97,Non-Response,0.000181947893963462,0.15089311179637,0.0402858563693918,0.463658533519278,mechanism,97,64,33,combination,0.00921631266749875,0.115906697490772,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_or_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,55,9,16,17,71,26,33,64,97,Non-Response,0.000182260060694708,0.15766288057286,0.0509628439935881,0.455033557816437,mechanism,97,64,33,combination,0.00922637650960091,0.116033262934482,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50_or_rna_geneset_KEGG_RIBOSOME_gt50,52,12,14,19,66,31,33,64,97,Non-Response,0.000184425817385844,0.173788511674217,0.0601743923675782,0.475987417884346,mechanism,97,64,33,combination,0.00933020194626741,0.117338998092751,Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_purity_polyclonalProportion_gt25,107,3,51,13,158,16,64,110,174,Non-Response,0.00018949776554639,0.11145576266422,0.0195153579943918,0.430128606713003,mechanism,174,110,64,combination,0.00956893095723973,0.120341314990551,Multikinase inhibitor
Prostate ## Anti-AR,rna_geneset_KEGG_PARKINSONS_DISEASE_lt75_or_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,52,6,10,11,62,17,21,58,79,Non-Response,0.00019660301248116,0.109145086694821,0.0261934574253874,0.405871503847803,mechanism,79,58,21,combination,0.00983607896104974,0.12370103638673,Anti-AR
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_or_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,58,9,21,19,79,28,40,67,107,Non-Response,0.000198310743543456,0.17482505967677,0.0594672578285905,0.478834570851697,mechanism,107,67,40,combination,0.0099154152148459,0.12469878933854,Taxane
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25,13,6,2,20,15,26,22,19,41,Non-Response,0.00020137001267797,0.0509673117425306,0.00441214133008168,0.313021512573191,mechanism,50,24,26,univariate,0.0100375111347065,0.126234298750894,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,62,5,25,15,87,20,40,67,107,Non-Response,0.000208682132391702,0.137315816049814,0.0351337015864547,0.450114362144856,mechanism,120,77,43,univariate,0.0102876874007668,0.129380579246767,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75,62,5,25,15,87,20,40,67,107,Non-Response,0.000208682132391702,0.137315816049814,0.0351337015864547,0.450114362144856,mechanism,107,67,40,combination,0.0102876874007668,0.129380579246767,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_or_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,62,5,25,15,87,20,40,67,107,Non-Response,0.000208682132391702,0.137315816049814,0.0351337015864547,0.450114362144856,mechanism,107,67,40,combination,0.0102876874007668,0.129380579246767,Taxane
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,23,35,0,21,23,56,21,58,79,Non-Response,0.000208496996361692,0,0,0.335537593568647,mechanism,79,58,21,combination,0.0102876874007668,0.129380579246767,Anti-AR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_and_signature_log_DBS_denovo_5_eq0,31,67,5,61,36,128,66,98,164,Non-Response,0.000209517096796435,0.178802049782867,0.051014400360762,0.504348425849105,mechanism,164,98,66,combination,0.0102921634153797,0.129436870747546,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_and_signature_log_SBS_denovo_26_eq0,31,67,5,61,36,128,66,98,164,Non-Response,0.000209517096796435,0.178802049782867,0.051014400360762,0.504348425849105,mechanism,164,98,66,combination,0.0102921634153797,0.129436870747546,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_and_signature_log_SBS20_eq0,31,67,5,61,36,128,66,98,164,Non-Response,0.000209517096796435,0.178802049782867,0.051014400360762,0.504348425849105,mechanism,164,98,66,combination,0.0102921634153797,0.129436870747546,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_DRUG_METABOLISM_CYTOCHROME_P450_gt75,32,159,4,114,36,273,118,191,309,Non-Response,0.000209684036000452,0.175109488100048,0.043774339229623,0.513601627708415,mechanism,409,247,162,univariate,0.0102941439871985,0.129461778923619,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_or_cn_simple_chr22_q_gt50,63,10,21,19,84,29,40,73,113,Non-Response,0.000210403113493318,0.178654134987538,0.0631240435514284,0.476668985305069,mechanism,113,73,40,combination,0.0103107671632871,0.12967083622362,Pyrimidine (ant)agonist
Prostate ## Anti-AR,chord_BRCA1_gt0_or_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,33,25,2,19,35,44,21,58,79,Non-Response,0.000212360875704035,0.0820898719800212,0.00850314227473681,0.390657042048362,mechanism,79,58,21,combination,0.0103410208814184,0.130051314694992,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_or_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,33,25,2,19,35,44,21,58,79,Non-Response,0.000212360875704035,0.0820898719800212,0.00850314227473681,0.390657042048362,mechanism,79,58,21,combination,0.0103410208814184,0.130051314694992,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_ASTHMA_gt50_or_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,33,25,2,19,35,44,21,58,79,Non-Response,0.000212360875704035,0.0820898719800212,0.00850314227473681,0.390657042048362,mechanism,79,58,21,combination,0.0103410208814184,0.130051314694992,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_or_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,33,25,2,19,35,44,21,58,79,Non-Response,0.000212360875704035,0.0820898719800212,0.00850314227473681,0.390657042048362,mechanism,79,58,21,combination,0.0103410208814184,0.130051314694992,Anti-AR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_and_signature_log_SBS_denovo_26_eq0,56,42,18,48,74,90,66,98,164,Non-Response,0.000213447389657642,0.283523712457536,0.134661209969147,0.578425529566538,mechanism,164,98,66,combination,0.0103507660791987,0.130173872786483,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_and_signature_log_SBS20_eq0,56,42,18,48,74,90,66,98,164,Non-Response,0.000213447389657642,0.283523712457536,0.134661209969147,0.578425529566538,mechanism,164,98,66,combination,0.0103507660791987,0.130173872786483,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_battle_tcell_gzmk_cd8_lt75,130,61,55,63,185,124,118,191,309,Non-Response,0.000215106334006204,0.410887586287594,0.248492415423508,0.675569522747362,mechanism,409,247,162,univariate,0.0104187845387968,0.131029290273372,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75_and_signature_log_SBS_denovo_26_eq0,54,44,17,49,71,93,66,98,164,Non-Response,0.000216689174421231,0.284977315891614,0.134031840888648,0.585292620139239,mechanism,164,98,66,combination,0.0104829593521402,0.131836369085158,Platinum/Pyrimidine (ant)agonist
Lung NSCLC ## Anti-PD-1,neo_ct_lt75,23,21,1,20,24,41,21,44,65,Non-Response,0.000217280488726177,0.0474790532363892,0.00106184371353997,0.348289060859496,mechanism,67,45,22,univariate,0.0105053145720782,0.132117514029798,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,50,141,11,107,61,248,118,191,309,Non-Response,0.000220511176210212,0.290949960080845,0.13020067877579,0.60008113654063,mechanism,309,191,118,combination,0.0106393698010172,0.13380342676174,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_or_cn_simple_chr15_q_gt50,20,4,12,23,32,27,35,24,59,Non-Response,0.000223932685860741,0.108994434124678,0.0219441329729839,0.423990148490486,mechanism,59,24,35,combination,0.0107526642681254,0.135228246860649,Aromatase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50,61,37,21,45,82,82,66,98,164,Non-Response,0.000224112494006849,0.285377511115192,0.138253258244409,0.574517571562453,mechanism,164,98,66,combination,0.0107526642681254,0.135228246860649,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25_and_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,19,45,0,33,19,78,33,64,97,Non-Response,0.000224446441690658,0,0,0.323508857075729,mechanism,97,64,33,combination,0.0107526642681254,0.135228246860649,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25_and_rna_geneset_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT_lt25,19,45,0,33,19,78,33,64,97,Non-Response,0.000224446441690658,0,0,0.323508857075729,mechanism,97,64,33,combination,0.0107526642681254,0.135228246860649,Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50_and_rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50,36,31,7,33,43,64,40,67,107,Non-Response,0.000225220818148452,0.185628197069198,0.0605193127511971,0.50397570057094,mechanism,107,67,40,combination,0.0107834083007368,0.135614891651911,Taxane
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_COLORECTAL_CANCER_lt50_or_rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75,32,0,10,7,42,7,17,32,49,Non-Response,0.000226401254734194,0,0,0.272659185623737,mechanism,49,32,17,combination,0.0108208087058408,0.136085248680456,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_COLORECTAL_CANCER_lt50_or_rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75,32,0,10,7,42,7,17,32,49,Non-Response,0.000226401254734194,0,0,0.272659185623737,mechanism,49,32,17,combination,0.0108208087058408,0.136085248680456,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75_or_rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,32,0,10,7,42,7,17,32,49,Non-Response,0.000226401254734194,0,0,0.272659185623737,mechanism,49,32,17,combination,0.0108208087058408,0.136085248680456,Anti-EGFR
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_purity_polyclonalProportion_gt25,78,32,27,37,105,69,64,110,174,Non-Response,0.000227288558806039,0.301642842824875,0.149335315183809,0.59910788818886,mechanism,174,110,64,combination,0.0108504595081457,0.136458144728703,Multikinase inhibitor
Prostate ## Anti-AR,purity_svTMB_gt75_or_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,39,19,4,17,43,36,21,58,79,Non-Response,0.000231028405495604,0.118140872024867,0.0253425831487137,0.427931308408037,mechanism,79,58,21,combination,0.0110031507547669,0.138378428769632,Anti-AR
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_or_cn_simple_chr18_p_gt25,69,4,27,13,96,17,40,73,113,Non-Response,0.000231617812838905,0.122984162668397,0.0268137912400514,0.44302073841011,mechanism,113,73,40,combination,0.0110150901234221,0.138528581313374,Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50,38,72,6,58,44,130,64,110,174,Non-Response,0.000234887853267974,0.19763865515233,0.0638069525745042,0.515298246581234,mechanism,174,110,64,univariate,0.0111111964815755,0.139737239372546,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_drivers_total_gt50,38,72,6,58,44,130,64,110,174,Non-Response,0.000234887853267974,0.19763865515233,0.0638069525745042,0.515298246581234,mechanism,174,110,64,combination,0.0111111964815755,0.139737239372546,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,17,64,0,49,17,113,49,81,130,Non-Response,0.000234937044143572,0,0,0.339467998875617,mechanism,130,81,49,combination,0.0111111964815755,0.139737239372546,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,clin_biopsy_site_Liver,51,196,12,150,63,346,162,247,409,Non-Response,0.000235302290567546,0.308226910517231,0.144263103639565,0.611893212599358,mechanism,409,247,162,univariate,0.0111252346152084,0.139913786519657,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_or_rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75,22,3,8,15,30,18,23,25,48,Non-Response,0.00023886390677881,0.0777814390804042,0.0113758417473616,0.372154681802445,mechanism,48,25,23,combination,0.0112576213085278,0.14157871532231,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,64,17,23,26,87,43,49,81,130,Non-Response,0.00023932392255875,0.237934467567383,0.100512498742366,0.546505006495651,mechanism,130,81,49,combination,0.0112662394789252,0.141687099630136,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_and_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,57,41,19,47,76,88,66,98,164,Non-Response,0.000240468654864338,0.293074134461479,0.140447086638993,0.594249813890606,mechanism,164,98,66,combination,0.0112907081558278,0.141994823948317,Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75,12,2,3,14,15,16,17,14,31,Non-Response,0.000244416557991519,0.0420178788332547,0.0030136717224629,0.317874769435824,mechanism,37,17,20,univariate,0.0113840285008035,0.143168444395568,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75,12,2,3,14,15,16,17,14,31,Non-Response,0.000244416557991519,0.0420178788332547,0.0030136717224629,0.317874769435824,mechanism,37,17,20,univariate,0.0113840285008035,0.143168444395568,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_HALLMARK_COMPLEMENT_lt50,12,2,3,14,15,16,17,14,31,Non-Response,0.000244416557991519,0.0420178788332547,0.0030136717224629,0.317874769435824,mechanism,37,17,20,univariate,0.0113840285008035,0.143168444395568,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_gene_set_t_cell_gep_10_lt75,12,2,3,14,15,16,17,14,31,Non-Response,0.000244416557991519,0.0420178788332547,0.0030136717224629,0.317874769435824,mechanism,31,14,17,combination,0.0113840285008035,0.143168444395568,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_gene_set_t_cell_gep_6_lt75,12,2,3,14,15,16,17,14,31,Non-Response,0.000244416557991519,0.0420178788332547,0.0030136717224629,0.317874769435824,mechanism,31,14,17,combination,0.0113840285008035,0.143168444395568,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,clin_age_lt25_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,37,44,7,42,44,86,49,81,130,Non-Response,0.000244748136002072,0.200594664064228,0.0678148868249609,0.521347491582032,mechanism,130,81,49,combination,0.0113923809074538,0.143273486390763,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_or_cn_simple_chr18_p_gt25,65,8,23,17,88,25,40,73,113,Non-Response,0.000244876144058052,0.169650610799735,0.0553119011226961,0.479727621902772,mechanism,113,73,40,combination,0.0113923809074538,0.143273486390763,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt50,22,29,5,44,27,73,49,51,100,Non-Response,0.000248560801304822,0.15272183255859,0.0404977095457167,0.474610127062798,mechanism,116,59,57,univariate,0.0114816730598186,0.144396447260889,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50_or_rna_geneset_gene_set_t_cell_gep_6_lt50,22,29,5,44,27,73,49,51,100,Non-Response,0.000248560801304822,0.15272183255859,0.0404977095457167,0.474610127062798,mechanism,100,51,49,combination,0.0114816730598186,0.144396447260889,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt25_or_rna_geneset_gene_set_t_cell_gep_6_lt50,22,29,5,44,27,73,49,51,100,Non-Response,0.000248560801304822,0.15272183255859,0.0404977095457167,0.474610127062798,mechanism,100,51,49,combination,0.0114816730598186,0.144396447260889,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50,63,35,23,43,86,78,66,98,164,Non-Response,0.000248716627510821,0.299502839832754,0.146373159368427,0.59960830495755,mechanism,164,98,66,combination,0.0114823470187406,0.144404923140095,Platinum/Pyrimidine (ant)agonist
Lung NSCLC ## Anti-PD-1,clin_hasSystemicPreTreatment_and_neo_ct_lt75,22,22,1,20,23,42,21,44,65,Non-Response,0.000249437764173415,0.0519010172552296,0.00116023026194187,0.381034109650429,mechanism,65,44,21,combination,0.0115063835254642,0.144707212375938,Anti-PD-1
Lung NSCLC ## Anti-PD-1,clin_pretreatment_contains_Platinum_and_neo_ct_lt75,22,22,1,20,23,42,21,44,65,Non-Response,0.000249437764173415,0.0519010172552296,0.00116023026194187,0.381034109650429,mechanism,65,44,21,combination,0.0115063835254642,0.144707212375938,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_or_rna_geneset_Colostage_one_gt25,63,18,22,27,85,45,49,81,130,Non-Response,0.00024952034041493,0.235753301599015,0.100356446629493,0.537600358072243,mechanism,130,81,49,combination,0.0115063835254642,0.144707212375938,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_signature_log_DBS_denovo_5_eq0,107,6,57,18,164,24,75,113,188,Non-Response,0.00025215976407481,0.179298899736591,0.05508853672091,0.504350067466125,mechanism,188,113,75,combination,0.0115886583716891,0.145741921815225,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_Colostage_one_lt50_or_rna_geneset_KEGG_RIBOFLAVIN_METABOLISM_lt50,23,1,5,8,28,9,13,24,37,Non-Response,0.000254036015993747,0.031211606899332,0.00059524455311506,0.309138388462503,mechanism,37,24,13,combination,0.0116551208037673,0.146577770303369,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_gene_set_tgfb_rand1_lt50_or_rna_geneset_KEGG_RIBOFLAVIN_METABOLISM_lt50,23,1,5,8,28,9,13,24,37,Non-Response,0.000254036015993747,0.031211606899332,0.00059524455311506,0.309138388462503,mechanism,37,24,13,combination,0.0116551208037673,0.146577770303369,Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr3_q_gt25_or_rna_geneset_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION_lt25,18,2,10,18,28,20,28,20,48,Non-Response,0.000254628354573706,0.0658998341168285,0.0061964541023684,0.362137172796132,mechanism,48,20,28,combination,0.011675708177376,0.146836682361921,Aromatase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt25,137,54,60,58,197,112,118,191,309,Non-Response,0.000255055705453237,0.409002208326354,0.24559379896505,0.67748152598379,mechanism,409,247,162,univariate,0.0116881349854365,0.14699296506788,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25,51,30,14,35,65,65,49,81,130,Non-Response,0.000255330665003693,0.238118980186605,0.100852001615644,0.538302258822908,mechanism,130,81,49,combination,0.0116881349854365,0.14699296506788,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,51,30,14,35,65,65,49,81,130,Non-Response,0.000255330665003693,0.238118980186605,0.100852001615644,0.538302258822908,mechanism,130,81,49,combination,0.0116881349854365,0.14699296506788,Multikinase inhibitor
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25,11,3,2,15,13,18,17,14,31,Non-Response,0.000259123409432805,0.0427577997119286,0.00305813045023407,0.325274501386123,mechanism,37,17,20,univariate,0.011785440035512,0.148216698182229,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt50,11,3,2,15,13,18,17,14,31,Non-Response,0.000259123409432805,0.0427577997119286,0.00305813045023407,0.325274501386123,mechanism,37,17,20,univariate,0.011785440035512,0.148216698182229,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_HALLMARK_INTERFERON_GAMMA_RESPONSE_lt50,11,3,2,15,13,18,17,14,31,Non-Response,0.000259123409432805,0.0427577997119286,0.00305813045023407,0.325274501386123,mechanism,37,17,20,univariate,0.011785440035512,0.148216698182229,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_KEGG_AUTOIMMUNE_THYROID_DISEASE_lt50,11,3,2,15,13,18,17,14,31,Non-Response,0.000259123409432805,0.0427577997119286,0.00305813045023407,0.325274501386123,mechanism,37,17,20,univariate,0.011785440035512,0.148216698182229,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_or_rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50,73,25,30,36,103,61,66,98,164,Non-Response,0.000258077161747764,0.28778805961698,0.139135185088901,0.583897595398719,mechanism,164,98,66,combination,0.011785440035512,0.148216698182229,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_signature_log_SBS_denovo_26_eq0,93,5,49,17,142,22,66,98,164,Non-Response,0.000264286853056804,0.156821392412508,0.0426235624957178,0.476784264633402,mechanism,164,98,66,combination,0.0119934450832627,0.150832622686529,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,48,19,14,26,62,45,40,67,107,Non-Response,0.000266239424478483,0.216607588002034,0.0843062104873113,0.532950169187096,mechanism,107,67,40,combination,0.0120685804129781,0.151777543746217,Taxane
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_purity_polyclonalProportion_gt25,73,37,24,40,97,77,64,110,174,Non-Response,0.000268541834242952,0.306338806759913,0.151816239316608,0.606208193210292,mechanism,174,110,64,combination,0.0121518364032049,0.152824592302583,Multikinase inhibitor
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,11,4,8,34,19,38,42,15,57,Non-Response,0.000273083828828899,0.090636610435866,0.0164096003176082,0.401190839682279,mechanism,57,15,42,combination,0.0122524515452322,0.154089953977113,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_and_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,32,49,5,44,37,93,49,81,130,Non-Response,0.00027326829283681,0.176151425763162,0.0492261073997338,0.510519774528851,mechanism,130,81,49,combination,0.0122539652175068,0.154108990305498,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt25,40,151,7,111,47,262,118,191,309,Non-Response,0.000273734483224695,0.239017511639616,0.0870461219140021,0.565744693877683,mechanism,409,247,162,univariate,0.0122613442158041,0.154201790469109,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,40,151,7,111,47,262,118,191,309,Non-Response,0.000273734483224695,0.239017511639616,0.0870461219140021,0.565744693877683,mechanism,309,191,118,combination,0.0122613442158041,0.154201790469109,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum,31,42,4,36,35,78,40,73,113,Non-Response,0.000275674823615804,0.152827005903702,0.0357975895514637,0.491551800247928,mechanism,113,73,40,univariate,0.0123177177714434,0.154910758675342,Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75_and_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,32,35,5,35,37,70,40,67,107,Non-Response,0.000280004959400003,0.158877729186138,0.0432420588353054,0.476351861845732,mechanism,107,67,40,combination,0.0124496161849936,0.156569546747148,Taxane
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_purity_tml_lt75,72,175,22,140,94,315,162,247,409,Non-Response,0.000282601160981901,0.382793577807197,0.214715129131334,0.661336367442369,mechanism,409,247,162,combination,0.0125581808071427,0.157934883110139,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75,92,18,37,27,129,45,64,110,174,Non-Response,0.000284332921677528,0.270394971343061,0.123865458913866,0.576928639084095,mechanism,174,110,64,univariate,0.0126075714204861,0.158556032053997,Multikinase inhibitor
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr20_q_gt25,24,1,12,13,36,14,25,25,50,Non-Response,0.000286752727587379,0.0410485797591945,0.000875738089736911,0.3307828371611,mechanism,50,25,25,univariate,0.0126527598372463,0.159124333102417,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_and_cn_simple_chr21_p_gt75,13,12,1,24,14,36,25,25,50,Non-Response,0.000286752727587379,0.0410485797591944,0.000875738089736907,0.3307828371611,mechanism,50,25,25,combination,0.0126527598372463,0.159124333102417,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr16_q_gt50_or_cn_simple_chr20_q_gt25,24,1,12,13,36,14,25,25,50,Non-Response,0.000286752727587379,0.0410485797591945,0.000875738089736911,0.3307828371611,mechanism,50,25,25,combination,0.0126527598372463,0.159124333102417,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr20_q_gt25_or_cn_simple_chr21_p_gt75,24,1,12,13,36,14,25,25,50,Non-Response,0.000286752727587379,0.0410485797591945,0.000875738089736911,0.3307828371611,mechanism,50,25,25,combination,0.0126527598372463,0.159124333102417,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt25_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,31,20,12,37,43,57,49,51,100,Non-Response,0.000289129198794427,0.212839065900062,0.0803463278993418,0.534266125627856,mechanism,100,51,49,combination,0.0127187404095871,0.159954121599669,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,50,31,14,35,64,66,49,81,130,Non-Response,0.000290097233464566,0.250841123590344,0.106488958143857,0.566142693843437,mechanism,130,81,49,combination,0.0127449959380901,0.160284317819074,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,50,31,14,35,64,66,49,81,130,Non-Response,0.000290097233464566,0.250841123590344,0.106488958143857,0.566142693843437,mechanism,130,81,49,combination,0.0127449959380901,0.160284317819074,Multikinase inhibitor
Pan-Cancer ## Anti-EGFR,cn_simple_chr1_p_lt75_and_rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75,27,5,5,12,32,17,17,32,49,Non-Response,0.000292473292008045,0.0828309192196467,0.0147426976427252,0.379375561667062,mechanism,49,32,17,combination,0.0128355121009242,0.161422672156882,Anti-EGFR
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_ACUTE_MYELOID_LEUKEMIA_gt75_or_rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75,10,5,6,36,16,41,42,15,57,Non-Response,0.000293018284152871,0.0886467190627367,0.016667980551495,0.39676524317205,mechanism,57,15,42,combination,0.0128420989128541,0.161505509582794,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_APOPTOSIS_gt75_or_rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75,10,5,6,36,16,41,42,15,57,Non-Response,0.000293018284152871,0.0886467190627367,0.016667980551495,0.39676524317205,mechanism,57,15,42,combination,0.0128420989128541,0.161505509582794,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_q_gt25_or_rna_geneset_HALLMARK_XENOBIOTIC_METABOLISM_lt50,30,1,16,12,46,13,28,31,59,Non-Response,0.000293219492554721,0.046708701660404,0.00101270558174743,0.366351450909675,mechanism,59,31,28,combination,0.0128439932786672,0.161529333610164,Aromatase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt75,25,166,2,116,27,282,118,191,309,Non-Response,0.000294883079456622,0.115056356025745,0.0129701591744699,0.476449416701059,mechanism,409,247,162,univariate,0.0129064330964974,0.162314592676097,Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_and_rna_geneset_gene_set_t_cell_gep_18_lt50,11,8,1,21,12,29,22,19,41,Non-Response,0.000298764539519851,0.0380432575091856,0.00077559481930176,0.332287944780703,mechanism,41,19,22,combination,0.0129923820799275,0.163395509001473,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_EMT2_lt25_and_rna_geneset_gene_set_tim3_lt75,11,8,1,21,12,29,22,19,41,Non-Response,0.000298764539519851,0.0380432575091856,0.00077559481930176,0.332287944780703,mechanism,41,19,22,combination,0.0129923820799275,0.163395509001473,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_or_rna_geneset_gene_set_immune_checkpoint_genes_lt75,65,2,29,11,94,13,40,67,107,Non-Response,0.000303505136175609,0.0831376067156928,0.00843232959068363,0.415969833162902,mechanism,107,67,40,combination,0.0131563124851724,0.165457139566294,Taxane
Prostate ## Anti-AR,purity_svTMB_gt75_or_rna_geneset_KEGG_ASTHMA_gt50,35,23,3,18,38,41,21,58,79,Non-Response,0.000305506653929118,0.112617263183233,0.0191003997145999,0.448059639968984,mechanism,79,58,21,combination,0.0132220846325986,0.16628430685869,Anti-AR
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,48,33,13,36,61,69,49,81,130,Non-Response,0.000306701437727272,0.251071306847385,0.1051422294322,0.571449640605348,mechanism,130,81,49,combination,0.0132493165992572,0.166626783013249,Multikinase inhibitor
Skin Melanoma ## Anti-PD-1,driver_B2M_or_rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50,26,25,8,41,34,66,49,51,100,Non-Response,0.000307035910318707,0.190987342177398,0.0641777346454247,0.516916804925636,mechanism,100,51,49,combination,0.0132493165992572,0.166626783013249,Anti-PD-1
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_gt0_or_rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50,26,25,8,41,34,66,49,51,100,Non-Response,0.000307035910318707,0.190987342177398,0.0641777346454247,0.516916804925636,mechanism,100,51,49,combination,0.0132493165992572,0.166626783013249,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_or_rna_geneset_gene_set_t_cell_gep_6_lt50,26,25,8,41,34,66,49,51,100,Non-Response,0.000307035910318707,0.190987342177398,0.0641777346454247,0.516916804925636,mechanism,100,51,49,combination,0.0132493165992572,0.166626783013249,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_and_fusion_total_gt50,38,35,7,33,45,68,40,73,113,Non-Response,0.000308520409652827,0.198203071311709,0.0653349106883853,0.531318361072242,mechanism,113,73,40,combination,0.0132992581041173,0.167254860109251,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HISTIDINE_METABOLISM_gt25,131,60,56,62,187,122,118,191,309,Non-Response,0.000309907710420788,0.41493156629701,0.250739911921098,0.682745722924735,mechanism,409,247,162,univariate,0.013344908341896,0.167828969136526,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_or_rna_geneset_HALLMARK_MYC_TARGETS_V1_lt75,30,4,7,12,37,16,19,34,53,Non-Response,0.000317272065975547,0.0829679816248824,0.014683168237196,0.372643164115131,mechanism,53,34,19,combination,0.013601684450145,0.171058250930169,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,32,19,13,36,45,55,49,51,100,Non-Response,0.000317460193165354,0.218056062709831,0.0834325049780788,0.542434045459221,mechanism,100,51,49,combination,0.013601684450145,0.171058250930169,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt50_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,32,19,13,36,45,55,49,51,100,Non-Response,0.000317460193165354,0.218056062709831,0.0834325049780788,0.542434045459221,mechanism,100,51,49,combination,0.013601684450145,0.171058250930169,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_and_rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75,13,12,1,22,14,34,23,25,48,Non-Response,0.000318218074460457,0.0447615189069491,0.000951397057650233,0.363052596501716,mechanism,48,25,23,combination,0.0136269745775932,0.171376306019812,Multikinase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_or_rna_geneset_battle_tcell_term_diff_cd8_lt25,16,4,7,21,23,25,28,20,48,Non-Response,0.000321764339901567,0.0889255704492592,0.015839430896578,0.392396509307981,mechanism,48,20,28,combination,0.0137246165108381,0.172604275862779,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_or_rna_geneset_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION_lt25,16,4,7,21,23,25,28,20,48,Non-Response,0.000321764339901567,0.0889255704492592,0.015839430896578,0.392396509307981,mechanism,48,20,28,combination,0.0137246165108381,0.172604275862779,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_q_gt50_or_rna_geneset_HALLMARK_ALLOGRAFT_REJECTION_lt25,16,4,7,21,23,25,28,20,48,Non-Response,0.000321764339901567,0.0889255704492592,0.015839430896578,0.392396509307981,mechanism,48,20,28,combination,0.0137246165108381,0.172604275862779,Aromatase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50,50,48,15,51,65,99,66,98,164,Non-Response,0.000322170986226731,0.28457526865023,0.130455563518885,0.595365906955763,mechanism,164,98,66,combination,0.0137256711471737,0.172617539238177,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_drivers_pathway_perplexity_total_gt75,17,93,0,64,17,157,64,110,174,Non-Response,0.000324268586651899,0,0,0.37055790250695,mechanism,174,110,64,combination,0.0137520666803405,0.172949496191924,Multikinase inhibitor
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50_and_rna_geneset_Colostage_one_lt50,19,5,2,11,21,16,13,24,37,Non-Response,0.000325490706960314,0.0535179154246843,0.00440660283730162,0.351656099310429,mechanism,37,24,13,combination,0.0137679859444155,0.173149700915004,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50_and_rna_geneset_gene_set_tgfb_rand1_lt50,19,5,2,11,21,16,13,24,37,Non-Response,0.000325490706960314,0.0535179154246843,0.00440660283730162,0.351656099310429,mechanism,37,24,13,combination,0.0137679859444155,0.173149700915004,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_Colostage_one_lt50_and_rna_geneset_gene_set_cd8_t_effector_lt50,19,5,2,11,21,16,13,24,37,Non-Response,0.000325490706960314,0.0535179154246843,0.00440660283730162,0.351656099310429,mechanism,37,24,13,combination,0.0137679859444155,0.173149700915004,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_gene_set_cd8_t_effector_lt50_and_rna_geneset_gene_set_tgfb_rand1_lt50,19,5,2,11,21,16,13,24,37,Non-Response,0.000325490706960314,0.0535179154246843,0.00440660283730162,0.351656099310429,mechanism,37,24,13,combination,0.0137679859444155,0.173149700915004,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25_and_cn_simple_chr2_q_gt50,14,7,4,23,18,30,27,21,48,Non-Response,0.000326763843521991,0.0927174245545553,0.0164096523339536,0.413755968445543,mechanism,48,21,27,combination,0.0138074707455792,0.173646271839741,Alkaloid/Platinum
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_and_rna_geneset_KEGG_STEROID_BIOSYNTHESIS_gt25,61,6,24,16,85,22,40,67,107,Non-Response,0.000327434202237723,0.150607913579529,0.0428922739953543,0.463657072365138,mechanism,107,67,40,combination,0.0138250185446506,0.173866957434075,Taxane
Pan-Cancer ## Alkylating ## Anthracycline,rna_geneset_KEGG_PROPANOATE_METABOLISM_gt75,10,8,1,22,11,30,23,18,41,Non-Response,0.000328618609913901,0.0399126093331872,0.000809109882635794,0.35344603531586,mechanism,45,18,27,univariate,0.0138678247430004,0.174405299096501,Alkylating/Anthracycline
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_or_rna_geneset_KEGG_RIBOSOME_gt50,58,6,19,14,77,20,33,64,97,Non-Response,0.000329409471775475,0.143869254798143,0.0393843538760695,0.46507263043847,mechanism,97,64,33,combination,0.0138770809715993,0.174521707786921,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25,22,3,9,16,31,19,25,25,50,Non-Response,0.00033121877105002,0.0815613578282204,0.0122148437399598,0.379515143218813,mechanism,50,25,25,univariate,0.0139089642911134,0.174922680540694,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_and_cn_simple_chr16_q_gt50,16,9,3,22,19,31,25,25,50,Non-Response,0.00033121877105002,0.0815613578282205,0.0122148437399598,0.379515143218813,mechanism,50,25,25,combination,0.0139089642911134,0.174922680540694,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_or_signature_log_SBS20_eq0,95,3,52,14,147,17,66,98,164,Non-Response,0.000330950941945491,0.118826072564058,0.0209715711401382,0.452744038620204,mechanism,164,98,66,combination,0.0139089642911134,0.174922680540694,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_or_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,64,0,26,7,90,7,33,64,97,Non-Response,0.000332552384143448,0,0,0.311301197839921,mechanism,97,64,33,combination,0.0139361733394217,0.175264868468238,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_or_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,64,0,26,7,90,7,33,64,97,Non-Response,0.000332552384143448,0,0,0.311301197839921,mechanism,97,64,33,combination,0.0139361733394217,0.175264868468238,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt50_and_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,20,31,4,45,24,76,49,51,100,Non-Response,0.000334388248035511,0.140498698169808,0.0317967574596901,0.475050155458283,mechanism,100,51,49,combination,0.0139878724862562,0.175915050117761,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_STEROID_HORMONE_BIOSYNTHESIS_gt75,34,157,5,113,39,270,118,191,309,Non-Response,0.000336969384140018,0.205174498275757,0.0607368158369745,0.550115053661184,mechanism,409,247,162,univariate,0.0140668929197429,0.176908831232851,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_RETINOL_METABOLISM_gt75,28,163,3,115,31,278,118,191,309,Non-Response,0.000338404266254312,0.152551093463693,0.0290122621680101,0.511904537295151,mechanism,409,247,162,univariate,0.0141061483031777,0.177402516941748,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,28,163,3,115,31,278,118,191,309,Non-Response,0.000338404266254312,0.152551093463693,0.0290122621680101,0.511904537295151,mechanism,309,191,118,combination,0.0141061483031777,0.177402516941748,Anti-PD-1
Skin Melanoma ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_HALLMARK_FATTY_ACID_METABOLISM_gt50,33,18,14,35,47,53,49,51,100,Non-Response,0.000339814270380921,0.221854241635052,0.0856695484827853,0.548503167876936,mechanism,100,51,49,combination,0.0141384648759972,0.177808938399532,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,93,98,33,85,126,183,118,191,309,Non-Response,0.000343277619866384,0.410294797585526,0.241601280422191,0.686651629106486,mechanism,409,247,162,univariate,0.0142752568887556,0.179529269622436,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_q_gt50_or_rna_geneset_battle_tcell_term_diff_cd8_lt25,15,5,6,22,21,27,28,20,48,Non-Response,0.00034582277871222,0.0968576975983006,0.0186184731569719,0.415672070833128,mechanism,48,20,28,combination,0.0143389367977834,0.180330124391389,Aromatase inhibitor
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_or_cn_simple_chr2_q_gt50,15,6,5,22,20,28,27,21,48,Non-Response,0.000345822778712219,0.0968576975983006,0.0186184731569719,0.415672070833128,mechanism,48,21,27,combination,0.0143389367977834,0.180330124391389,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr2_q_gt50_or_cn_simple_chr3_p_gt50,15,6,5,22,20,28,27,21,48,Non-Response,0.000345822778712219,0.0968576975983006,0.0186184731569719,0.415672070833128,mechanism,48,21,27,combination,0.0143389367977834,0.180330124391389,Alkaloid/Platinum
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_and_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,48,16,12,21,60,37,33,64,97,Non-Response,0.000347093210774161,0.194261311360765,0.0693971327280062,0.51638292900297,mechanism,97,64,33,combination,0.014349519930195,0.180463220562406,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_and_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,48,16,12,21,60,37,33,64,97,Non-Response,0.000347093210774161,0.194261311360765,0.0693971327280062,0.51638292900297,mechanism,97,64,33,combination,0.014349519930195,0.180463220562406,Pyrimidine (ant)agonist
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_HALLMARK_MYC_TARGETS_V1_lt75,15,19,0,19,15,38,19,34,53,Non-Response,0.000347678189854338,0,0,0.339465106491861,mechanism,53,34,19,combination,0.0143554541173021,0.180537850412183,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50_and_fusion_total_gt50,34,39,5,35,39,74,40,73,113,Non-Response,0.000347669257032399,0.166355261195368,0.0456837673737271,0.493139825651965,mechanism,113,73,40,combination,0.0143554541173021,0.180537850412183,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_rna_geneset_HALLMARK_ADIPOGENESIS_lt25,51,42,17,48,68,90,65,93,158,Non-Response,0.000349144043935386,0.294043757735574,0.137187587529632,0.609206031413924,mechanism,158,93,65,combination,0.0144086607248238,0.181206990271584,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_PPAR_SIGNALING_PATHWAY_gt75,31,160,4,114,35,274,118,191,309,Non-Response,0.000349518232308423,0.181881123034266,0.0453896743013902,0.535018449934892,mechanism,409,247,162,univariate,0.0144167847632889,0.181309160250268,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25_and_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,41,40,9,40,50,80,49,81,130,Non-Response,0.000350353448549535,0.222088713213062,0.0835262529104394,0.540904542057202,mechanism,130,81,49,combination,0.014436586423532,0.181558190977242,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25_and_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,41,40,9,40,50,80,49,81,130,Non-Response,0.000350353448549535,0.222088713213062,0.0835262529104394,0.540904542057202,mechanism,130,81,49,combination,0.014436586423532,0.181558190977242,Multikinase inhibitor
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_HALLMARK_MYC_TARGETS_V1_lt75,28,6,6,13,34,19,19,34,53,Non-Response,0.000350888723046578,0.104587776009173,0.0216805138740739,0.430201519583886,mechanism,53,34,19,combination,0.014444001162007,0.181651440618438,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50_or_rna_geneset_HALLMARK_MYC_TARGETS_V1_lt75,28,6,6,13,34,19,19,34,53,Non-Response,0.000350888723046578,0.104587776009173,0.0216805138740739,0.430201519583886,mechanism,53,34,19,combination,0.014444001162007,0.181651440618438,Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_tim3_lt50,10,4,1,16,11,20,17,14,31,Non-Response,0.00035143718463349,0.0295712748573517,0.000551036844651096,0.299688946369321,mechanism,37,17,20,univariate,0.0144519431833678,0.181751321503618,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50_and_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,52,15,17,23,69,38,40,67,107,Non-Response,0.000356196078283933,0.216735427904989,0.0834106576333225,0.541232848096714,mechanism,107,67,40,combination,0.0145812613133965,0.183377659272103,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75_or_signature_log_SBS20_eq0,94,4,51,15,145,19,66,98,164,Non-Response,0.00035702169581518,0.146437974587479,0.0335859250730791,0.491495198070084,mechanism,164,98,66,combination,0.0146077034967682,0.183710202910716,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_signature_log_SBS_denovo_26_eq0,109,4,60,15,169,19,75,113,188,Non-Response,0.000357698802805384,0.148318781450244,0.034261991090317,0.493160381738114,mechanism,188,113,75,combination,0.0146206912867144,0.183873540667874,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_rand1_lt75,126,65,53,65,179,130,118,191,309,Non-Response,0.000358655686277828,0.421865279431891,0.255718572205021,0.691772807087721,mechanism,409,247,162,univariate,0.0146524365018599,0.184272776585903,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_and_cn_simple_chr22_q_gt25,48,25,12,28,60,53,40,73,113,Non-Response,0.000359816540205652,0.226465952984581,0.0884842733349857,0.550562048689751,mechanism,113,73,40,combination,0.014673945471853,0.184543278875514,Pyrimidine (ant)agonist
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25_and_rna_geneset_KEGG_JAK_STAT_SIGNALING_PATHWAY_lt75,37,4,8,10,45,14,18,41,59,Non-Response,0.000359904147294246,0.0915427407865767,0.0164241577997982,0.412184896249763,mechanism,59,41,18,combination,0.014673945471853,0.184543278875514,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25_and_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,37,4,8,10,45,14,18,41,59,Non-Response,0.000359904147294246,0.0915427407865767,0.0164241577997982,0.412184896249763,mechanism,59,41,18,combination,0.014673945471853,0.184543278875514,Taxane
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,34,47,6,43,40,90,49,81,130,Non-Response,0.00036174242768365,0.195190338435024,0.0608965263168149,0.532106813475223,mechanism,130,81,49,combination,0.0147415025705529,0.18539289417014,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_and_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,51,16,16,24,67,40,40,67,107,Non-Response,0.000368248456626277,0.212648166565443,0.0822487121689997,0.528015925404742,mechanism,107,67,40,combination,0.0149691156376298,0.188255414123881,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_and_rna_geneset_KEGG_RIBOSOME_lt25,30,68,5,61,35,129,66,98,164,Non-Response,0.000377997957935248,0.187470860226441,0.0534020202786876,0.530178662376241,mechanism,164,98,66,combination,0.0153080229051944,0.192517598313612,Platinum/Pyrimidine (ant)agonist
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,20,5,6,17,26,22,23,25,48,Non-Response,0.000379536475648706,0.0940671354348396,0.0181700855836177,0.400525964870335,mechanism,61,34,27,univariate,0.0153435782863074,0.19296475185012,Multikinase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,20,5,6,17,26,22,23,25,48,Non-Response,0.000379536475648706,0.0940671354348396,0.0181700855836177,0.400525964870335,mechanism,48,25,23,combination,0.0153435782863074,0.19296475185012,Multikinase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,20,5,6,17,26,22,23,25,48,Non-Response,0.000379536475648706,0.0940671354348396,0.0181700855836177,0.400525964870335,mechanism,48,25,23,combination,0.0153435782863074,0.19296475185012,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75_and_signature_log_DBS_denovo_5_eq0,53,45,17,49,70,94,66,98,164,Non-Response,0.000380437249052518,0.29684007249568,0.139711363503792,0.609505688593699,mechanism,164,98,66,combination,0.015372349856223,0.193326590447708,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_and_rna_geneset_KEGG_RIBOSOME_gt50,34,30,5,28,39,58,33,64,97,Non-Response,0.000382308848263664,0.160550443978391,0.0428920576224697,0.493238553215276,mechanism,97,64,33,combination,0.0154096812369795,0.193796079408463,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,27,24,9,40,36,64,49,51,100,Non-Response,0.00038201024668798,0.203484561455752,0.0713439760718971,0.536145082564641,mechanism,100,51,49,combination,0.0154096812369795,0.193796079408463,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75,124,67,52,66,176,133,118,191,309,Non-Response,0.000384775324576834,0.426933315480175,0.259026347082481,0.6994112382437,mechanism,409,247,162,univariate,0.015497572015245,0.194901416240684,Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_or_rna_geneset_KEGG_AXON_GUIDANCE_gt75,124,67,52,66,176,133,118,191,309,Non-Response,0.000384775324576834,0.426933315480175,0.259026347082481,0.6994112382437,mechanism,309,191,118,combination,0.015497572015245,0.194901416240684,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_vhio_tcell_lt25,42,149,8,110,50,259,118,191,309,Non-Response,0.00038596300515185,0.25901267167123,0.100907324552141,0.587330427391061,mechanism,409,247,162,univariate,0.0155076056741528,0.195027602092847,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75_and_rna_geneset_vhio_tcell_lt75,42,149,8,110,50,259,118,191,309,Non-Response,0.00038596300515185,0.25901267167123,0.100907324552141,0.587330427391061,mechanism,309,191,118,combination,0.0155076056741528,0.195027602092847,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_or_signature_log_SBS_denovo_26_eq0,96,2,54,12,150,14,66,98,164,Non-Response,0.000386073554219428,0.0950183942523749,0.00997081164477232,0.450476265049778,mechanism,164,98,66,combination,0.0155076056741528,0.195027602092847,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75_or_signature_log_DBS_denovo_5_eq0,96,2,54,12,150,14,66,98,164,Non-Response,0.000386073554219428,0.0950183942523749,0.00997081164477232,0.450476265049778,mechanism,164,98,66,combination,0.0155076056741528,0.195027602092847,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,20,61,1,48,21,109,49,81,130,Non-Response,0.0003893359235911,0.0644210898313567,0.00150704590696535,0.431840210463271,mechanism,130,81,49,combination,0.015602910279238,0.196226177101054,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_and_cn_simple_chr18_p_gt25,25,48,2,38,27,86,40,73,113,Non-Response,0.000389196144212273,0.102672275307348,0.0110986452818231,0.455200254044533,mechanism,113,73,40,combination,0.015602910279238,0.196226177101054,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_COLORECTAL_CANCER_lt50,29,3,7,10,36,13,17,32,49,Non-Response,0.000391478412364672,0.0778273739869281,0.0108249534478007,0.401473597277024,mechanism,57,38,19,univariate,0.0156627969718678,0.196979327413635,Anti-EGFR
Pan-Cancer ## Anti-PD-1,cn_simple_chr9_p_lt25,89,158,32,130,121,288,162,247,409,Non-Response,0.000392794907696356,0.437852150834524,0.264986656475697,0.710972832557878,mechanism,409,247,162,univariate,0.0157077389084142,0.197544528664055,Anti-PD-1
Pan-Cancer ## Anti-PD-1,signature_log_ID2_lt75,202,45,107,55,309,100,162,247,409,Non-Response,0.000395249344425635,0.434325288149246,0.266808444904961,0.703604624678489,mechanism,409,247,162,univariate,0.0157903569790957,0.198583554581602,Anti-PD-1
Prostate ## Taxane,cn_simple_chr18_q_lt25_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt50,32,9,5,13,37,22,18,41,59,Non-Response,0.000396885427262953,0.113404664187297,0.0244023046743729,0.446244915922141,mechanism,59,41,18,combination,0.0158479314101428,0.199307625303087,Taxane
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75,19,6,5,18,24,24,23,25,48,Non-Response,0.000400196931741732,0.0935282974437409,0.0180830482689615,0.39762688480089,mechanism,61,34,27,univariate,0.0159527385896892,0.200625707110074,Multikinase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75,19,6,5,18,24,24,23,25,48,Non-Response,0.000400196931741732,0.0935282974437409,0.0180830482689615,0.39762688480089,mechanism,61,34,27,univariate,0.0159527385896892,0.200625707110074,Multikinase inhibitor
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_or_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,27,31,1,20,28,51,21,58,79,Non-Response,0.000407664871302692,0.0589713853846419,0.00134156857928821,0.41799357727781,mechanism,79,58,21,combination,0.0161462329167686,0.203059141092198,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,22,36,0,21,22,57,21,58,79,Non-Response,0.000408807422513273,0,0,0.361316939498367,mechanism,97,68,29,univariate,0.0161769942287207,0.203446003192854,Anti-AR
Prostate ## Taxane,cn_simple_chr1_q_lt75_or_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,41,0,12,6,53,6,18,41,59,Non-Response,0.000412007117842424,0,0,0.299439430538323,mechanism,59,41,18,combination,0.0162877542783716,0.204838949811758,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,41,0,12,6,53,6,18,41,59,Non-Response,0.000412007117842424,0,0,0.299439430538323,mechanism,59,41,18,combination,0.0162877542783716,0.204838949811758,Taxane
Pan-Cancer ## Anti-PD-1,rna_geneset_tcga_gt25,135,56,59,59,194,115,118,191,309,Non-Response,0.000416713776138728,0.416058508534301,0.250472741148949,0.687429966541212,mechanism,409,247,162,univariate,0.0164020398384422,0.206276234148409,Anti-PD-1
Pan-Cancer ## Anti-PD-1,neo_ct_lt25,31,189,4,129,35,318,133,220,353,Non-Response,0.000421922504008495,0.189736701432264,0.047518780500672,0.555303517966346,mechanism,409,247,162,univariate,0.0165503177815493,0.208141015359324,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_or_rna_geneset_KEGG_RIBOSOME_lt25,61,37,22,44,83,81,66,98,164,Non-Response,0.000422604669875704,0.305614163462257,0.149059528152586,0.612509718516173,mechanism,164,98,66,combination,0.0165529842780524,0.208174549899079,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_or_rna_geneset_KEGG_RIBOSOME_lt25,61,37,22,44,83,81,66,98,164,Non-Response,0.000422604669875704,0.305614163462257,0.149059528152586,0.612509718516173,mechanism,164,98,66,combination,0.0165529842780524,0.208174549899079,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75,8,7,3,39,11,46,42,15,57,Non-Response,0.000424426357413594,0.0722370155794639,0.00982858750731835,0.388306770520097,mechanism,68,18,50,univariate,0.0165891530920037,0.208629418123335,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,8,7,3,39,11,46,42,15,57,Non-Response,0.000424426357413594,0.0722370155794639,0.00982858750731835,0.388306770520097,mechanism,68,18,50,univariate,0.0165891530920037,0.208629418123335,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_IL6_JAK_STAT3_SIGNALING_gt50_and_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,8,7,3,39,11,46,42,15,57,Non-Response,0.000424426357413594,0.0722370155794639,0.00982858750731835,0.388306770520097,mechanism,57,15,42,combination,0.0165891530920037,0.208629418123335,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75_and_rna_geneset_tcga_gt25,8,7,3,39,11,46,42,15,57,Non-Response,0.000424426357413594,0.0722370155794639,0.00982858750731835,0.388306770520097,mechanism,57,15,42,combination,0.0165891530920037,0.208629418123335,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION_lt50,76,115,24,94,100,209,118,191,309,Non-Response,0.000430798387962286,0.387497103364692,0.21646731908016,0.676537989559681,mechanism,409,247,162,univariate,0.0167781827341739,0.211006703089921,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_and_cn_simple_chr3_q_gt25,16,8,7,28,23,36,35,24,59,Non-Response,0.000432012818380384,0.13045691009455,0.0320962022624629,0.469336787266888,mechanism,59,24,35,combination,0.0167781827341739,0.211006703089921,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_p_gt50_and_cn_simple_chr21_q_gt50,16,8,7,28,23,36,35,24,59,Non-Response,0.000432012818380384,0.13045691009455,0.0320962022624629,0.469336787266888,mechanism,59,24,35,combination,0.0167781827341739,0.211006703089921,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_p_gt50_and_cn_simple_chr3_q_gt25,16,8,7,28,23,36,35,24,59,Non-Response,0.000432012818380384,0.13045691009455,0.0320962022624629,0.469336787266888,mechanism,59,24,35,combination,0.0167781827341739,0.211006703089921,Aromatase inhibitor
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_or_rna_geneset_KEGG_COLORECTAL_CANCER_lt50,30,2,8,9,38,11,17,32,49,Non-Response,0.000435629752810716,0.0639193839136152,0.00565653184739338,0.390297368290405,mechanism,49,32,17,combination,0.0168528495235586,0.211945731666973,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75_and_rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75,30,2,8,9,38,11,17,32,49,Non-Response,0.000435629752810716,0.0639193839136152,0.00565653184739338,0.390297368290405,mechanism,49,32,17,combination,0.0168528495235586,0.211945731666973,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75_and_rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,30,2,8,9,38,11,17,32,49,Non-Response,0.000435629752810716,0.0639193839136152,0.00565653184739338,0.390297368290405,mechanism,49,32,17,combination,0.0168528495235586,0.211945731666973,Anti-EGFR
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_tim3_lt75,16,3,6,16,22,19,22,19,41,Non-Response,0.000436636925088215,0.0763515090701589,0.0103900788602111,0.395285017418671,mechanism,50,24,26,univariate,0.0168597223332922,0.212032165874171,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt50_or_rna_geneset_gene_set_tim3_lt75,16,3,6,16,22,19,22,19,41,Non-Response,0.000436636925088215,0.0763515090701589,0.0103900788602111,0.395285017418671,mechanism,41,19,22,combination,0.0168597223332922,0.212032165874171,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr2_q_gt50_and_cn_simple_chr3_p_gt50,10,11,1,26,11,37,27,21,48,Non-Response,0.000437086099665075,0.0453277718276645,0.000945924060881803,0.38329885422385,mechanism,48,21,27,combination,0.0168690542685359,0.212149526670654,Alkaloid/Platinum
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt50,17,8,4,21,21,29,25,25,50,Non-Response,0.000440890172372083,0.0950916482752437,0.0175157881013224,0.405799394361388,mechanism,50,25,25,univariate,0.0169675408869482,0.213388119489608,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_and_cn_simple_chr22_q_gt25,17,8,4,21,21,29,25,25,50,Non-Response,0.000440890172372083,0.0950916482752437,0.0175157881013224,0.405799394361388,mechanism,50,25,25,combination,0.0169675408869482,0.213388119489608,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50,59,39,21,45,80,84,66,98,164,Non-Response,0.000444423059552781,0.310789521435639,0.151025582424913,0.624276234781589,mechanism,196,120,76,univariate,0.017083286202639,0.214843762085053,Platinum/Pyrimidine (ant)agonist
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25,23,11,3,16,26,27,19,34,53,Non-Response,0.00044896009153496,0.0944113414569182,0.0145844925911128,0.425097994902712,mechanism,59,37,22,univariate,0.0171764736384474,0.216015711032735,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_or_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,23,11,3,16,26,27,19,34,53,Non-Response,0.00044896009153496,0.0944113414569182,0.0145844925911128,0.425097994902712,mechanism,53,34,19,combination,0.0171764736384474,0.216015711032735,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_or_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,23,11,3,16,26,27,19,34,53,Non-Response,0.00044896009153496,0.0944113414569182,0.0145844925911128,0.425097994902712,mechanism,53,34,19,combination,0.0171764736384474,0.216015711032735,Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr2_q_gt50_and_cn_simple_chr3_p_gt25,13,8,3,24,16,32,27,21,48,Non-Response,0.000450410205248456,0.0821812735687713,0.011918666312265,0.399115937661226,mechanism,48,21,27,combination,0.0172197974495623,0.216560562325243,Alkaloid/Platinum
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,39,152,7,111,46,263,118,191,309,Non-Response,0.000450339152219865,0.246750185941158,0.089740746269251,0.585211178160646,mechanism,309,191,118,combination,0.0172197974495623,0.216560562325243,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75,58,9,22,18,80,27,40,67,107,Non-Response,0.000461025453289547,0.193067995167054,0.0655973782022583,0.530984475386803,mechanism,107,67,40,combination,0.0175185362594003,0.220317577751027,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75_or_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,58,9,22,18,80,27,40,67,107,Non-Response,0.000461025453289547,0.193067995167054,0.0655973782022583,0.530984475386803,mechanism,107,67,40,combination,0.0175185362594003,0.220317577751027,Taxane
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt50,13,6,3,19,16,25,22,19,41,Non-Response,0.0004644133079522,0.079069431846852,0.0107094605966599,0.413533481463977,mechanism,50,24,26,univariate,0.0175692589684532,0.2209554794701,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_gene_set_t_cell_gep_18_lt50,13,6,3,19,16,25,22,19,41,Non-Response,0.0004644133079522,0.079069431846852,0.0107094605966599,0.413533481463977,mechanism,41,19,22,combination,0.0175692589684532,0.2209554794701,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt50_and_rna_geneset_gene_set_t_cell_gep_6_lt75,13,6,3,19,16,25,22,19,41,Non-Response,0.0004644133079522,0.079069431846852,0.0107094605966599,0.413533481463977,mechanism,41,19,22,combination,0.0175692589684532,0.2209554794701,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt50_and_rna_geneset_gene_set_tim3_lt75,13,6,3,19,16,25,22,19,41,Non-Response,0.0004644133079522,0.079069431846852,0.0107094605966599,0.413533481463977,mechanism,41,19,22,combination,0.0175692589684532,0.2209554794701,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,73,8,31,18,104,26,49,81,130,Non-Response,0.000478794839424376,0.191479007255931,0.064708530787539,0.520690278194057,mechanism,130,81,49,combination,0.0179794649655253,0.226114334657295,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,16,65,0,49,16,114,49,81,130,Non-Response,0.00047991929165529,0,0,0.368494948808556,mechanism,130,81,49,combination,0.0180133695716913,0.226540727627261,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_and_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,57,41,20,46,77,87,66,98,164,Non-Response,0.00048089792458824,0.315063784505463,0.15233454483881,0.635027007584355,mechanism,164,98,66,combination,0.0180417722063218,0.226897926400656,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_MELANOMA_gt50,12,3,11,31,23,34,42,15,57,Non-Response,0.000481317752944815,0.093340815308909,0.0142302465571159,0.430579289456127,mechanism,57,15,42,combination,0.0180491937253969,0.226991261316407,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_SBS_denovo_26_eq0,112,8,57,19,169,27,76,120,196,Non-Response,0.000484490970413366,0.216099623655488,0.0768637254270371,0.555086611808192,mechanism,196,120,76,univariate,0.0181514430431503,0.228277174801448,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_DBS_denovo_5_eq0_or_signature_log_SBS_denovo_26_eq0,112,8,57,19,169,27,76,120,196,Non-Response,0.000484490970413366,0.216099623655488,0.0768637254270371,0.555086611808192,mechanism,196,120,76,combination,0.0181514430431503,0.228277174801448,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,50,17,16,24,66,41,40,67,107,Non-Response,0.000485171388167336,0.230216310483841,0.0899750678476761,0.567372487930449,mechanism,107,67,40,combination,0.0181685622692843,0.228492470553271,Taxane
Prostate ## Taxane,cn_simple_chr18_q_lt25_or_rna_geneset_KEGG_PENTOSE_PHOSPHATE_PATHWAY_gt50,25,16,2,16,27,32,18,41,59,Non-Response,0.000493714806894372,0.0835016483871505,0.00824015087523514,0.42864020939143,mechanism,59,41,18,combination,0.0183826517452281,0.231184914377544,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_and_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50,40,58,10,56,50,114,66,98,164,Non-Response,0.000494180460260313,0.261001774256746,0.1058601663259,0.594616951040344,mechanism,164,98,66,combination,0.0183915666004592,0.231297029869468,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50_and_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,38,26,7,26,45,52,33,64,97,Non-Response,0.000499455585018687,0.187590373812482,0.0595102930152352,0.526498011966277,mechanism,97,64,33,combination,0.0184748347279488,0.232344231067144,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50_and_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,38,26,7,26,45,52,33,64,97,Non-Response,0.000499455585018687,0.187590373812482,0.0595102930152352,0.526498011966277,mechanism,97,64,33,combination,0.0184748347279488,0.232344231067144,Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_and_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,31,50,5,44,36,94,49,81,130,Non-Response,0.000501780790686946,0.185469481339302,0.0517735895096808,0.53857306030206,mechanism,130,81,49,combination,0.018534428215383,0.233093693956442,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,31,50,5,44,36,94,49,81,130,Non-Response,0.000501780790686946,0.185469481339302,0.0517735895096808,0.53857306030206,mechanism,130,81,49,combination,0.018534428215383,0.233093693956442,Multikinase inhibitor
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75,15,4,5,17,20,21,22,19,41,Non-Response,0.000506168431411162,0.0849767356413859,0.0134384784948369,0.417095137926577,mechanism,50,24,26,univariate,0.0185825185393073,0.2336984901291,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_gene_set_tim3_lt75,15,4,5,17,20,21,22,19,41,Non-Response,0.000506168431411162,0.0849767356413859,0.0134384784948369,0.417095137926577,mechanism,41,19,22,combination,0.0185825185393073,0.2336984901291,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_gene_set_tim3_lt75,15,4,5,17,20,21,22,19,41,Non-Response,0.000506168431411162,0.0849767356413859,0.0134384784948369,0.417095137926577,mechanism,41,19,22,combination,0.0185825185393073,0.2336984901291,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_12_chemokine_lt25,36,155,6,112,42,267,118,191,309,Non-Response,0.000511211086964526,0.231576800915979,0.0770894446436148,0.580394846904136,mechanism,409,247,162,univariate,0.018679078723204,0.234912855616508,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_ABC_TRANSPORTERS_gt75,36,155,6,112,42,267,118,191,309,Non-Response,0.000511211086964526,0.231576800915979,0.0770894446436148,0.580394846904136,mechanism,409,247,162,univariate,0.018679078723204,0.234912855616508,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_and_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,21,30,5,44,26,74,49,51,100,Non-Response,0.000515573426130609,0.165348180841866,0.0437730858876509,0.515638467901592,mechanism,100,51,49,combination,0.0187962349645706,0.236386242372918,Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_vhio_tgfb_lt25,14,5,4,18,18,23,22,19,41,Non-Response,0.000517147090304256,0.0859638938821085,0.0135675061485219,0.423376372048738,mechanism,50,24,26,univariate,0.0188367120495724,0.236895292512153,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt50,79,112,26,92,105,204,118,191,309,Non-Response,0.000519793508977875,0.401823595775454,0.227859837015087,0.693231870047413,mechanism,409,247,162,univariate,0.0189161559921183,0.237894399785131,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50,92,6,49,17,141,23,66,98,164,Non-Response,0.000521105836095318,0.190008704073785,0.0575022230174638,0.5454726597187,mechanism,164,98,66,combination,0.0189384816131932,0.238175172486924,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,92,6,49,17,141,23,66,98,164,Non-Response,0.000521105836095318,0.190008704073785,0.0575022230174638,0.5454726597187,mechanism,164,98,66,combination,0.0189384816131932,0.238175172486924,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_or_signature_log_DBS_denovo_5_eq0,92,6,49,17,141,23,66,98,164,Non-Response,0.000521105836095318,0.190008704073785,0.0575022230174638,0.5454726597187,mechanism,164,98,66,combination,0.0189384816131932,0.238175172486924,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,54,27,17,32,71,59,49,81,130,Non-Response,0.00052375960876021,0.268570439784734,0.117078383120218,0.597144977839802,mechanism,130,81,49,combination,0.0190221721834248,0.23922768643221,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,51,30,15,34,66,64,49,81,130,Non-Response,0.000527205230367725,0.262400392921264,0.11278709385548,0.587775765851626,mechanism,130,81,49,combination,0.019108897915143,0.240318371342063,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,51,30,15,34,66,64,49,81,130,Non-Response,0.000527205230367725,0.262400392921264,0.11278709385548,0.587775765851626,mechanism,130,81,49,combination,0.019108897915143,0.240318371342063,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_cyt_lt25,43,148,9,109,52,257,118,191,309,Non-Response,0.000530885287443517,0.285184888460767,0.117147965495075,0.625190668458321,mechanism,409,247,162,univariate,0.0191483720228396,0.240814807783032,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25,59,14,19,21,78,35,40,73,113,Non-Response,0.000530240313320748,0.218076327093387,0.0838707945342759,0.546235690818555,mechanism,113,73,40,univariate,0.0191483720228396,0.240814807783032,Pyrimidine (ant)agonist
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_or_cn_simple_chr21_p_gt50,20,4,13,22,33,26,35,24,59,Non-Response,0.000529458287554852,0.123005911440454,0.0249401066020882,0.475746716850231,mechanism,59,24,35,combination,0.0191483720228396,0.240814807783032,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_or_cn_simple_chr21_q_gt50,20,4,13,22,33,26,35,24,59,Non-Response,0.000529458287554852,0.123005911440454,0.0249401066020882,0.475746716850231,mechanism,59,24,35,combination,0.0191483720228396,0.240814807783032,Aromatase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_or_rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50,17,8,4,19,21,27,23,25,48,Non-Response,0.000530234546724968,0.104966164793799,0.0192226550414769,0.452892271517629,mechanism,48,25,23,combination,0.0191483720228396,0.240814807783032,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_or_cn_simple_chr22_q_gt50,59,14,19,21,78,35,40,73,113,Non-Response,0.000530240313320748,0.218076327093387,0.0838707945342759,0.546235690818555,mechanism,113,73,40,combination,0.0191483720228396,0.240814807783032,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt50,29,22,11,38,40,60,49,51,100,Non-Response,0.000530991833357215,0.223237860377877,0.0829719344600165,0.566325866514717,mechanism,100,51,49,combination,0.0191483720228396,0.240814807783032,Anti-PD-1
Skin Melanoma ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt50,29,22,11,38,40,60,49,51,100,Non-Response,0.000530991833357215,0.223237860377877,0.0829719344600165,0.566325866514717,mechanism,100,51,49,combination,0.0191483720228396,0.240814807783032,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_gt75,53,138,13,105,66,243,118,191,309,Non-Response,0.000535646882405022,0.323454869427031,0.153458914047766,0.640124242002294,mechanism,409,247,162,univariate,0.0192944421323198,0.242651822715444,Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_and_cn_simple_chr2_q_gt50,8,13,0,27,8,40,27,21,48,Non-Response,0.000539262071015353,0,0,0.345197829624199,mechanism,48,21,27,combination,0.0193945884147212,0.243911287891799,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_and_cn_simple_chr3_p_gt50,8,13,0,27,8,40,27,21,48,Non-Response,0.000539262071015353,0,0,0.345197829624199,mechanism,48,21,27,combination,0.0193945884147212,0.243911287891799,Alkaloid/Platinum
Pan-Cancer ## Anti-PD-1,signature_log_SBS2_gt0,129,118,56,106,185,224,162,247,409,Non-Response,0.000540253445777168,0.48411850984356,0.3140338979245,0.741628473589577,mechanism,409,247,162,univariate,0.0194148032412092,0.244165514702792,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50,65,28,27,38,92,66,65,93,158,Non-Response,0.000540301754427924,0.308549920280517,0.149394925623739,0.625317049004181,mechanism,158,93,65,combination,0.0194148032412092,0.244165514702792,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,49,32,14,35,63,67,49,81,130,Non-Response,0.000544093498418317,0.264080839788783,0.112309531147429,0.595182363197206,mechanism,130,81,49,combination,0.0195165485673553,0.245445089860903,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,49,32,14,35,63,67,49,81,130,Non-Response,0.000544093498418317,0.264080839788783,0.112309531147429,0.595182363197206,mechanism,130,81,49,combination,0.0195165485673553,0.245445089860903,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,49,32,14,35,63,67,49,81,130,Non-Response,0.000544093498418317,0.264080839788783,0.112309531147429,0.595182363197206,mechanism,130,81,49,combination,0.0195165485673553,0.245445089860903,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_or_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,66,1,31,9,97,10,40,67,107,Non-Response,0.000545517887318196,0.0535653896728277,0.00117877561736928,0.415362192257015,mechanism,107,67,40,combination,0.0195415941884513,0.245760069976333,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_or_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,66,1,31,9,97,10,40,67,107,Non-Response,0.000545517887318196,0.0535653896728277,0.00117877561736928,0.415362192257015,mechanism,107,67,40,combination,0.0195415941884513,0.245760069976333,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_or_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,93,5,50,16,143,21,66,98,164,Non-Response,0.000552105642975228,0.169930970576781,0.0459232749463278,0.521708606719571,mechanism,164,98,66,combination,0.0197082927193164,0.247856513194592,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,47,34,13,36,60,70,49,81,130,Non-Response,0.000556550152666572,0.264053451055806,0.110700458749956,0.600401717986377,mechanism,174,110,64,univariate,0.0197887473700589,0.248868331391497,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,clin_hasSystemicPreTreatment_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,52,139,13,105,65,244,118,191,309,Non-Response,0.00055623233941822,0.332039110740559,0.157377686905161,0.657889818468596,mechanism,309,191,118,combination,0.0197887473700589,0.248868331391497,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,47,34,13,36,60,70,49,81,130,Non-Response,0.000556550152666572,0.264053451055806,0.110700458749956,0.600401717986377,mechanism,130,81,49,combination,0.0197887473700589,0.248868331391497,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_and_signature_log_SBS20_eq0,35,78,7,68,42,146,75,113,188,Non-Response,0.000564334952445076,0.231042661746083,0.0812276935774831,0.57261978950758,mechanism,188,113,75,combination,0.0200392519322264,0.252018740622902,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,25,42,3,37,28,79,40,67,107,Non-Response,0.000566004194143148,0.138396643972424,0.0247530399879108,0.509509610641883,mechanism,107,67,40,combination,0.0200809840626855,0.252543574533738,Taxane
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM_gt50_and_rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,26,6,5,12,31,18,17,32,49,Non-Response,0.000569778009397635,0.102285876096532,0.0193913275744629,0.4495195977441,mechanism,49,32,17,combination,0.0201916827576707,0.253935749540726,Anti-EGFR
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt75,30,161,4,114,34,275,118,191,309,Non-Response,0.000587170452298906,0.189103645559772,0.0471062603536702,0.557940849790126,mechanism,409,247,162,univariate,0.0206785231108723,0.260058377925919,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_rna_geneset_KEGG_RIBOSOME_lt25,52,41,18,47,70,88,65,93,158,Non-Response,0.00059177117708803,0.304356262399823,0.143504675452933,0.626093129689269,mechanism,158,93,65,combination,0.0207968818733617,0.261546887894512,Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50,18,6,10,25,28,31,35,24,59,Non-Response,0.000592931570547735,0.138761424242359,0.0340397246616357,0.493817841771749,mechanism,59,24,35,univariate,0.0208182870887326,0.261816085339544,Aromatase inhibitor
Skin Melanoma ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,35,16,16,33,51,49,49,51,100,Non-Response,0.0005979864649063,0.225340544094605,0.087612670771159,0.554664144866677,mechanism,100,51,49,combination,0.0209595609443489,0.263592781360722,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,30,21,12,37,42,58,49,51,100,Non-Response,0.000598733812470049,0.230718797821367,0.0874355657076843,0.577716293032522,mechanism,116,59,57,univariate,0.0209711201562043,0.263738152955643,Anti-PD-1
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_ACUTE_MYELOID_LEUKEMIA_gt75_or_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,9,6,5,37,14,43,42,15,57,Non-Response,0.000599090106431624,0.0956748467101259,0.0177478969135046,0.439204315146252,mechanism,57,15,42,combination,0.0209711201562043,0.263738152955643,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_APOPTOSIS_gt75_or_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,9,6,5,37,14,43,42,15,57,Non-Response,0.000599090106431624,0.0956748467101259,0.0177478969135046,0.439204315146252,mechanism,57,15,42,combination,0.0209711201562043,0.263738152955643,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Prostate ## Taxane,cn_simple_chr18_q_lt25_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25,39,2,10,8,49,10,18,41,59,Non-Response,0.000603529046915117,0.0681876617196244,0.00614878965173737,0.411315857006152,mechanism,59,41,18,combination,0.0210901818117997,0.265235502687115,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25_or_rna_geneset_KEGG_PENTOSE_PHOSPHATE_PATHWAY_gt50,39,2,10,8,49,10,18,41,59,Non-Response,0.000603529046915117,0.0681876617196244,0.00614878965173737,0.411315857006152,mechanism,59,41,18,combination,0.0210901818117997,0.265235502687115,Taxane
Prostate ## Taxane,rna_geneset_KEGG_JAK_STAT_SIGNALING_PATHWAY_lt75_and_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,39,2,10,8,49,10,18,41,59,Non-Response,0.000603529046915117,0.0681876617196244,0.00614878965173737,0.411315857006152,mechanism,59,41,18,combination,0.0210901818117997,0.265235502687115,Taxane
Prostate ## Taxane,cn_simple_chr18_q_lt25_or_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,40,1,11,7,51,8,18,41,59,Non-Response,0.000608144033157833,0.0420576046481183,0.000857539569742084,0.379698639742931,mechanism,59,41,18,combination,0.0211685427732285,0.266220990113495,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt50,40,1,11,7,51,8,18,41,59,Non-Response,0.000608144033157833,0.0420576046481183,0.000857539569742084,0.379698639742931,mechanism,59,41,18,combination,0.0211685427732285,0.266220990113495,Taxane
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt50_or_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,40,1,11,7,51,8,18,41,59,Non-Response,0.000608144033157833,0.0420576046481183,0.000857539569742084,0.379698639742931,mechanism,59,41,18,combination,0.0211685427732285,0.266220990113495,Taxane
Prostate ## Taxane,rna_geneset_KEGG_PENTOSE_PHOSPHATE_PATHWAY_gt50_or_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,40,1,11,7,51,8,18,41,59,Non-Response,0.000608144033157833,0.0420576046481183,0.000857539569742084,0.379698639742931,mechanism,59,41,18,combination,0.0211685427732285,0.266220990113495,Taxane
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75_or_rna_geneset_KEGG_INSULIN_SIGNALING_PATHWAY_gt50,13,2,14,28,27,30,42,15,57,Non-Response,0.000608669615932974,0.0806877029084732,0.00779416039484612,0.42919383807656,mechanism,57,15,42,combination,0.0211697245372128,0.266235852278612,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_FGFR3_related_gt25,124,67,53,65,177,132,118,191,309,Non-Response,0.000613781637275682,0.441784383134914,0.268269938925182,0.723439809003841,mechanism,409,247,162,univariate,0.0213383935552173,0.268357076845446,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt50,82,109,28,90,110,199,118,191,309,Non-Response,0.00061656973272497,0.41471551965062,0.238243249854078,0.708198489833795,mechanism,409,247,162,univariate,0.0214261605902147,0.269460857450783,Anti-PD-1
Pan-Cancer ## Anti-PD-1,purity_tml_lt25,32,215,5,157,37,372,162,247,409,Non-Response,0.000618885272023597,0.214623963494984,0.0638401524747374,0.572121525894746,mechanism,409,247,162,univariate,0.0214745000982699,0.270068787426592,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_gt50,37,27,7,26,44,53,33,64,97,Non-Response,0.000624253108967927,0.199893132213827,0.0635076729821232,0.560340950455401,mechanism,113,73,40,univariate,0.0216422829449823,0.272178867277357,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_tim3_lt50,12,7,2,20,14,27,22,19,41,Non-Response,0.000624824477207884,0.063546854862717,0.00558782550671591,0.385048179623011,mechanism,50,24,26,univariate,0.021643632370057,0.272195837991086,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_or_rna_geneset_gene_set_t_cell_gep_10_lt50,25,26,8,41,33,67,49,51,100,Non-Response,0.000626894029217932,0.206363865470888,0.0693744334077219,0.559087167496452,mechanism,100,51,49,combination,0.0216783741732831,0.272632759764695,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION_gt50,84,107,29,89,113,196,118,191,309,Non-Response,0.000643440841041573,0.416229993929168,0.240480761451053,0.707448455372391,mechanism,409,247,162,univariate,0.0219667918627982,0.27625997415028,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_and_cn_simple_chr22_q_gt50,39,34,8,32,47,66,40,73,113,Non-Response,0.000646471496727426,0.220929614485642,0.0770913852829944,0.573115994593652,mechanism,113,73,40,combination,0.0220274460236559,0.277022776338935,Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_and_rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25,28,53,4,45,32,98,49,81,130,Non-Response,0.000649844674266492,0.170263969863881,0.0403604864819473,0.539164910016771,mechanism,130,81,49,combination,0.0221238367559429,0.278235010759702,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,fusion_total_gt50_and_rna_geneset_KEGG_RIBOSOME_gt50,24,40,2,31,26,71,33,64,97,Non-Response,0.000654149337247557,0.109543550381909,0.0116596871221072,0.497625497652188,mechanism,97,64,33,combination,0.0222424454073146,0.27972666339458,Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25,80,1,40,9,120,10,49,81,130,Non-Response,0.000655510143990596,0.0566963996513024,0.00125751643109375,0.433376456635052,mechanism,130,81,49,combination,0.0222793976573125,0.280191384310268,Multikinase inhibitor
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_p_gt50_or_rna_geneset_HALLMARK_ANDROGEN_RESPONSE_lt50,23,8,8,20,31,28,28,31,59,Non-Response,0.000657190021138726,0.144687889579046,0.0374717427912574,0.499276125722672,mechanism,59,31,28,combination,0.0223271590173662,0.280792043349432,Aromatase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,driver_DNM2_or_signature_log_DBS_denovo_5_eq0,109,11,54,22,163,33,76,120,196,Non-Response,0.000664959815195519,0.249625516324545,0.101363760780476,0.582782791293839,mechanism,196,120,76,combination,0.0225184500524959,0.283197768170343,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_SBS_denovo_26_eq0_and_signature_log_SBS20_eq0,109,11,54,22,163,33,76,120,196,Non-Response,0.000664959815195519,0.249625516324545,0.101363760780476,0.582782791293839,mechanism,196,120,76,combination,0.0225184500524959,0.283197768170343,Platinum/Pyrimidine (ant)agonist
Lung NSCLC ## Anti-PD-1,cn_simple_chr3_p_lt75_and_purity_tmbPerMb_lt75,16,29,0,22,16,51,22,45,67,Non-Response,0.000667702649257513,0,0,0.397123750983228,mechanism,67,45,22,combination,0.0225711258552959,0.283860232494253,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_CD_8_T_effector_lt25,45,146,10,108,55,254,118,191,309,Non-Response,0.000679450672971776,0.301443356657,0.129492612403511,0.64099647247475,mechanism,409,247,162,univariate,0.0228238840317981,0.287038983754015,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_cd8_t_effector_lt25,45,146,10,108,55,254,118,191,309,Non-Response,0.000679450672971776,0.301443356657,0.129492612403511,0.64099647247475,mechanism,409,247,162,univariate,0.0228238840317981,0.287038983754015,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_COAGULATION_gt50,86,105,30,88,116,193,118,191,309,Non-Response,0.000676786602807271,0.417397804322994,0.242450368469146,0.706363543054024,mechanism,409,247,162,univariate,0.0228238840317981,0.287038983754015,Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_KEGG_TYPE_I_DIABETES_MELLITUS_lt50,13,1,5,12,18,13,17,14,31,Non-Response,0.000679151086595921,0.0368123938719451,0.000704927726268672,0.356836825887135,mechanism,37,17,20,univariate,0.0228238840317981,0.287038983754015,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75_or_rna_geneset_gene_set_t_cell_gep_10_lt75,13,1,5,12,18,13,17,14,31,Non-Response,0.000679151086595921,0.0368123938719451,0.000704927726268672,0.356836825887135,mechanism,31,14,17,combination,0.0228238840317981,0.287038983754015,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75_or_rna_geneset_gene_set_t_cell_gep_6_lt75,13,1,5,12,18,13,17,14,31,Non-Response,0.000679151086595921,0.0368123938719451,0.000704927726268672,0.356836825887135,mechanism,31,14,17,combination,0.0228238840317981,0.287038983754015,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_or_rna_geneset_HALLMARK_COMPLEMENT_lt50,13,1,5,12,18,13,17,14,31,Non-Response,0.000679151086595921,0.0368123938719451,0.000704927726268672,0.356836825887135,mechanism,31,14,17,combination,0.0228238840317981,0.287038983754015,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_or_rna_geneset_HALLMARK_COMPLEMENT_lt50,13,1,5,12,18,13,17,14,31,Non-Response,0.000679151086595921,0.0368123938719451,0.000704927726268672,0.356836825887135,mechanism,31,14,17,combination,0.0228238840317981,0.287038983754015,Anti-CTLA-4/Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,22,3,9,14,31,17,23,25,48,Non-Response,0.000685117480111507,0.0930523341406468,0.0137730438873411,0.441528666003653,mechanism,48,25,23,combination,0.0229640758670729,0.288802072011553,Multikinase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_and_cn_simple_chr21_q_gt50,15,9,6,29,21,38,35,24,59,Non-Response,0.000689971545133191,0.129566386850589,0.0307861425052565,0.476602552243418,mechanism,59,24,35,combination,0.0230861858315873,0.290337758053053,Aromatase inhibitor
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_or_rna_geneset_Colostage_one_gt25,69,12,28,21,97,33,49,81,130,Non-Response,0.00071086368097626,0.234852153029825,0.0916699403734784,0.576161056671413,mechanism,130,81,49,combination,0.0235599292293881,0.296295675788503,Multikinase inhibitor
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_APOPTOSIS_gt75_and_rna_geneset_KEGG_MTOR_SIGNALING_PATHWAY_gt50,5,10,0,42,5,52,42,15,57,Non-Response,0.000717201809555335,0,0,0.318613166202725,mechanism,57,15,42,combination,0.0237584366767901,0.298792156049729,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_HALLMARK_MYC_TARGETS_V1_lt75,32,2,10,9,42,11,19,34,53,Non-Response,0.000722091077786138,0.0738682798554772,0.00671839610861467,0.436290651192694,mechanism,53,34,19,combination,0.0238155304393246,0.299510181761469,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr18_p_gt25_or_rna_geneset_KEGG_RIBOSOME_gt50,56,8,18,15,74,23,33,64,97,Non-Response,0.000729833930634838,0.175188891030253,0.0544223771338128,0.523134108081863,mechanism,97,64,33,combination,0.0240513857830084,0.302476358686904,Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,32,35,6,34,38,69,40,67,107,Non-Response,0.000731899649906466,0.195932074467306,0.0592607036927969,0.555483768269905,mechanism,120,77,43,univariate,0.0240755450688836,0.302780192024656,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_and_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,32,35,6,34,38,69,40,67,107,Non-Response,0.000731899649906466,0.195932074467306,0.0592607036927969,0.555483768269905,mechanism,107,67,40,combination,0.0240755450688836,0.302780192024656,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_STEROID_BIOSYNTHESIS_gt25_and_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,32,35,6,34,38,69,40,67,107,Non-Response,0.000731899649906466,0.195932074467306,0.0592607036927969,0.555483768269905,mechanism,107,67,40,combination,0.0240755450688836,0.302780192024656,Taxane
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_BILE_ACID_METABOLISM_gt50,76,115,25,93,101,208,118,191,309,Non-Response,0.000732610968401742,0.407919040913838,0.229534571175943,0.708261243506174,mechanism,409,247,162,univariate,0.0240891968129801,0.30295187983846,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50,43,30,10,30,53,60,40,73,113,Non-Response,0.000736777154859097,0.235710293605838,0.0886487710116406,0.585061746572842,mechanism,113,73,40,univariate,0.0241285985550412,0.303447406190749,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt25_and_cn_simple_chr22_q_gt50,43,30,10,30,53,60,40,73,113,Non-Response,0.000736777154859097,0.235710293605838,0.0886487710116406,0.585061746572842,mechanism,113,73,40,combination,0.0241285985550412,0.303447406190749,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_effector_lt25,38,153,7,111,45,264,118,191,309,Non-Response,0.000743581547788957,0.254889224849791,0.0925862117373622,0.605778220226033,mechanism,409,247,162,univariate,0.0242985863158468,0.305585215603218,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_and_rna_geneset_KEGG_RIBOSOME_lt25,33,65,7,59,40,124,66,98,164,Non-Response,0.000750073947483727,0.23561345067057,0.0816350659994027,0.59501411562079,mechanism,164,98,66,combination,0.0243957365745622,0.306807002021965,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75_and_signature_log_SBS20_eq0,53,45,18,48,71,93,66,98,164,Non-Response,0.00075018562880731,0.320698586496224,0.152678618326948,0.653408582188561,mechanism,164,98,66,combination,0.0243957365745622,0.306807002021965,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25_and_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,33,65,7,59,40,124,66,98,164,Non-Response,0.000750073947483727,0.23561345067057,0.0816350659994027,0.59501411562079,mechanism,164,98,66,combination,0.0243957365745622,0.306807002021965,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_TASTE_TRANSDUCTION_gt50,89,102,32,86,121,188,118,191,309,Non-Response,0.000758724070099699,0.427615996811967,0.250725862617736,0.718271757803954,mechanism,409,247,162,univariate,0.0246487545154987,0.309989020145469,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,65,16,25,24,90,40,49,81,130,Non-Response,0.000759761712290563,0.259390150664577,0.108572797969395,0.601986882860718,mechanism,130,81,49,combination,0.02467260533154,0.310288974087956,Multikinase inhibitor
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr16_q_gt50_and_cn_simple_chr21_p_gt75,12,13,1,24,13,37,25,25,50,Non-Response,0.000762033491544358,0.0479191861667097,0.00102063838587518,0.388001004124001,mechanism,50,25,25,combination,0.0246773793384046,0.310349013215255,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr20_q_gt25_or_cn_simple_chr22_q_gt25,24,1,13,12,37,13,25,25,50,Non-Response,0.000762033491544358,0.0479191861667097,0.00102063838587517,0.388001004124001,mechanism,50,25,25,combination,0.0246773793384046,0.310349013215255,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr21_p_gt75_and_cn_simple_chr22_q_gt25,12,13,1,24,13,37,25,25,50,Non-Response,0.000762033491544358,0.0479191861667097,0.00102063838587518,0.388001004124001,mechanism,50,25,25,combination,0.0246773793384046,0.310349013215255,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25,61,12,21,19,82,31,40,73,113,Non-Response,0.00076539776335675,0.220831665893391,0.0821360278220303,0.569514614355262,mechanism,113,73,40,univariate,0.024766596124633,0.311471026261638,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr7_p_gt25,61,12,21,19,82,31,40,73,113,Non-Response,0.00076539776335675,0.220831665893391,0.0821360278220303,0.569514614355262,mechanism,113,73,40,univariate,0.024766596124633,0.311471026261638,Pyrimidine (ant)agonist
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,14,20,0,19,14,39,19,34,53,Non-Response,0.000779316045332524,0,0,0.383747990351625,mechanism,59,37,22,univariate,0.0251518916909444,0.316316601521522,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_and_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,14,20,0,19,14,39,19,34,53,Non-Response,0.000779316045332524,0,0,0.383747990351625,mechanism,53,34,19,combination,0.0251518916909444,0.316316601521522,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_gt50,91,100,33,85,124,185,118,191,309,Non-Response,0.000788145007945213,0.427807737965247,0.251894579607242,0.716135041238481,mechanism,409,247,162,univariate,0.0254015464820368,0.319456323815267,Anti-PD-1
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,39,19,5,16,44,35,21,58,79,Non-Response,0.000804234819423015,0.156273137929393,0.0387183897737079,0.530506301650854,mechanism,79,58,21,combination,0.0258330646322686,0.324883206073404,Anti-AR
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt50_or_rna_geneset_KEGG_PENTOSE_PHOSPHATE_PATHWAY_gt50,33,8,6,12,39,20,18,41,59,Non-Response,0.000805098313855154,0.126815373008552,0.028702062858237,0.492566003253252,mechanism,59,41,18,combination,0.0258505876058887,0.325103579456535,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,52,15,18,22,70,37,40,67,107,Non-Response,0.00080699893061743,0.23961465951636,0.0926607146707785,0.597537980594308,mechanism,120,77,43,univariate,0.0258962723742911,0.325678122749735,Taxane
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_rna_geneset_Colostage_one_gt25,58,23,20,29,78,52,49,81,130,Non-Response,0.0008073624124062,0.276452039121656,0.121035347793048,0.615482519531219,mechanism,130,81,49,combination,0.0258977142498369,0.325696256144157,Multikinase inhibitor
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_or_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,33,25,3,18,36,43,21,58,79,Non-Response,0.000814118880340854,0.129490491048232,0.0219959580261348,0.514026551391345,mechanism,79,58,21,combination,0.0260835668385541,0.328033585676637,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50_or_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,33,25,3,18,36,43,21,58,79,Non-Response,0.000814118880340854,0.129490491048232,0.0219959580261348,0.514026551391345,mechanism,79,58,21,combination,0.0260835668385541,0.328033585676637,Anti-AR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50,56,42,20,46,76,88,66,98,164,Non-Response,0.00081587262811043,0.328402548107763,0.158925861366591,0.661510768600348,mechanism,196,120,76,univariate,0.0260986145161322,0.32822282910575,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75_and_rna_geneset_KEGG_MELANOMA_gt50,6,9,1,41,7,50,42,15,57,Non-Response,0.000819427406844897,0.0396598034837605,0.000783914292869087,0.383724424969055,mechanism,57,15,42,combination,0.0261762784868697,0.329199550999524,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75_and_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,6,9,1,41,7,50,42,15,57,Non-Response,0.000819427406844897,0.0396598034837605,0.000783914292869087,0.383724424969055,mechanism,57,15,42,combination,0.0261762784868697,0.329199550999524,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_MTOR_SIGNALING_PATHWAY_gt50_and_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,6,9,1,41,7,50,42,15,57,Non-Response,0.000819427406844897,0.0396598034837605,0.000783914292869087,0.383724424969055,mechanism,57,15,42,combination,0.0261762784868697,0.329199550999524,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,42,27,15,univariate,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_Colostage_one_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,42,27,15,univariate,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_gene_set_cd8_t_effector_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,42,27,15,univariate,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_gene_set_tgfb_rand1_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,42,27,15,univariate,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOFLAVIN_METABOLISM_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,42,27,15,univariate,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_vhio_tcell_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,42,27,15,univariate,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt25,128,63,56,62,184,125,118,191,309,Non-Response,0.000824354353792749,0.445771259518767,0.270230611647894,0.73164734898733,mechanism,409,247,162,univariate,0.0261893154764232,0.329363507503485,Anti-PD-1
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50_and_rna_geneset_gene_set_cd8_t_effector_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,37,24,13,combination,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50_or_rna_geneset_gene_set_cd8_t_effector_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,37,24,13,combination,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_Colostage_one_lt50_and_rna_geneset_gene_set_tgfb_rand1_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,37,24,13,combination,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_Colostage_one_lt50_or_rna_geneset_gene_set_tgfb_rand1_lt50,21,3,4,9,25,12,13,24,37,Non-Response,0.000824828623690103,0.0705487869782234,0.00820975475515405,0.430962342234432,mechanism,37,24,13,combination,0.0261893154764232,0.329363507503485,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_or_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,65,2,30,10,95,12,40,67,107,Non-Response,0.000820828543303357,0.0944744401777406,0.00949953805047906,0.482234340239995,mechanism,107,67,40,combination,0.0261893154764232,0.329363507503485,Taxane
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50,12,13,1,22,13,35,23,25,48,Non-Response,0.000828044708760609,0.0522533637344412,0.00110891366220563,0.425819052606332,mechanism,61,34,27,univariate,0.0262197494751816,0.329746253229979,Multikinase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,12,13,1,22,13,35,23,25,48,Non-Response,0.000828044708760609,0.0522533637344412,0.00110891366220563,0.425819052606332,mechanism,48,25,23,combination,0.0262197494751816,0.329746253229979,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_or_rna_geneset_KEGG_RIBOSOME_gt50,58,6,20,13,78,19,33,64,97,Non-Response,0.000839844962794127,0.162775197724473,0.0443678324151594,0.531617846767282,mechanism,97,64,33,combination,0.0265468723290046,0.333860233628462,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,fusion_total_gt50_or_rna_geneset_battle_tgfb_caf_Lrrc15_Fibroblasts_gt25,62,2,24,9,86,11,33,64,97,Non-Response,0.000843169098302882,0.0884942872759519,0.0086959339996397,0.470419456547953,mechanism,97,64,33,combination,0.0266208949603596,0.334791161109926,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,fusion_total_gt50_or_rna_geneset_gene_set_tgfb_caf_Lrrc15_Fibroblasts_gt25,62,2,24,9,86,11,33,64,97,Non-Response,0.000843169098302882,0.0884942872759519,0.0086959339996397,0.470419456547953,mechanism,97,64,33,combination,0.0266208949603596,0.334791161109926,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_GRAFT_VERSUS_HOST_DISEASE_lt50,80,111,27,91,107,202,118,191,309,Non-Response,0.000844602478630392,0.412838151688328,0.235640614425046,0.70859734679787,mechanism,409,247,162,univariate,0.0266454547575368,0.335100031379908,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_PROTEASOME_lt50,80,111,27,91,107,202,118,191,309,Non-Response,0.000844602478630392,0.412838151688328,0.235640614425046,0.70859734679787,mechanism,409,247,162,univariate,0.0266454547575368,0.335100031379908,Anti-PD-1
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_IL6_JAK_STAT3_SIGNALING_gt50_and_rna_geneset_tcga_gt25,13,2,15,27,28,29,42,15,57,Non-Response,0.000845568965218308,0.089351528157082,0.00866682811244371,0.473352683349093,mechanism,57,15,42,combination,0.0266655978678368,0.335353356269839,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450_gt75,35,156,6,112,41,268,118,191,309,Non-Response,0.00084842637547333,0.239710710328302,0.0796715657188406,0.602223065047492,mechanism,409,247,162,univariate,0.0267349674029482,0.336225765226795,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt75,35,156,6,112,41,268,118,191,309,Non-Response,0.00084842637547333,0.239710710328302,0.0796715657188406,0.602223065047492,mechanism,409,247,162,univariate,0.0267349674029482,0.336225765226795,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,67,26,29,36,96,62,65,93,158,Non-Response,0.000854981913011681,0.315084923643831,0.151968164698139,0.641383017843625,mechanism,158,93,65,combination,0.0268790311469206,0.338037547595126,Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_and_rna_geneset_gene_set_t_cell_gep_6_lt50,17,34,3,46,20,80,49,51,100,Non-Response,0.000855389212923478,0.132956182899457,0.0231249795855645,0.512174823280174,mechanism,100,51,49,combination,0.0268814409050892,0.33806785332814,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_and_rna_geneset_KEGG_RIBOSOME_gt50,32,32,5,28,37,60,33,64,97,Non-Response,0.000864946047899399,0.181665793734103,0.0485626037237624,0.558311325375605,mechanism,97,64,33,combination,0.0270533407785156,0.340229709956355,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_battle_tcell_term_diff_cd8_lt75,125,66,54,64,179,130,118,191,309,Non-Response,0.000870864453040175,0.446710778803732,0.271217542168175,0.731807655656976,mechanism,409,247,162,univariate,0.0271838775840711,0.341871374098924,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_Immune_Checkpoint_lt25,34,157,6,112,40,269,118,191,309,Non-Response,0.000873675738324348,0.248322378029212,0.0823854556235763,0.625490571460237,mechanism,409,247,162,univariate,0.0272155540106488,0.342269744914388,Anti-PD-1
Prostate ## Anti-AR,chord_BRCA1_gt0_or_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,50,8,10,11,60,19,21,58,79,Non-Response,0.000874892070097179,0.150143817661631,0.0401286249012658,0.523606261670574,mechanism,79,58,21,combination,0.0272155540106488,0.342269744914388,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_ASTHMA_gt50_or_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,50,8,10,11,60,19,21,58,79,Non-Response,0.000874892070097179,0.150143817661631,0.0401286249012658,0.523606261670574,mechanism,79,58,21,combination,0.0272155540106488,0.342269744914388,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_PARKINSONS_DISEASE_lt75_or_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,50,8,10,11,60,19,21,58,79,Non-Response,0.000874892070097179,0.150143817661631,0.0401286249012658,0.523606261670574,mechanism,79,58,21,combination,0.0272155540106488,0.342269744914388,Anti-AR
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_12_chemokine_lt50,79,112,27,91,106,203,118,191,309,Non-Response,0.000875636240562649,0.421800187847051,0.240703783332425,0.724261490005547,mechanism,409,247,162,univariate,0.0272282848428008,0.342429851104824,Anti-PD-1
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_or_rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75,32,0,11,6,43,6,17,32,49,Non-Response,0.000885023086688213,0,0,0.358938542572668,mechanism,49,32,17,combination,0.0274781332536433,0.345572008409902,Anti-EGFR
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,26,32,1,20,27,52,21,58,79,Non-Response,0.000895039635058118,0.0631582768149133,0.00143575847496215,0.448188581720518,mechanism,79,58,21,combination,0.0276728759424187,0.348021142106942,Anti-AR
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,36,5,8,10,44,15,18,41,59,Non-Response,0.000907870755057675,0.116705124995457,0.0237885866962521,0.492831850600461,mechanism,59,41,18,combination,0.0279844491053778,0.351939565629258,Taxane
Pan-Cancer ## Anti-PD-1,purity_tml_lt50,62,185,19,143,81,328,162,247,409,Non-Response,0.00091254694821781,0.397296872117327,0.2142312574451,0.709526428583914,mechanism,409,247,162,univariate,0.028107275750392,0.353484264827417,Anti-PD-1
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_q_gt25_and_rna_geneset_HALLMARK_ANDROGEN_RESPONSE_lt50,10,21,0,28,10,49,28,31,59,Non-Response,0.000914798323244152,0,0,0.389701474601022,mechanism,59,31,28,combination,0.0281606167669164,0.354155095048699,Aromatase inhibitor
Pan-Cancer ## Platinum ## Taxane,cn_simple_chr7_p_gt75_and_rna_geneset_KEGG_DRUG_METABOLISM_OTHER_ENZYMES_gt50,8,20,0,34,8,54,34,28,62,Non-Response,0.000919258920919739,0,0,0.397380034624888,mechanism,62,28,34,combination,0.028276515706339,0.355612669655355,Platinum/Taxane
Pan-Cancer ## Anti-PD-1,rna_geneset_FGFR3_related_gt50,95,96,36,82,131,178,118,191,309,Non-Response,0.000924849840940404,0.444817625257114,0.264728497614819,0.738393696705606,mechanism,409,247,162,univariate,0.0284211585084491,0.357431734406438,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_and_cn_simple_chr13_q_gt25,55,18,17,23,72,41,40,73,113,Non-Response,0.000925359556352044,0.245326126535972,0.0979358083317016,0.595004500601052,mechanism,113,73,40,combination,0.0284211585084491,0.357431734406438,Pyrimidine (ant)agonist
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,21,37,0,21,21,58,21,58,79,Non-Response,0.000926243913622342,0,0,0.389783301369931,mechanism,79,58,21,combination,0.0284375770141929,0.357638217720009,Anti-AR
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,21,4,8,15,29,19,23,25,48,Non-Response,0.000927100051566561,0.1075793530654,0.0196144751918359,0.467318281191128,mechanism,48,25,23,combination,0.0284423800348339,0.357698621731956,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_and_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,30,51,5,44,35,95,49,81,130,Non-Response,0.000927602158983799,0.195406515025311,0.0544762083660306,0.568589219824732,mechanism,130,81,49,combination,0.0284470493863538,0.357757344686962,Multikinase inhibitor
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_and_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0285077078798791,0.358520201364349,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0285077078798791,0.358520201364349,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_signature_log_SBS1_gt25,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0285077078798791,0.358520201364349,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0285077078798791,0.358520201364349,Anti-AR
Colorectum ## Platinum ## Pyrimidine (ant)agonist,cn_simple_chr9_p_gt25,27,0,9,6,36,6,15,27,42,Non-Response,0.000954099156923291,0,0,0.36205642300047,mechanism,42,27,15,univariate,0.0290369301254928,0.365175835232332,Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_battle_tcell_gzmk_cd8_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,37,17,20,univariate,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_battle_tcell_term_diff_cd8_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,37,17,20,univariate,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_cyt_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,37,17,20,univariate,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_infiltrate_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,37,17,20,univariate,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,37,17,20,univariate,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_tim3_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,37,17,20,univariate,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_Immune_Checkpoint_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,37,17,20,univariate,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_SBS_denovo_26_eq0_or_signature_log_SBS20_eq0,112,8,58,18,170,26,76,120,196,Non-Response,0.000961798149479741,0.23201193645104,0.0820767230673994,0.601169679989791,mechanism,196,120,76,combination,0.0290369301254928,0.365175835232332,Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_or_rna_geneset_gene_set_impres_lt75,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,31,14,17,combination,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_immune_checkpoint_genes_lt75_or_rna_geneset_HALLMARK_COMPLEMENT_lt50,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,31,14,17,combination,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75_or_rna_geneset_HALLMARK_COMPLEMENT_lt50,12,2,4,13,16,15,17,14,31,Non-Response,0.000965052278614514,0.0583802749461146,0.00450178262295835,0.41459667394682,mechanism,31,14,17,combination,0.0290369301254928,0.365175835232332,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-PD-1,clin_pretreatment_contains_Platinum,100,147,40,122,140,269,162,247,409,Non-Response,0.000973777572919601,0.482813550620348,0.302282196659884,0.762198212579876,mechanism,409,247,162,univariate,0.02918882810985,0.367086143004815,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_MYOGENESIS_gt25,145,46,68,50,213,96,118,191,309,Non-Response,0.000972767759125231,0.432687672759012,0.255807085592423,0.728656249543341,mechanism,409,247,162,univariate,0.02918882810985,0.367086143004815,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_RIBOSOME_lt25,35,63,8,58,43,121,66,98,164,Non-Response,0.000973348523131381,0.250265591766793,0.0924936189420062,0.606860382958014,mechanism,196,120,76,univariate,0.02918882810985,0.367086143004815,Platinum/Pyrimidine (ant)agonist
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,25,33,1,20,26,53,21,58,79,Non-Response,0.000974768057642071,0.0676765866874505,0.00153720083832879,0.480968877321353,mechanism,97,68,29,univariate,0.02918882810985,0.367086143004815,Anti-AR
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_ACUTE_MYELOID_LEUKEMIA_gt75,11,4,9,33,20,37,42,15,57,Non-Response,0.000974204409437512,0.104462916144483,0.0193147373065269,0.454079376675583,mechanism,57,15,42,combination,0.02918882810985,0.367086143004815,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ANGIOGENESIS_gt75_or_rna_geneset_KEGG_APOPTOSIS_gt75,11,4,9,33,20,37,42,15,57,Non-Response,0.000974204409437512,0.104462916144483,0.0193147373065269,0.454079376675583,mechanism,57,15,42,combination,0.02918882810985,0.367086143004815,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,42,39,11,38,53,77,49,81,130,Non-Response,0.00097226346743738,0.271559578087584,0.109228319051412,0.634298834318412,mechanism,130,81,49,combination,0.02918882810985,0.367086143004815,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_and_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,35,63,8,58,43,121,66,98,164,Non-Response,0.000973348523131381,0.250265591766793,0.0924936189420062,0.606860382958014,mechanism,164,98,66,combination,0.02918882810985,0.367086143004815,Platinum/Pyrimidine (ant)agonist
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,25,33,1,20,26,53,21,58,79,Non-Response,0.000974768057642071,0.0676765866874505,0.00153720083832879,0.480968877321353,mechanism,79,58,21,combination,0.02918882810985,0.367086143004815,Anti-AR
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_or_rna_geneset_gene_set_t_cell_gep_18_lt25,23,28,7,42,30,70,49,51,100,Non-Response,0.000977184207695756,0.206276747452827,0.0654994941567529,0.579813878149583,mechanism,100,51,49,combination,0.029250404602893,0.367860544678148,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,clin_age_gt25_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,14,67,0,49,14,116,49,81,130,Non-Response,0.000980780674647441,0,0,0.440593158766242,mechanism,130,81,49,combination,0.029311385741086,0.368627459017123,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,14,67,0,49,14,116,49,81,130,Non-Response,0.000980780674647441,0,0,0.440593158766242,mechanism,130,81,49,combination,0.029311385741086,0.368627459017123,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,14,67,0,49,14,116,49,81,130,Non-Response,0.000980780674647441,0,0,0.440593158766242,mechanism,130,81,49,combination,0.029311385741086,0.368627459017123,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,48,50,15,51,63,101,66,98,164,Non-Response,0.000981024128236447,0.308608730591471,0.141482945744283,0.645935087948808,mechanism,164,98,66,combination,0.029311385741086,0.368627459017123,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,29,162,4,114,33,276,118,191,309,Non-Response,0.000992841139424072,0.196823646587612,0.0489543344485621,0.582572163202152,mechanism,309,191,118,combination,0.0295883401004537,0.372110507640591,Anti-PD-1
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM_gt50_and_rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75,27,5,6,11,33,16,17,32,49,Non-Response,0.000993986964572199,0.107336039804321,0.020166761190089,0.478760239164005,mechanism,49,32,17,combination,0.0296116329178289,0.372403444049611,Anti-EGFR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_and_rna_geneset_KEGG_RIBOSOME_lt25,30,68,6,60,36,128,66,98,164,Non-Response,0.000999048398408257,0.228528057736396,0.0726938620831147,0.608797639252986,mechanism,164,98,66,combination,0.0297134207946563,0.373683554335936,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,15,66,0,49,15,115,49,81,130,Non-Response,0.00100097868227478,0,0,0.401836795906867,mechanism,130,81,49,combination,0.029743627883866,0.374063446390104,Multikinase inhibitor
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25,18,3,10,17,28,20,27,21,48,Non-Response,0.00101626218833354,0.103541441160564,0.0155811165314734,0.480574890104945,mechanism,48,21,27,univariate,0.030098761256586,0.378529694214561,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25_or_cn_simple_chr11_q_gt75,18,3,10,17,28,20,27,21,48,Non-Response,0.00101626218833354,0.103541441160564,0.0155811165314734,0.480574890104945,mechanism,48,21,27,combination,0.030098761256586,0.378529694214561,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25_or_cn_simple_chr3_p_gt50,18,3,10,17,28,20,27,21,48,Non-Response,0.00101626218833354,0.103541441160564,0.0155811165314734,0.480574890104945,mechanism,48,21,27,combination,0.030098761256586,0.378529694214561,Alkaloid/Platinum
Pan-Cancer ## Taxane,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50_or_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,48,19,15,25,63,44,40,67,107,Non-Response,0.001020227111817,0.241054036803638,0.0948855289653955,0.589454843214325,mechanism,107,67,40,combination,0.0301612523504037,0.379315598140384,Taxane
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50_or_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,48,33,14,35,62,68,49,81,130,Non-Response,0.00102085189454827,0.2778695879968,0.118354605034766,0.625499488146117,mechanism,130,81,49,combination,0.0301687525172228,0.379409922150212,Multikinase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_p_gt50_or_rna_geneset_HALLMARK_ALLOGRAFT_REJECTION_lt25,16,4,8,20,24,24,28,20,48,Non-Response,0.0010222242348282,0.105931031883929,0.0193588475174087,0.458210332275806,mechanism,48,20,28,combination,0.030198331419803,0.379781913969192,Aromatase inhibitor
Skin Melanoma ## Anti-PD-1,drivers_pathway_IMMUNE_EVASION_eq0_and_rna_geneset_gene_set_t_cell_gep_6_lt50,20,31,5,44,25,75,49,51,100,Non-Response,0.00104122249287985,0.179230183133962,0.0473451589453417,0.561346303629342,mechanism,100,51,49,combination,0.0306815322394487,0.385858770652611,Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_p_gt50_or_rna_geneset_battle_tcell_term_diff_cd8_lt25,15,5,7,21,22,26,28,20,48,Non-Response,0.00105117507321218,0.117458503625469,0.0235752714669582,0.489826955269814,mechanism,48,20,28,combination,0.030924364855103,0.388912695528965,Aromatase inhibitor
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,10,4,2,15,12,19,17,14,31,Non-Response,0.00105302187615869,0.0606452367218549,0.0046462611501623,0.436395003466093,mechanism,37,17,20,univariate,0.0309339206900905,0.389032872145702,Anti-CTLA-4/Anti-PD-1
Breast ER+/HER- ## Aromatase inhibitor,rna_geneset_battle_tcell_term_diff_cd8_lt25_or_rna_geneset_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION_lt25,7,13,0,28,7,41,28,20,48,Non-Response,0.00105284499579188,0,0,0.391463383919254,mechanism,48,20,28,combination,0.0309339206900905,0.389032872145702,Aromatase inhibitor
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr2_q_gt50,14,7,5,22,19,29,27,21,48,Non-Response,0.0010633945829197,0.120071807496573,0.0240121330852032,0.50391338435743,mechanism,48,21,27,univariate,0.0311598184165755,0.391873819538892,Alkaloid/Platinum
Prostate ## Taxane,cn_simple_chr1_q_lt75_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,31,10,5,13,36,23,18,41,59,Non-Response,0.00106547454988688,0.129494937550002,0.0284234077420323,0.501900020053589,mechanism,59,41,18,combination,0.031198276762562,0.392357481501661,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50_or_rna_geneset_KEGG_PENTOSE_PHOSPHATE_PATHWAY_gt50,31,10,5,13,36,23,18,41,59,Non-Response,0.00106547454988688,0.129494937550002,0.0284234077420323,0.501900020053589,mechanism,59,41,18,combination,0.031198276762562,0.392357481501661,Taxane
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_TYPE_I_DIABETES_MELLITUS_lt75,22,2,5,8,27,10,13,24,37,Non-Response,0.00106984139896527,0.0632758415934038,0.00506719602607026,0.440014586855327,mechanism,42,27,15,univariate,0.0313148644084527,0.393823717456423,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,86,105,31,87,117,192,118,191,309,Non-Response,0.00109055384766291,0.436207046375727,0.254562572121186,0.735589226402107,mechanism,309,191,118,combination,0.0318009100649738,0.39993635153358,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,86,105,31,87,117,192,118,191,309,Non-Response,0.00109055384766291,0.436207046375727,0.254562572121186,0.735589226402107,mechanism,309,191,118,combination,0.0318009100649738,0.39993635153358,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_or_signature_log_SBS20_eq0,107,6,59,16,166,22,75,113,188,Non-Response,0.00109754896733576,0.208594231630627,0.0633188652132502,0.598496968854548,mechanism,188,113,75,combination,0.0319190246808907,0.401421791052641,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50_or_rna_geneset_Colostage_one_lt50,23,1,6,7,29,8,13,24,37,Non-Response,0.0011000564131494,0.0418437470465845,0.000800746352179779,0.417023560937635,mechanism,37,24,13,combination,0.031934828185193,0.401620539951311,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_CD_8_T_effector_lt50_or_rna_geneset_gene_set_tgfb_rand1_lt50,23,1,6,7,29,8,13,24,37,Non-Response,0.0011000564131494,0.0418437470465845,0.000800746352179779,0.417023560937635,mechanism,37,24,13,combination,0.031934828185193,0.401620539951311,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_Colostage_one_lt50_or_rna_geneset_gene_set_cd8_t_effector_lt50,23,1,6,7,29,8,13,24,37,Non-Response,0.0011000564131494,0.0418437470465845,0.000800746352179779,0.417023560937635,mechanism,37,24,13,combination,0.031934828185193,0.401620539951311,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_gene_set_cd8_t_effector_lt50_or_rna_geneset_gene_set_tgfb_rand1_lt50,23,1,6,7,29,8,13,24,37,Non-Response,0.0011000564131494,0.0418437470465845,0.000800746352179779,0.417023560937635,mechanism,37,24,13,combination,0.031934828185193,0.401620539951311,Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_KEGG_ALLOGRAFT_REJECTION_lt50,11,3,3,14,14,17,17,14,31,Non-Response,0.00110917942273911,0.0663427378743779,0.00676487975386833,0.44073631139514,mechanism,37,17,20,univariate,0.0320965217616184,0.403654039586694,Anti-CTLA-4/Anti-PD-1
Skin Melanoma ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_vhio_tgfb_lt25,11,3,3,14,14,17,17,14,31,Non-Response,0.00110917942273911,0.0663427378743779,0.00676487975386833,0.44073631139514,mechanism,37,17,20,univariate,0.0320965217616184,0.403654039586694,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75,29,38,5,35,34,73,40,67,107,Non-Response,0.00111618450519125,0.18997342918505,0.0516222239027159,0.571743649064652,mechanism,107,67,40,combination,0.032276252565372,0.405914379990933,Taxane
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75,29,38,5,35,34,73,40,67,107,Non-Response,0.00111618450519125,0.18997342918505,0.0516222239027159,0.571743649064652,mechanism,107,67,40,combination,0.032276252565372,0.405914379990933,Taxane
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_q_gt50_or_rna_geneset_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION_lt25,14,6,6,22,20,28,28,20,48,Non-Response,0.00112716194030098,0.123442085854863,0.0253868734789359,0.511608880737819,mechanism,48,20,28,combination,0.0324781635954384,0.408453664575372,Aromatase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_or_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,93,5,51,15,144,20,66,98,164,Non-Response,0.00114161999838133,0.184782152986191,0.0496101711779216,0.573718986590275,mechanism,164,98,66,combination,0.0328133513340653,0.412669071021017,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,fusion_total_gt50_or_rna_geneset_KEGG_RIBOSOME_gt50,55,9,18,15,73,24,33,64,97,Non-Response,0.00114263372638357,0.200274586826209,0.0648023431653177,0.583127294080016,mechanism,97,64,33,combination,0.0328295544927295,0.41287284607482,Pyrimidine (ant)agonist
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr15_q_gt50,17,7,9,26,26,33,35,24,59,Non-Response,0.00114653381341291,0.148165398109774,0.0376661044052046,0.519577363334823,mechanism,59,24,35,univariate,0.0329080503077339,0.413860029454143,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr21_q_gt50,17,7,9,26,26,33,35,24,59,Non-Response,0.00114653381341291,0.148165398109774,0.0376661044052046,0.519577363334823,mechanism,59,24,35,univariate,0.0329080503077339,0.413860029454143,Aromatase inhibitor
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr15_q_gt50_and_cn_simple_chr3_q_gt25,16,8,8,27,24,35,35,24,59,Non-Response,0.00115543185928847,0.153899676659557,0.0394520782123995,0.539627294162873,mechanism,59,24,35,combination,0.0331283564550497,0.416630655722318,Aromatase inhibitor
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_or_purity_svTMB_gt75,62,6,18,11,80,17,29,68,97,Non-Response,0.00116099634180346,0.162147455356174,0.0427705601935554,0.555050848915206,mechanism,97,68,29,combination,0.0332561160071018,0.418237392416863,Anti-AR
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75,25,12,5,17,30,29,22,37,59,Non-Response,0.00119316231404949,0.146555029443343,0.0337005465688166,0.537934388229356,mechanism,59,37,22,univariate,0.0338756427343843,0.426028718466359,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_APM_lt75_and_rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,36,155,7,111,43,266,118,191,309,Non-Response,0.00119291579648878,0.272521659275334,0.0986639947318268,0.650682228541892,mechanism,309,191,118,combination,0.0338756427343843,0.426028718466359,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,47,34,14,35,61,69,49,81,130,Non-Response,0.00119531150667481,0.292269681175751,0.124673480962924,0.657223726836434,mechanism,174,110,64,univariate,0.03388241795485,0.426113925366046,Multikinase inhibitor
Skin Melanoma ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_APM_lt50,29,22,12,37,41,59,49,51,100,Non-Response,0.00119516562467884,0.249767903967694,0.0949557036996709,0.624439582523573,mechanism,100,51,49,combination,0.03388241795485,0.426113925366046,Anti-PD-1
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr15_q_gt50,16,9,4,21,20,30,25,25,50,Non-Response,0.00120858998162652,0.112925392597279,0.02118459830977,0.476225669431414,mechanism,50,25,25,univariate,0.0341348469398139,0.429288536629106,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr16_q_gt50_and_cn_simple_chr22_q_gt25,16,9,4,21,20,30,25,25,50,Non-Response,0.00120858998162652,0.112925392597279,0.02118459830977,0.476225669431414,mechanism,50,25,25,combination,0.0341348469398139,0.429288536629106,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_SBS20_eq0,109,11,55,21,164,32,76,120,196,Non-Response,0.00121591728208382,0.266233077043892,0.107664392203464,0.625709958276008,mechanism,196,120,76,univariate,0.0342822469624181,0.431142276887979,Platinum/Pyrimidine (ant)agonist
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_or_rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50,19,6,6,17,25,23,23,25,48,Non-Response,0.00121528061968953,0.117839959300259,0.0244185755985824,0.481889699186727,mechanism,48,25,23,combination,0.0342822469624181,0.431142276887979,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,signature_log_DBS_denovo_5_eq0_or_signature_log_SBS20_eq0,109,11,55,21,164,32,76,120,196,Non-Response,0.00121591728208382,0.266233077043892,0.107664392203464,0.625709958276008,mechanism,196,120,76,combination,0.0342822469624181,0.431142276887979,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_LONG_TERM_DEPRESSION_gt75,54,137,15,103,69,240,118,191,309,Non-Response,0.00123794329367768,0.370581245179913,0.183541831304626,0.711474825081745,mechanism,409,247,162,univariate,0.0347869484384398,0.437489531306841,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_and_rna_geneset_gene_set_impres_lt75,62,5,27,13,89,18,40,67,107,Non-Response,0.00125324243274194,0.17064552038713,0.0431816821783111,0.572207078045719,mechanism,107,67,40,combination,0.0350912197484026,0.441316124864518,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_or_rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50,62,5,27,13,89,18,40,67,107,Non-Response,0.00125324243274194,0.17064552038713,0.0431816821783111,0.572207078045719,mechanism,107,67,40,combination,0.0350912197484026,0.441316124864518,Taxane
Pan-Cancer ## Multikinase inhibitor,rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25_and_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,38,43,9,40,47,83,49,81,130,Non-Response,0.00125918027810983,0.257260897155225,0.0967341744127824,0.627474728542463,mechanism,130,81,49,combination,0.0352210897746606,0.442949403420668,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,lilac_hla_cn_B44_gt0_and_signature_log_SBS_denovo_26_eq0,35,78,8,67,43,145,75,113,188,Non-Response,0.0012670406549159,0.267827962030959,0.100233865181539,0.639548128761454,mechanism,188,113,75,combination,0.0353861690841662,0.445025482898345,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_and_rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_gt50,44,23,13,27,57,50,40,67,107,Non-Response,0.00126884447900407,0.255214613734966,0.100063440592671,0.622771597678048,mechanism,107,67,40,combination,0.0354122167176629,0.445353064577154,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_or_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,80,18,38,28,118,46,66,98,164,Non-Response,0.00127700218722048,0.307750692460318,0.141132382949942,0.655671523273161,mechanism,164,98,66,combination,0.0356276598554694,0.448062532398083,Platinum/Pyrimidine (ant)agonist
Lung NSCLC ## Anti-PD-1,clin_hasSystemicPreTreatment_or_purity_tmbPerMb_lt75,42,3,13,9,55,12,22,45,67,Non-Response,0.00128914608234593,0.107599857549509,0.0162953943426122,0.511284714391441,mechanism,67,45,22,combination,0.0358618605127944,0.451007899566066,Anti-PD-1
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_INSULIN_SIGNALING_PATHWAY_gt50_and_rna_geneset_tcga_gt25,11,4,10,32,21,36,42,15,57,Non-Response,0.00129548289958709,0.119086107643406,0.0224198228009837,0.51035806881233,mechanism,57,15,42,combination,0.0359888823692229,0.452605358812396,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,purity_tmlStatus_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,50,141,13,105,63,246,118,191,309,Non-Response,0.00129664166210363,0.350226652876752,0.165676466243713,0.695784816525659,mechanism,309,191,118,combination,0.0360074932915174,0.452839414515391,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,clin_pretreatment_contains_Platinum_and_cn_simple_chr13_q_gt25,26,47,3,37,29,84,40,73,113,Non-Response,0.00129642615858393,0.148710087733978,0.0267509892906736,0.542482484594204,mechanism,113,73,40,combination,0.0360074932915174,0.452839414515391,Pyrimidine (ant)agonist
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50,29,12,4,14,33,26,18,41,59,Non-Response,0.00131399866695594,0.123260626390905,0.0243362975481558,0.494596584239104,mechanism,67,46,21,univariate,0.0362862695736586,0.456345376104096,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25_and_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50,29,12,4,14,33,26,18,41,59,Non-Response,0.00131399866695594,0.123260626390905,0.0243362975481558,0.494596584239104,mechanism,59,41,18,combination,0.0362862695736586,0.456345376104096,Taxane
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50_and_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,29,12,4,14,33,26,18,41,59,Non-Response,0.00131399866695594,0.123260626390905,0.0243362975481558,0.494596584239104,mechanism,59,41,18,combination,0.0362862695736586,0.456345376104096,Taxane
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_or_rna_geneset_HALLMARK_INTERFERON_ALPHA_RESPONSE_lt50,30,21,13,36,43,57,49,51,100,Non-Response,0.00131320599787534,0.256544225062334,0.099065568757826,0.634608942003874,mechanism,100,51,49,combination,0.0362862695736586,0.456345376104096,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,drivers_pathway_perplexity_total_gt75_or_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,60,21,22,27,82,48,49,81,130,Non-Response,0.00132043014273603,0.288185401935703,0.125709288061781,0.645465882189791,mechanism,130,81,49,combination,0.036426756082218,0.458112170247979,Multikinase inhibitor
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_vhio_tcell_lt75,16,3,7,15,23,18,22,19,41,Non-Response,0.00133479578119964,0.0939874083882392,0.013119806773352,0.476498715358237,mechanism,50,24,26,univariate,0.0367358030520479,0.461998823721535,Anti-CTLA-4/Anti-PD-1
Prostate ## Taxane,cn_simple_chr1_q_lt75_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50,37,4,9,9,46,13,18,41,59,Non-Response,0.0013384159468718,0.113587827625868,0.0205281986248023,0.515395819739161,mechanism,59,41,18,combination,0.0367918438088691,0.462703606564997,Taxane
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_or_fusion_total_gt50,71,2,31,9,102,11,40,73,113,Non-Response,0.00134644372887302,0.099191053466227,0.00987685832306743,0.518013176933616,mechanism,113,73,40,combination,0.0369350126062326,0.464504133856637,Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_or_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,64,34,26,40,90,74,66,98,164,Non-Response,0.0013601884689197,0.347647428574181,0.171931094284907,0.691316749585947,mechanism,164,98,66,combination,0.0372643512501104,0.46864598059569,Platinum/Pyrimidine (ant)agonist
Prostate ## Anti-AR,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,29,29,2,19,31,48,21,58,79,Non-Response,0.00136468523291589,0.107912773316939,0.011186643793476,0.513057592616113,mechanism,97,68,29,univariate,0.0373623656342243,0.469878634475727,Anti-AR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,91,7,49,17,140,24,66,98,164,Non-Response,0.00136978550984263,0.223884924493852,0.0732325638525491,0.615159689691445,mechanism,196,120,76,univariate,0.0374263794873789,0.470683689011147,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt50_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50,74,24,33,33,107,57,66,98,164,Non-Response,0.00136959484768443,0.326724308773196,0.157601221009125,0.66603250437254,mechanism,164,98,66,combination,0.0374263794873789,0.470683689011147,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75,63,4,28,12,91,16,40,67,107,Non-Response,0.0013922225634347,0.151095860614725,0.0326056443639016,0.553852592544245,mechanism,120,77,43,univariate,0.0379056604771191,0.476711248914447,Taxane
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75,63,4,28,12,91,16,40,67,107,Non-Response,0.0013922225634347,0.151095860614725,0.0326056443639016,0.553852592544245,mechanism,120,77,43,univariate,0.0379056604771191,0.476711248914447,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_rna_geneset_KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION_lt75,98,0,59,7,157,7,66,98,164,Non-Response,0.00140056752960522,0,0,0.438742118380132,mechanism,164,98,66,combination,0.0380500382921887,0.478526981120958,Platinum/Pyrimidine (ant)agonist
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50,16,9,4,19,20,28,23,25,48,Non-Response,0.00140272096787477,0.124684986915502,0.0232197548316804,0.531536218615769,mechanism,61,34,27,univariate,0.0380830896534483,0.478942643465475,Multikinase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt75,16,9,4,19,20,28,23,25,48,Non-Response,0.00140272096787477,0.124684986915502,0.0232197548316804,0.531536218615769,mechanism,48,25,23,combination,0.0380830896534483,0.478942643465475,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_or_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,69,12,29,20,98,32,49,81,130,Non-Response,0.00141695400219787,0.255173580141501,0.0994158248147958,0.629039763243157,mechanism,130,81,49,combination,0.0383670086343662,0.482513280944951,Multikinase inhibitor
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_HALLMARK_INTERFERON_GAMMA_RESPONSE_lt50,12,7,3,19,15,26,22,19,41,Non-Response,0.00142468291020883,0.0988217362528929,0.0136793873957073,0.508793389182582,mechanism,50,24,26,univariate,0.0384737737641813,0.48385598643363,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_KEGG_AUTOIMMUNE_THYROID_DISEASE_lt50,12,7,3,19,15,26,22,19,41,Non-Response,0.00142468291020883,0.0988217362528929,0.0136793873957073,0.508793389182582,mechanism,50,24,26,univariate,0.0384737737641813,0.48385598643363,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75,31,1,10,7,41,8,17,32,49,Non-Response,0.00143387461331656,0.0495928913896264,0.000997985228070793,0.456833350621745,mechanism,57,38,19,univariate,0.0386118070931647,0.485591928765811,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75,31,1,10,7,41,8,17,32,49,Non-Response,0.00143387461331656,0.0495928913896264,0.000997985228070793,0.456833350621745,mechanism,57,38,19,univariate,0.0386118070931647,0.485591928765811,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_or_rna_geneset_KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM_lt50,31,1,10,7,41,8,17,32,49,Non-Response,0.00143387461331656,0.0495928913896264,0.000997985228070793,0.456833350621745,mechanism,49,32,17,combination,0.0386118070931647,0.485591928765811,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_or_rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,31,1,10,7,41,8,17,32,49,Non-Response,0.00143387461331656,0.0495928913896264,0.000997985228070793,0.456833350621745,mechanism,49,32,17,combination,0.0386118070931647,0.485591928765811,Anti-EGFR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_rna_geneset_KEGG_RIBOSOME_lt25,89,9,47,19,136,28,66,98,164,Non-Response,0.00143173066534463,0.252406833520002,0.0928418667714319,0.639718622409616,mechanism,164,98,66,combination,0.0386118070931647,0.485591928765811,Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr1_p_gt50,17,8,5,20,22,28,25,25,50,Non-Response,0.00144154716512442,0.123808076658586,0.0259260952648499,0.496442265329813,mechanism,50,25,25,univariate,0.0386213026783491,0.485711347665665,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr10_q_gt50,20,5,8,17,28,22,25,25,50,Non-Response,0.00144154716512442,0.123808076658586,0.0259260952648499,0.496442265329813,mechanism,50,25,25,univariate,0.0386213026783491,0.485711347665665,Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50,21,30,6,43,27,73,49,51,100,Non-Response,0.00145011761302086,0.20262880491771,0.0595270984504007,0.597898433882188,mechanism,116,59,57,univariate,0.0387644225982098,0.487511260261371,Anti-PD-1
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr10_q_gt75,13,12,2,23,15,35,25,25,50,Non-Response,0.00148815688092308,0.0847215756730502,0.00801160039237356,0.464910918995883,mechanism,50,25,25,univariate,0.0395442609126215,0.497318705696571,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr12_q_gt25,23,2,12,13,35,15,25,25,50,Non-Response,0.00148815688092308,0.0847215756730501,0.00801160039237356,0.464910918995883,mechanism,50,25,25,univariate,0.0395442609126215,0.497318705696571,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt50,81,110,29,89,110,199,118,191,309,Non-Response,0.00149398878704827,0.443653181872617,0.2561555531079,0.754791062495732,mechanism,409,247,162,univariate,0.0396150666660918,0.498209176901723,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25,24,1,13,10,37,11,23,25,48,Non-Response,0.0015229397146101,0.0574234661991882,0.00120537665441972,0.480401578836091,mechanism,61,34,27,univariate,0.0400261546638015,0.503379124353772,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_gene_set_impres_lt75_or_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,66,1,32,8,98,9,40,67,107,Non-Response,0.00151335494507005,0.0621220894491865,0.00135139597494943,0.496032453795949,mechanism,107,67,40,combination,0.0400261546638015,0.503379124353772,Taxane
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_lt25_or_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,66,1,32,8,98,9,40,67,107,Non-Response,0.00151335494507005,0.0621220894491865,0.00135139597494943,0.496032453795949,mechanism,107,67,40,combination,0.0400261546638015,0.503379124353772,Taxane
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_or_rna_geneset_KEGG_ASTHMA_gt50,51,7,11,10,62,17,21,58,79,Non-Response,0.00152353394014379,0.155768188946925,0.0399654008120982,0.564002201856333,mechanism,79,58,21,combination,0.0400261546638015,0.503379124353772,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_or_signature_log_SBS1_lt25,51,7,11,10,62,17,21,58,79,Non-Response,0.00152353394014379,0.155768188946925,0.0399654008120982,0.564002201856333,mechanism,79,58,21,combination,0.0400261546638015,0.503379124353772,Anti-AR
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ALLOGRAFT_REJECTION_lt50,19,5,3,10,22,15,13,24,37,Non-Response,0.00152912842175421,0.08633244770476,0.0108158134820521,0.492784673862484,mechanism,42,27,15,univariate,0.0400762770987091,0.504009476872174,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_Colostage_one_lt50_and_rna_geneset_KEGG_RIBOFLAVIN_METABOLISM_lt50,19,5,3,10,22,15,13,24,37,Non-Response,0.00152912842175421,0.08633244770476,0.0108158134820521,0.492784673862484,mechanism,37,24,13,combination,0.0400762770987091,0.504009476872174,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_gene_set_tgfb_rand1_lt50_and_rna_geneset_KEGG_RIBOFLAVIN_METABOLISM_lt50,19,5,3,10,22,15,13,24,37,Non-Response,0.00152912842175421,0.08633244770476,0.0108158134820521,0.492784673862484,mechanism,37,24,13,combination,0.0400762770987091,0.504009476872174,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75,52,139,14,104,66,243,118,191,309,Non-Response,0.00154256913587135,0.360936799830072,0.174923476450232,0.704250580349746,mechanism,409,247,162,univariate,0.0403009004517606,0.506834397420207,Anti-PD-1
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr17_q_gt50,18,7,6,19,24,26,25,25,50,Non-Response,0.00156716133269682,0.129120382575593,0.0283477497046461,0.506240094971107,mechanism,50,25,25,univariate,0.0406289914302978,0.510960553201885,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr19_p_gt50,18,7,6,19,24,26,25,25,50,Non-Response,0.00156716133269682,0.129120382575593,0.0283477497046461,0.506240094971107,mechanism,50,25,25,univariate,0.0406289914302978,0.510960553201885,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr4_q_gt50,19,6,7,18,26,24,25,25,50,Non-Response,0.00156716133269682,0.129120382575593,0.028347749704646,0.506240094971108,mechanism,50,25,25,univariate,0.0406289914302978,0.510960553201885,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr8_q_gt50,18,7,6,19,24,26,25,25,50,Non-Response,0.00156716133269682,0.129120382575593,0.0283477497046461,0.506240094971107,mechanism,50,25,25,univariate,0.0406289914302978,0.510960553201885,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_VEGF_SIGNALING_PATHWAY_lt75,30,2,9,8,39,10,17,32,49,Non-Response,0.00156429856494044,0.0801339822350519,0.00707046504438734,0.496240248336946,mechanism,57,38,19,univariate,0.0406289914302978,0.510960553201885,Anti-EGFR
Pan-Cancer ## Anti-PD-1,rna_geneset_EMT2_gt50,107,84,44,74,151,158,118,191,309,Non-Response,0.00156496685902922,0.467954838635384,0.283474125001679,0.766392983754713,mechanism,409,247,162,univariate,0.0406289914302978,0.510960553201885,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,17,64,1,48,18,112,49,81,130,Non-Response,0.00156774684209675,0.0794391853173236,0.00184375689122409,0.541968653669267,mechanism,174,110,64,univariate,0.0406289914302978,0.510960553201885,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50_and_rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_gt75,26,41,4,36,30,77,40,67,107,Non-Response,0.0015756889024591,0.177811394621715,0.041172625626136,0.581919247367485,mechanism,107,67,40,combination,0.0407578530324602,0.512581149559546,Taxane
Pan-Cancer ## Alkaloid ## Platinum,purity_msIndelsPerMb_gt75,7,14,0,27,7,41,27,21,48,Non-Response,0.00157926749368782,0,0,0.43363464483531,mechanism,48,21,27,univariate,0.0407978063172183,0.51308361225339,Alkaloid/Platinum
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt75,15,4,6,16,21,20,22,19,41,Non-Response,0.00158074625640214,0.107108563254704,0.017863108391501,0.508060758226607,mechanism,50,24,26,univariate,0.0407978063172183,0.51308361225339,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_Immune_Checkpoint_lt75,15,4,6,16,21,20,22,19,41,Non-Response,0.00158074625640214,0.107108563254704,0.017863108391501,0.508060758226607,mechanism,50,24,26,univariate,0.0407978063172183,0.51308361225339,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_KEGG_TYPE_I_DIABETES_MELLITUS_lt50,15,4,6,16,21,20,22,19,41,Non-Response,0.00158074625640214,0.107108563254704,0.017863108391501,0.508060758226607,mechanism,50,24,26,univariate,0.0407978063172183,0.51308361225339,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_or_signature_log_DBS_denovo_5_eq0,118,2,66,10,184,12,76,120,196,Non-Response,0.00158290844986611,0.113074129424067,0.0116898056932605,0.553428531001672,mechanism,196,120,76,combination,0.0408406455302015,0.513622369116262,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt25,38,153,8,110,46,263,118,191,309,Non-Response,0.00158813619791089,0.293865554378496,0.113854177435207,0.671723968900629,mechanism,409,247,162,univariate,0.0409495352851118,0.51499179443174,Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr20_q_gt25,64,9,24,16,88,25,40,73,113,Non-Response,0.00160350272022874,0.214281894800156,0.0727058750169493,0.594420505912192,mechanism,113,73,40,univariate,0.041267226227248,0.518987156704505,Pyrimidine (ant)agonist
Prostate ## Taxane,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt50_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,28,13,4,14,32,27,18,41,59,Non-Response,0.00160765058135668,0.137833514443322,0.0274784058205909,0.548892238621392,mechanism,59,41,18,combination,0.0413477964611568,0.520000428504774,Taxane
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25,69,41,24,40,93,81,64,110,174,Non-Response,0.00160904373112782,0.358766120650504,0.179079667581248,0.706070955390795,mechanism,174,110,64,univariate,0.0413574601002089,0.520121960892907,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,drivers_total_gt50_and_purity_polyclonalProportion_gt25,31,79,5,59,36,138,64,110,174,Non-Response,0.00160884390848089,0.217575359986782,0.0622860215517439,0.611348569541675,mechanism,174,110,64,combination,0.0413574601002089,0.520121960892907,Multikinase inhibitor
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_p_gt25_and_cn_simple_chr22_q_gt50,41,32,10,30,51,62,40,73,113,Non-Response,0.00162563660610855,0.263392555765645,0.0993152884480313,0.652561602984562,mechanism,113,73,40,combination,0.0416305383762602,0.523556262904513,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_KEGG_ALLOGRAFT_REJECTION_lt50,13,6,4,18,17,24,22,19,41,Non-Response,0.00163540191755824,0.109788591007344,0.0182436294308608,0.524781598586459,mechanism,50,24,26,univariate,0.0418036599577322,0.525733484044543,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt25,61,12,22,18,83,30,40,73,113,Non-Response,0.00163813443271296,0.243898259027066,0.0906755855705017,0.631703654056297,mechanism,113,73,40,univariate,0.0418162981104693,0.52589242467503,Pyrimidine (ant)agonist
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50,51,16,18,22,69,38,40,67,107,Non-Response,0.00166166758484007,0.260328485250251,0.10190387739647,0.643659273553877,mechanism,120,77,43,univariate,0.0421883262745095,0.530571145701881,Taxane
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,51,16,18,22,69,38,40,67,107,Non-Response,0.00166166758484007,0.260328485250251,0.10190387739647,0.643659273553877,mechanism,107,67,40,combination,0.0421883262745095,0.530571145701881,Taxane
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY_lt50,25,7,5,12,30,19,17,32,49,Non-Response,0.00167031986345345,0.123158596827361,0.0243804461387781,0.525377088217476,mechanism,57,38,19,univariate,0.0423368151454098,0.532438579594492,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY_lt50,25,7,5,12,30,19,17,32,49,Non-Response,0.00167031986345345,0.123158596827361,0.0243804461387781,0.525377088217476,mechanism,57,38,19,univariate,0.0423368151454098,0.532438579594492,Anti-EGFR
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_INSULIN_SIGNALING_PATHWAY_gt50_or_rna_geneset_KEGG_MELANOMA_gt50,14,1,19,23,33,24,42,15,57,Non-Response,0.00166952934033006,0.0615225131907424,0.00134401577689129,0.473644182235684,mechanism,57,15,42,combination,0.0423368151454098,0.532438579594492,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_and_rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25,41,40,11,38,52,78,49,81,130,Non-Response,0.00168140643865149,0.28519766773455,0.114739779234772,0.666187611655334,mechanism,130,81,49,combination,0.0425779978370744,0.535471754606161,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_PEROXISOME_gt75,28,163,4,114,32,277,118,191,309,Non-Response,0.0016860053196082,0.205094365907023,0.0509072794054065,0.609168723481895,mechanism,409,247,162,univariate,0.0426811603546091,0.536769152724439,Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_gene_set_impres_lt75,14,5,5,17,19,22,22,19,41,Non-Response,0.00168820403890123,0.112394904337309,0.0196543798461502,0.524059853974116,mechanism,50,24,26,univariate,0.0426836573343589,0.536800555378292,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-CTLA-4 ## Anti-PD-1,rna_geneset_HALLMARK_COMPLEMENT_lt50,14,5,5,17,19,22,22,19,41,Non-Response,0.00168820403890123,0.112394904337309,0.0196543798461502,0.524059853974116,mechanism,50,24,26,univariate,0.0426836573343589,0.536800555378292,Anti-CTLA-4/Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_ALLOGRAFT_REJECTION_lt25,43,148,10,108,53,256,118,191,309,Non-Response,0.00169022461905965,0.319734515801206,0.137012578646416,0.682219984086829,mechanism,409,247,162,univariate,0.0427081806697531,0.537108967095596,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450_gt25,131,60,59,59,190,119,118,191,309,Non-Response,0.0016941548207334,0.459221094774297,0.277776125397427,0.755791263410003,mechanism,409,247,162,univariate,0.0427615447151709,0.537780086934112,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,9,16,0,23,9,39,23,25,48,Non-Response,0.00170541629958605,0,0,0.425467744784737,mechanism,61,34,27,univariate,0.0428779563717249,0.539244109602114,Multikinase inhibitor
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_and_signature_log_DBS_denovo_5_eq0,29,69,6,60,35,129,66,98,164,Non-Response,0.00170590966536297,0.239820782076805,0.0761445531707317,0.640735441938827,mechanism,164,98,66,combination,0.0428779563717249,0.539244109602114,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_and_signature_log_SBS_denovo_26_eq0,29,69,6,60,35,129,66,98,164,Non-Response,0.00170590966536297,0.239820782076805,0.0761445531707317,0.640735441938827,mechanism,164,98,66,combination,0.0428779563717249,0.539244109602114,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_ADIPOGENESIS_lt25_and_signature_log_SBS20_eq0,29,69,6,60,35,129,66,98,164,Non-Response,0.00170590966536297,0.239820782076805,0.0761445531707317,0.640735441938827,mechanism,164,98,66,combination,0.0428779563717249,0.539244109602114,Platinum/Pyrimidine (ant)agonist
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS_lt25,17,8,5,18,22,26,23,25,48,Non-Response,0.00170847727121576,0.137352205730825,0.0285164887119598,0.557770947898306,mechanism,61,34,27,univariate,0.0429292207302025,0.539888823242426,Multikinase inhibitor
Prostate ## Taxane,cn_simple_chr1_q_lt75_or_rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_gt25,41,0,13,5,54,5,18,41,59,Non-Response,0.001711414181807,0,0,0.408887456872944,mechanism,59,41,18,combination,0.0429631809685741,0.540315915857192,Taxane
Prostate ## Taxane,cn_simple_chr1_q_lt75_or_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25,41,0,13,5,54,5,18,41,59,Non-Response,0.001711414181807,0,0,0.408887456872944,mechanism,59,41,18,combination,0.0429631809685741,0.540315915857192,Taxane
Prostate ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt25_or_rna_geneset_KEGG_PROTEIN_EXPORT_gt25,41,0,13,5,54,5,18,41,59,Non-Response,0.001711414181807,0,0,0.408887456872944,mechanism,59,41,18,combination,0.0429631809685741,0.540315915857192,Taxane
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos10_14868368_or_purity_tmbPerMb_lt75,134,113,62,100,196,213,162,247,409,Non-Response,0.00171614866822035,0.523669401515536,0.341836928464248,0.798330582264389,mechanism,409,247,162,combination,0.0430687360943498,0.541643404026623,Anti-PD-1
Pan-Cancer ## Anti-PD-1,hotspot_ACVR2A_pos30_4956123_or_purity_tmbPerMb_lt75,134,113,62,100,196,213,162,247,409,Non-Response,0.00171614866822035,0.523669401515536,0.341836928464248,0.798330582264389,mechanism,409,247,162,combination,0.0430687360943498,0.541643404026623,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_gene_set_impres_lt75,50,17,17,23,67,40,40,67,107,Non-Response,0.00173752949764624,0.254925079052561,0.100298743241805,0.626475575191305,mechanism,107,67,40,combination,0.0435334763771914,0.547488096293309,Taxane
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_UNFOLDED_PROTEIN_RESPONSE_lt50_or_signature_log_DBS_denovo_5_eq0,92,6,50,16,142,22,66,98,164,Non-Response,0.00177056857388428,0.205891313720952,0.0619222865148684,0.597092154187906,mechanism,164,98,66,combination,0.044026748581807,0.553691613281466,Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Aromatase inhibitor,cn_simple_chr11_q_gt50_and_cn_simple_chr21_p_gt50,14,10,6,29,20,39,35,24,59,Non-Response,0.00178983294527508,0.153523671921966,0.0370316327718698,0.561314282013763,mechanism,59,24,35,combination,0.0442497884448013,0.556496619454881,Aromatase inhibitor
Skin Melanoma ## Anti-PD-1,purity_tmbPerMb_lt75_or_rna_geneset_gene_set_t_cell_gep_18_lt25,26,25,10,39,36,64,49,51,100,Non-Response,0.00178964397165277,0.250215480290716,0.0909350765859139,0.645619922369725,mechanism,100,51,49,combination,0.0442497884448013,0.556496619454881,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_ALLOGRAFT_REJECTION_lt75,130,61,59,59,189,120,118,191,309,Non-Response,0.00180437646533854,0.470424609556813,0.284900054311568,0.773524933269045,mechanism,409,247,162,univariate,0.0445882356493747,0.560753017775158,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_CARDIAC_MUSCLE_CONTRACTION_lt50_or_rna_geneset_KEGG_P53_SIGNALING_PATHWAY_lt75,77,21,36,30,113,51,66,98,164,Non-Response,0.00180855132389524,0.329670642653889,0.155773173166759,0.685056719920263,mechanism,164,98,66,combination,0.0446570733732298,0.561618738538187,Platinum/Pyrimidine (ant)agonist
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75,13,21,0,19,13,40,19,34,53,Non-Response,0.00181237019890678,0,0,0.435638065266545,mechanism,59,37,22,univariate,0.0447377819343927,0.562633749977264,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_KEGG_APOPTOSIS_lt75,64,3,29,11,93,14,40,67,107,Non-Response,0.00182358566493511,0.126228457269693,0.0210589026871337,0.525443557908624,mechanism,120,77,43,univariate,0.0449123571564858,0.564829252472301,Taxane
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_or_rna_geneset_gene_set_impres_lt75,64,3,29,11,93,14,40,67,107,Non-Response,0.00182358566493511,0.126228457269693,0.0210589026871337,0.525443557908624,mechanism,107,67,40,combination,0.0449123571564858,0.564829252472301,Taxane
Pan-Cancer ## Taxane,rna_geneset_gene_set_immune_checkpoint_genes_lt75_or_rna_geneset_gene_set_impres_lt75,64,3,29,11,93,14,40,67,107,Non-Response,0.00182358566493511,0.126228457269693,0.0210589026871337,0.525443557908624,mechanism,107,67,40,combination,0.0449123571564858,0.564829252472301,Taxane
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,13,68,0,49,13,117,49,81,130,Non-Response,0.0018254152900871,0,0,0.486055199411062,mechanism,130,81,49,combination,0.0449301960850109,0.565053599384859,Multikinase inhibitor
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_COLORECTAL_CANCER_lt50_and_rna_geneset_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM_lt75,28,4,7,10,35,14,17,32,49,Non-Response,0.00182942434744183,0.106266483993745,0.0182704801375394,0.498577892045251,mechanism,49,32,17,combination,0.0449753160769102,0.565621039904786,Anti-EGFR
Pan-Cancer ## Anti-EGFR,rna_geneset_KEGG_COLORECTAL_CANCER_lt50_and_rna_geneset_KEGG_NON_SMALL_CELL_LUNG_CANCER_lt75,28,4,7,10,35,14,17,32,49,Non-Response,0.00182942434744183,0.106266483993745,0.0182704801375394,0.498577892045251,mechanism,49,32,17,combination,0.0449753160769102,0.565621039904786,Anti-EGFR
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50_and_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,45,36,13,36,58,72,49,81,130,Non-Response,0.00183760730729852,0.291744062779817,0.122594780972026,0.662456454462842,mechanism,130,81,49,combination,0.0451210016538999,0.567453218858573,Multikinase inhibitor
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_IL6_JAK_STAT3_SIGNALING_gt50_and_rna_geneset_KEGG_MTOR_SIGNALING_PATHWAY_gt50,7,8,3,39,10,47,42,15,57,Non-Response,0.00184395505968028,0.0933937632397796,0.0127514849830078,0.512181853622196,mechanism,57,15,42,combination,0.0452495328695886,0.56906966019172,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_INSULIN_SIGNALING_PATHWAY_gt50_and_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,7,8,3,39,10,47,42,15,57,Non-Response,0.00184395505968028,0.0933937632397796,0.0127514849830078,0.512181853622196,mechanism,57,15,42,combination,0.0452495328695886,0.56906966019172,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_INSULIN_SIGNALING_PATHWAY_gt50_or_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,12,3,13,29,25,32,42,15,57,Non-Response,0.00185286016082629,0.116980435257849,0.0181069498269321,0.531111836086621,mechanism,57,15,42,combination,0.0453995413547368,0.570956205140486,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Skin Melanoma ## Anti-PD-1,rna_geneset_APM_lt50_and_rna_geneset_gene_set_t_cell_gep_18_lt25,12,39,1,48,13,87,49,51,100,Non-Response,0.00185966451020769,0.0691462515765753,0.00155729595679533,0.504824021027322,mechanism,100,51,49,combination,0.0455172306135371,0.572436295260018,Anti-PD-1
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75,40,18,6,15,46,33,21,58,79,Non-Response,0.00186682479146184,0.184400874669521,0.0498829010370023,0.602430396229566,mechanism,79,58,21,combination,0.0456268664529726,0.573815103524674,Anti-AR
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,driver_DNM2_or_signature_log_SBS_denovo_26_eq0,112,8,59,17,171,25,76,120,196,Non-Response,0.00188462530180493,0.249811597003917,0.0878169718246663,0.65360986751598,mechanism,196,120,76,combination,0.045921819994437,0.577524514450467,Platinum/Pyrimidine (ant)agonist
Colorectum ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_ALLOGRAFT_REJECTION_lt25,17,7,2,11,19,18,13,24,37,Non-Response,0.00189119041176884,0.0813116183152085,0.00700850768661878,0.508383501922478,mechanism,42,27,15,univariate,0.0460197214266372,0.578755747818445,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0,101,19,49,27,150,46,76,120,196,Non-Response,0.00190043076572104,0.343438490151679,0.162980038093137,0.710433940760549,mechanism,196,120,76,univariate,0.0462169072157807,0.581235606568499,Platinum/Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr8_q_gt25,24,1,14,11,38,12,25,25,50,Non-Response,0.00192150964097788,0.0560302584930269,0.00118974420244371,0.457429399122459,mechanism,50,25,25,univariate,0.0465254722867379,0.585116199558988,Pyrimidine (ant)agonist
Breast ER+/HER- ## Pyrimidine (ant)agonist,cn_simple_chr11_q_gt50_or_cn_simple_chr20_q_gt25,24,1,14,11,38,12,25,25,50,Non-Response,0.00192150964097788,0.0560302584930269,0.00118974420244371,0.457429399122459,mechanism,50,25,25,combination,0.0465254722867379,0.585116199558988,Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_HALLMARK_IL6_JAK_STAT3_SIGNALING_gt50_or_rna_geneset_KEGG_MELANOMA_gt50,14,1,20,22,34,23,42,15,57,Non-Response,0.00193273975973702,0.0675498356542241,0.00147567754673056,0.520102128341129,mechanism,57,15,42,combination,0.0467300549373561,0.587689083124527,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_vhio_tgfb_gt25,139,52,65,53,204,105,118,191,309,Non-Response,0.00193817379686754,0.460013970445876,0.275254906711598,0.765843066402058,mechanism,409,247,162,univariate,0.0468335834482194,0.588991084068203,Anti-PD-1
Prostate ## Anti-AR,rna_geneset_KEGG_ASTHMA_gt50,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,97,68,29,univariate,0.046949302662835,0.590446398409873,Anti-AR
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,79,58,21,combination,0.046949302662835,0.590446398409873,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,79,58,21,combination,0.046949302662835,0.590446398409873,Anti-AR
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt25,14,37,2,47,16,84,49,51,100,Non-Response,0.00195286721958892,0.11467431482846,0.0119001682460404,0.547218660678873,mechanism,116,59,57,univariate,0.0470278886508767,0.5914347158283,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50_and_rna_geneset_gene_set_t_cell_gep_18_lt25,14,37,2,47,16,84,49,51,100,Non-Response,0.00195286721958892,0.11467431482846,0.0119001682460404,0.547218660678873,mechanism,100,51,49,combination,0.0470278886508767,0.5914347158283,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_18_lt25_and_rna_geneset_gene_set_t_cell_gep_6_lt50,14,37,2,47,16,84,49,51,100,Non-Response,0.00195286721958892,0.11467431482846,0.0119001682460404,0.547218660678873,mechanism,100,51,49,combination,0.0470278886508767,0.5914347158283,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_vhio_tgfb_gt50,93,98,36,82,129,180,118,191,309,Non-Response,0.00198058935723796,0.463782941530041,0.27602018765001,0.770011750389586,mechanism,409,247,162,univariate,0.0476249435534129,0.598943430481361,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_WNT_SIGNALING_PATHWAY_gt75,49,142,13,105,62,247,118,191,309,Non-Response,0.00198277939674591,0.359876543395614,0.17006847489455,0.715995261882299,mechanism,409,247,162,univariate,0.0476264901713055,0.598962881142236,Anti-PD-1
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,24,34,1,20,25,54,21,58,79,Non-Response,0.00199296233981728,0.0725701419018719,0.00164676605006766,0.516698409500218,mechanism,97,68,29,univariate,0.0478093376408395,0.601262417529817,Anti-AR
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,24,34,1,20,25,54,21,58,79,Non-Response,0.00199296233981728,0.0725701419018719,0.00164676605006766,0.516698409500218,mechanism,79,58,21,combination,0.0478093376408395,0.601262417529817,Anti-AR
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_gt75_or_rna_geneset_KEGG_MELANOMA_gt50,11,4,11,31,22,35,42,15,57,Non-Response,0.00202756486218629,0.134642170603336,0.0256231201812062,0.570405483345269,mechanism,57,15,42,combination,0.0485606114982717,0.610710629072509,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_MELANOMA_gt50_or_rna_geneset_KEGG_MTOR_SIGNALING_PATHWAY_gt50,11,4,11,31,22,35,42,15,57,Non-Response,0.00202756486218629,0.134642170603336,0.0256231201812062,0.570405483345269,mechanism,57,15,42,combination,0.0485606114982717,0.610710629072509,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Multikinase inhibitor,purity_polyclonalProportion_gt25_or_rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,63,18,25,24,88,42,49,81,130,Non-Response,0.00202933092193071,0.30067868668586,0.128658607431006,0.686707217341692,mechanism,130,81,49,combination,0.048586270141089,0.611033318705374,Multikinase inhibitor
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_GLYCOLYSIS_GLUCONEOGENESIS_lt50,11,14,1,22,12,36,23,25,48,Non-Response,0.0020507755630431,0.0610975443415285,0.00129273908255086,0.502000799014331,mechanism,61,34,27,univariate,0.0489038366876853,0.61502711654812,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ALZHEIMERS_DISEASE_lt50,46,35,14,35,60,70,49,81,130,Non-Response,0.00206321420298128,0.307235846057115,0.131225400745665,0.690390569469532,mechanism,174,110,64,univariate,0.0489038366876853,0.61502711654812,Multikinase inhibitor
Prostate ## Anti-AR,rna_geneset_battle_tgfb_caf_Pdgfra_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0489038366876853,0.61502711654812,Anti-AR
Prostate ## Anti-AR,rna_geneset_gene_set_tgfb_caf_Pdgfra_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0489038366876853,0.61502711654812,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_INOSITOL_PHOSPHATE_METABOLISM_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0489038366876853,0.61502711654812,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0489038366876853,0.61502711654812,Anti-AR
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50,19,32,5,44,24,76,49,51,100,Non-Response,0.00204781336039193,0.194565287041066,0.0512561110865436,0.612504234710032,mechanism,116,59,57,univariate,0.0489038366876853,0.61502711654812,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_and_rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50,11,14,1,22,12,36,23,25,48,Non-Response,0.0020507755630431,0.0610975443415285,0.00129273908255086,0.502000799014331,mechanism,48,25,23,combination,0.0489038366876853,0.61502711654812,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,75,6,35,14,110,20,49,81,130,Non-Response,0.0020588887824984,0.202735070559087,0.0586662100907323,0.618760155012476,mechanism,130,81,49,combination,0.0489038366876853,0.61502711654812,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,75,6,35,14,110,20,49,81,130,Non-Response,0.0020588887824984,0.202735070559087,0.0586662100907323,0.618760155012476,mechanism,130,81,49,combination,0.0489038366876853,0.61502711654812,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,46,35,14,35,60,70,49,81,130,Non-Response,0.00206321420298128,0.307235846057115,0.131225400745665,0.690390569469532,mechanism,130,81,49,combination,0.0489038366876853,0.61502711654812,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_gt75_and_rna_geneset_KEGG_CHRONIC_MYELOID_LEUKEMIA_lt50,23,44,3,37,26,81,40,67,107,Non-Response,0.00204620049287395,0.157477512790836,0.0280650031174066,0.583292516404691,mechanism,107,67,40,combination,0.0489038366876853,0.61502711654812,Taxane
Prostate ## Anti-AR,chord_BRCA1_eq0_and_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,79,58,21,combination,0.0489038366876853,0.61502711654812,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,79,58,21,combination,0.0489038366876853,0.61502711654812,Anti-AR
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50_and_rna_geneset_gene_set_t_cell_gep_6_lt50,19,32,5,44,24,76,49,51,100,Non-Response,0.00204781336039193,0.194565287041066,0.0512561110865436,0.612504234710032,mechanism,100,51,49,combination,0.0489038366876853,0.61502711654812,Anti-PD-1
Skin Melanoma ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt50_or_rna_geneset_gene_set_t_cell_gep_18_lt25,19,32,5,44,24,76,49,51,100,Non-Response,0.00204781336039193,0.194565287041066,0.0512561110865436,0.612504234710032,mechanism,100,51,49,combination,0.0489038366876853,0.61502711654812,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_infiltrate_lt25,40,151,9,109,49,260,118,191,309,Non-Response,0.00207356241606356,0.312714753603711,0.127973120956615,0.689467683083987,mechanism,409,247,162,univariate,0.0490267706452091,0.616573165335755,Anti-PD-1
Pan-Cancer ## Platinum ## Pyrimidine (ant)agonist,drivers_pathway_MYC_eq0_and_rna_geneset_HALLMARK_ADIPOGENESIS_lt50,49,49,17,49,66,98,66,98,164,Non-Response,0.00208962394682481,0.349211076598242,0.164582117462159,0.717037038839896,mechanism,164,98,66,combination,0.0492882992879604,0.619862216214795,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_GLYCEROPHOSPHOLIPID_METABOLISM_gt75,44,147,11,107,55,254,118,191,309,Non-Response,0.00209606419197173,0.34450679180287,0.153137430255541,0.717122851499052,mechanism,409,247,162,univariate,0.0493721346496044,0.620916551093795,Anti-PD-1
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_or_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,67,14,28,21,95,35,49,81,130,Non-Response,0.00210280935113052,0.281651145307167,0.114329913571186,0.673022671979885,mechanism,130,81,49,combination,0.0495166683381782,0.622734243605228,Multikinase inhibitor
Pan-Cancer ## Anti-PD-1,rna_geneset_HALLMARK_ESTROGEN_RESPONSE_LATE_gt25,122,69,54,64,176,133,118,191,309,Non-Response,0.00210886301222126,0.478380360157984,0.291130626790362,0.782233187008499,mechanism,409,247,162,univariate,0.0496232862606588,0.624075097776944,Anti-PD-1
Pan-Cancer ## Taxane,rna_geneset_CELL_PROLIFERATION_GO_0008283_lt50_and_rna_geneset_gene_set_immune_checkpoint_genes_lt75,49,18,17,23,66,41,40,67,107,Non-Response,0.00211266503982081,0.27516333610962,0.109249397798094,0.671755165886704,mechanism,107,67,40,combination,0.0496983666297431,0.625019327637725,Taxane
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_or_rna_geneset_Colostage_one_gt25,78,3,38,11,116,14,49,81,130,Non-Response,0.00211786453101342,0.135062269505707,0.022852371893675,0.55127186016189,mechanism,130,81,49,combination,0.0497487051450043,0.625652397637737,Multikinase inhibitor
Pan-Cancer ## Taxane,rna_geneset_KEGG_CITRATE_CYCLE_TCA_CYCLE_lt50_or_rna_geneset_KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY_lt75,67,0,34,6,101,6,40,67,107,Non-Response,0.00212388396644847,0,0,0.465632713408221,mechanism,107,67,40,combination,0.0498468945116323,0.626887252142477,Taxane
